CA2683641A1 - Methodes de traitement du cancer a l'aide d'inhibiteurs de pi3k alpha a base de pyridopyrimidinone - Google Patents
Methodes de traitement du cancer a l'aide d'inhibiteurs de pi3k alpha a base de pyridopyrimidinoneInfo
- Publication number
- CA2683641A1 CA2683641A1 CA002683641A CA2683641A CA2683641A1 CA 2683641 A1 CA2683641 A1 CA 2683641A1 CA 002683641 A CA002683641 A CA 002683641A CA 2683641 A CA2683641 A CA 2683641A CA 2683641 A1 CA2683641 A1 CA 2683641A1
- Authority
- CA
- Canada
- Prior art keywords
- pyrazolo
- methyl
- piperazin
- oxy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 394
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 146
- 201000011510 cancer Diseases 0.000 title claims abstract description 143
- 239000003112 inhibitor Substances 0.000 title claims description 44
- IAAQUOVTPAMQCR-UHFFFAOYSA-N 1h-pyrido[3,2-d]pyrimidin-2-one Chemical compound C1=CC=C2NC(=O)N=CC2=N1 IAAQUOVTPAMQCR-UHFFFAOYSA-N 0.000 title description 2
- 238000011282 treatment Methods 0.000 claims abstract description 377
- 150000001875 compounds Chemical class 0.000 claims abstract description 347
- 150000003839 salts Chemical class 0.000 claims abstract description 65
- 239000012453 solvate Substances 0.000 claims abstract description 49
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 531
- -1 cyano, amino Chemical group 0.000 claims description 442
- DRYRBWIFRVMRPV-UHFFFAOYSA-N quinazolin-4-amine Chemical compound C1=CC=C2C(N)=NC=NC2=C1 DRYRBWIFRVMRPV-UHFFFAOYSA-N 0.000 claims description 255
- 239000002246 antineoplastic agent Substances 0.000 claims description 247
- 229940127089 cytotoxic agent Drugs 0.000 claims description 246
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 128
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 96
- 125000000217 alkyl group Chemical group 0.000 claims description 79
- 229910052739 hydrogen Inorganic materials 0.000 claims description 54
- 239000001257 hydrogen Substances 0.000 claims description 51
- 229910052757 nitrogen Inorganic materials 0.000 claims description 48
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 41
- 125000001072 heteroaryl group Chemical group 0.000 claims description 37
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 36
- 125000005843 halogen group Chemical group 0.000 claims description 35
- 125000003118 aryl group Chemical group 0.000 claims description 34
- 230000005855 radiation Effects 0.000 claims description 33
- 238000001794 hormone therapy Methods 0.000 claims description 31
- 238000001356 surgical procedure Methods 0.000 claims description 31
- 125000003545 alkoxy group Chemical group 0.000 claims description 28
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 28
- 229960002930 sirolimus Drugs 0.000 claims description 28
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 27
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 claims description 26
- 229930012538 Paclitaxel Natural products 0.000 claims description 25
- 229960004562 carboplatin Drugs 0.000 claims description 25
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 25
- 229960001592 paclitaxel Drugs 0.000 claims description 25
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 24
- AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 claims description 23
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 23
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 23
- 206010006187 Breast cancer Diseases 0.000 claims description 21
- 208000026310 Breast neoplasm Diseases 0.000 claims description 21
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 21
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 20
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 18
- BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 claims description 18
- 125000003107 substituted aryl group Chemical group 0.000 claims description 18
- 239000002136 L01XE07 - Lapatinib Substances 0.000 claims description 17
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 17
- 125000003282 alkyl amino group Chemical group 0.000 claims description 17
- 239000005551 L01XE03 - Erlotinib Substances 0.000 claims description 16
- 229940123237 Taxane Drugs 0.000 claims description 15
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 15
- 229940121647 egfr inhibitor Drugs 0.000 claims description 15
- 125000001188 haloalkyl group Chemical group 0.000 claims description 15
- 238000009169 immunotherapy Methods 0.000 claims description 15
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
- 125000002252 acyl group Chemical group 0.000 claims description 14
- 229960001433 erlotinib Drugs 0.000 claims description 14
- 208000005017 glioblastoma Diseases 0.000 claims description 13
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims description 13
- 229960004891 lapatinib Drugs 0.000 claims description 13
- 206010060862 Prostate cancer Diseases 0.000 claims description 12
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 12
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims description 11
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims description 11
- 206010033128 Ovarian cancer Diseases 0.000 claims description 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 11
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 11
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims description 10
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 10
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 10
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 10
- 229960000397 bevacizumab Drugs 0.000 claims description 10
- 229960003668 docetaxel Drugs 0.000 claims description 10
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 9
- 201000001441 melanoma Diseases 0.000 claims description 9
- 229960000575 trastuzumab Drugs 0.000 claims description 9
- 206010009944 Colon cancer Diseases 0.000 claims description 8
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 8
- 229940100198 alkylating agent Drugs 0.000 claims description 8
- 239000002168 alkylating agent Substances 0.000 claims description 8
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims description 8
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims description 8
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 8
- 229940036571 iodine therapy Drugs 0.000 claims description 8
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims description 8
- 230000002285 radioactive effect Effects 0.000 claims description 8
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims description 7
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 7
- 206010014733 Endometrial cancer Diseases 0.000 claims description 7
- 206010014759 Endometrial neoplasm Diseases 0.000 claims description 7
- 208000015634 Rectal Neoplasms Diseases 0.000 claims description 7
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 7
- 201000010881 cervical cancer Diseases 0.000 claims description 7
- 229960005395 cetuximab Drugs 0.000 claims description 7
- 208000029742 colonic neoplasm Diseases 0.000 claims description 7
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 7
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 7
- 125000005842 heteroatom Chemical group 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 7
- 229960001972 panitumumab Drugs 0.000 claims description 7
- 206010038038 rectal cancer Diseases 0.000 claims description 7
- 201000001275 rectum cancer Diseases 0.000 claims description 7
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 7
- 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 claims description 6
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 6
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 5
- 206010041067 Small cell lung cancer Diseases 0.000 claims description 5
- 125000004104 aryloxy group Chemical group 0.000 claims description 5
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 5
- 201000002528 pancreatic cancer Diseases 0.000 claims description 5
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 5
- 208000000587 small cell lung carcinoma Diseases 0.000 claims description 5
- 206010051066 Gastrointestinal stromal tumour Diseases 0.000 claims description 4
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 4
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims description 4
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 208000033781 Thyroid carcinoma Diseases 0.000 claims description 3
- 208000024770 Thyroid neoplasm Diseases 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 201000001514 prostate carcinoma Diseases 0.000 claims description 3
- 201000002510 thyroid cancer Diseases 0.000 claims description 3
- 208000013077 thyroid gland carcinoma Diseases 0.000 claims description 3
- HVXKQKFEHMGHSL-GOOCMWNKSA-N 7-[[(3as,6ar)-2-methyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-5-yl]methoxy]-n-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3C[C@@H]4CN(C)C[C@@H]4C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1F HVXKQKFEHMGHSL-GOOCMWNKSA-N 0.000 claims description 2
- NPSLABWCQNFJHJ-GOOCMWNKSA-N 7-[[(3as,6ar)-2-methyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-5-yl]methoxy]-n-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3C[C@@H]4CN(C)C[C@@H]4C3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1F NPSLABWCQNFJHJ-GOOCMWNKSA-N 0.000 claims description 2
- 150000002367 halogens Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000004953 trihalomethyl group Chemical group 0.000 claims description 2
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 1
- 229910052740 iodine Chemical group 0.000 description 157
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 60
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 32
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical compound NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 description 30
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 29
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 28
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 27
- 150000004985 diamines Chemical class 0.000 description 25
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 23
- 201000010099 disease Diseases 0.000 description 21
- 125000004549 quinolin-4-yl group Chemical group N1=CC=C(C2=CC=CC=C12)* 0.000 description 21
- WDHAAJIGSXNPFO-UHFFFAOYSA-N 8h-pyrido[2,3-d]pyrimidin-7-one Chemical compound N1=CN=C2NC(=O)C=CC2=C1 WDHAAJIGSXNPFO-UHFFFAOYSA-N 0.000 description 20
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 18
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 18
- 229960004316 cisplatin Drugs 0.000 description 18
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 18
- 125000004122 cyclic group Chemical group 0.000 description 17
- CMOJBVDQMMHOIC-UHFFFAOYSA-N 2-methyl-8h-pyrido[2,3-d]pyrimidin-7-one Chemical compound C1=CC(=O)NC2=NC(C)=NC=C21 CMOJBVDQMMHOIC-UHFFFAOYSA-N 0.000 description 16
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 16
- UHTHHESEBZOYNR-UHFFFAOYSA-N vandetanib Chemical compound COC1=CC(C(/N=CN2)=N/C=3C(=CC(Br)=CC=3)F)=C2C=C1OCC1CCN(C)CC1 UHTHHESEBZOYNR-UHFFFAOYSA-N 0.000 description 16
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 15
- 229960000241 vandetanib Drugs 0.000 description 15
- 229940039407 aniline Drugs 0.000 description 14
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 14
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 14
- 229960001756 oxaliplatin Drugs 0.000 description 14
- 125000004289 pyrazol-3-yl group Chemical group [H]N1N=C(*)C([H])=C1[H] 0.000 description 14
- 150000003254 radicals Chemical class 0.000 description 14
- 229920006395 saturated elastomer Polymers 0.000 description 13
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 description 12
- 239000005511 L01XE05 - Sorafenib Substances 0.000 description 12
- 108091000080 Phosphotransferase Proteins 0.000 description 12
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 12
- 125000004429 atom Chemical group 0.000 description 12
- FEHLGOYZDFFMND-UHFFFAOYSA-N cyclopropane-1,1-dicarboxamide Chemical compound NC(=O)C1(C(N)=O)CC1 FEHLGOYZDFFMND-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 150000004677 hydrates Chemical class 0.000 description 12
- 102000020233 phosphotransferase Human genes 0.000 description 12
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 12
- 229960003787 sorafenib Drugs 0.000 description 12
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 11
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 11
- YIKSCQDJHCMVMK-UHFFFAOYSA-N Oxamide Chemical compound NC(=O)C(N)=O YIKSCQDJHCMVMK-UHFFFAOYSA-N 0.000 description 11
- 239000003886 aromatase inhibitor Substances 0.000 description 11
- 229910052799 carbon Inorganic materials 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 11
- 229960002949 fluorouracil Drugs 0.000 description 11
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 11
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 description 11
- 125000004497 pyrazol-5-yl group Chemical group N1N=CC=C1* 0.000 description 11
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 10
- 229940122815 Aromatase inhibitor Drugs 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 239000005517 L01XE01 - Imatinib Substances 0.000 description 10
- 239000002147 L01XE04 - Sunitinib Substances 0.000 description 10
- 125000003302 alkenyloxy group Chemical group 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 229960004397 cyclophosphamide Drugs 0.000 description 10
- 125000001207 fluorophenyl group Chemical group 0.000 description 10
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- 125000005017 substituted alkenyl group Chemical group 0.000 description 10
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 9
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 9
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 9
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 9
- 125000004546 quinazolin-4-yl group Chemical group N1=CN=C(C2=CC=CC=C12)* 0.000 description 9
- 125000006413 ring segment Chemical group 0.000 description 9
- 229960002920 sorbitol Drugs 0.000 description 9
- 125000001544 thienyl group Chemical group 0.000 description 9
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 9
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 8
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 8
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 description 8
- 239000004215 Carbon black (E152) Substances 0.000 description 8
- 208000009956 adenocarcinoma Diseases 0.000 description 8
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 description 8
- 125000002619 bicyclic group Chemical group 0.000 description 8
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 8
- 229960004679 doxorubicin Drugs 0.000 description 8
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 8
- 229930195733 hydrocarbon Natural products 0.000 description 8
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 description 8
- 229960004296 megestrol acetate Drugs 0.000 description 8
- 229940002612 prodrug Drugs 0.000 description 8
- 239000000651 prodrug Substances 0.000 description 8
- WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 description 8
- 229960001796 sunitinib Drugs 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 229960001603 tamoxifen Drugs 0.000 description 8
- 229960004964 temozolomide Drugs 0.000 description 8
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 8
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 7
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 7
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 7
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 7
- 206010025323 Lymphomas Diseases 0.000 description 7
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 7
- 206010039491 Sarcoma Diseases 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 7
- 229910052794 bromium Inorganic materials 0.000 description 7
- 229950002826 canertinib Drugs 0.000 description 7
- OMZCMEYTWSXEPZ-UHFFFAOYSA-N canertinib Chemical compound C1=C(Cl)C(F)=CC=C1NC1=NC=NC2=CC(OCCCN3CCOCC3)=C(NC(=O)C=C)C=C12 OMZCMEYTWSXEPZ-UHFFFAOYSA-N 0.000 description 7
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 7
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 7
- 229960005277 gemcitabine Drugs 0.000 description 7
- 125000000336 imidazol-5-yl group Chemical group [H]N1C([H])=NC([H])=C1[*] 0.000 description 7
- 125000004498 isoxazol-4-yl group Chemical group O1N=CC(=C1)* 0.000 description 7
- 229940090004 megace Drugs 0.000 description 7
- WVUNYSQLFKLYNI-AATRIKPKSA-N pelitinib Chemical compound C=12C=C(NC(=O)\C=C\CN(C)C)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Cl)=C1 WVUNYSQLFKLYNI-AATRIKPKSA-N 0.000 description 7
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 description 7
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 7
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 7
- 229960002066 vinorelbine Drugs 0.000 description 7
- GBABOYUKABKIAF-IELIFDKJSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-IELIFDKJSA-N 0.000 description 7
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 6
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 6
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 6
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 6
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 6
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 6
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- 108700012941 GNRH1 Proteins 0.000 description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 6
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 description 6
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 6
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 description 6
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 6
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 125000001309 chloro group Chemical group Cl* 0.000 description 6
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 description 6
- 125000004472 dialkylaminosulfonyl group Chemical group 0.000 description 6
- 229960005420 etoposide Drugs 0.000 description 6
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 6
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 6
- 235000008191 folinic acid Nutrition 0.000 description 6
- 239000011672 folinic acid Substances 0.000 description 6
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 6
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 6
- 125000004499 isoxazol-5-yl group Chemical group O1N=CC=C1* 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 229960001691 leucovorin Drugs 0.000 description 6
- BMGQWWVMWDBQGC-IIFHNQTCSA-N midostaurin Chemical compound CN([C@H]1[C@H]([C@]2(C)O[C@@H](N3C4=CC=CC=C4C4=C5C(=O)NCC5=C5C6=CC=CC=C6N2C5=C43)C1)OC)C(=O)C1=CC=CC=C1 BMGQWWVMWDBQGC-IIFHNQTCSA-N 0.000 description 6
- 229950010895 midostaurin Drugs 0.000 description 6
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical group OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 6
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Chemical group OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 6
- 239000003197 protein kinase B inhibitor Substances 0.000 description 6
- 229960004889 salicylic acid Drugs 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- 210000004881 tumor cell Anatomy 0.000 description 6
- 229960003048 vinblastine Drugs 0.000 description 6
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 6
- 229960004528 vincristine Drugs 0.000 description 6
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 6
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 6
- 201000009030 Carcinoma Diseases 0.000 description 5
- 101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 description 5
- 101150088952 IGF1 gene Proteins 0.000 description 5
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 5
- 101100335081 Mus musculus Flt3 gene Proteins 0.000 description 5
- 102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 description 5
- 238000002679 ablation Methods 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 125000004442 acylamino group Chemical group 0.000 description 5
- 125000004423 acyloxy group Chemical group 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 5
- 125000002431 aminoalkoxy group Chemical group 0.000 description 5
- 229940120638 avastin Drugs 0.000 description 5
- 210000001072 colon Anatomy 0.000 description 5
- VEQSYQFANVTOGA-UHFFFAOYSA-N cyclobutane-1,1-dicarboxamide Chemical compound NC(=O)C1(C(N)=O)CCC1 VEQSYQFANVTOGA-UHFFFAOYSA-N 0.000 description 5
- 229960003297 gemtuzumab ozogamicin Drugs 0.000 description 5
- 229940080856 gleevec Drugs 0.000 description 5
- 239000003481 heat shock protein 90 inhibitor Substances 0.000 description 5
- 229960001101 ifosfamide Drugs 0.000 description 5
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 5
- 229960002411 imatinib Drugs 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 229960004768 irinotecan Drugs 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 5
- 229960000485 methotrexate Drugs 0.000 description 5
- 125000002950 monocyclic group Chemical group 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 5
- 238000002271 resection Methods 0.000 description 5
- 229960004641 rituximab Drugs 0.000 description 5
- 206010041823 squamous cell carcinoma Diseases 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 description 5
- 229960000303 topotecan Drugs 0.000 description 5
- FDKXTQMXEQVLRF-ZHACJKMWSA-N (E)-dacarbazine Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 description 4
- 125000001724 1,2,3-oxadiazol-4-yl group Chemical group [H]C1=C(*)N=NO1 0.000 description 4
- 125000004503 1,2,3-oxadiazol-5-yl group Chemical group O1N=NC=C1* 0.000 description 4
- 125000001766 1,2,4-oxadiazol-3-yl group Chemical group [H]C1=NC(*)=NO1 0.000 description 4
- 125000004505 1,2,4-oxadiazol-5-yl group Chemical group O1N=CN=C1* 0.000 description 4
- 125000004509 1,3,4-oxadiazol-2-yl group Chemical group O1C(=NN=C1)* 0.000 description 4
- YABJJWZLRMPFSI-UHFFFAOYSA-N 1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-2-benzimidazolamine Chemical compound N=1C2=CC(OC=3C=C(N=CC=3)C=3NC(=CN=3)C(F)(F)F)=CC=C2N(C)C=1NC1=CC=C(C(F)(F)F)C=C1 YABJJWZLRMPFSI-UHFFFAOYSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 4
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 4
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 4
- OONFNUWBHFSNBT-HXUWFJFHSA-N AEE788 Chemical compound C1CN(CC)CCN1CC1=CC=C(C=2NC3=NC=NC(N[C@H](C)C=4C=CC=CC=4)=C3C=2)C=C1 OONFNUWBHFSNBT-HXUWFJFHSA-N 0.000 description 4
- 229940126638 Akt inhibitor Drugs 0.000 description 4
- ZBNZXTGUTAYRHI-UHFFFAOYSA-N Dasatinib Chemical compound C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl ZBNZXTGUTAYRHI-UHFFFAOYSA-N 0.000 description 4
- 206010024612 Lipoma Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 4
- 108700020796 Oncogene Proteins 0.000 description 4
- 108091008611 Protein Kinase B Proteins 0.000 description 4
- 229940124674 VEGF-R inhibitor Drugs 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229960000548 alemtuzumab Drugs 0.000 description 4
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 4
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 description 4
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 4
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- 229960002932 anastrozole Drugs 0.000 description 4
- 229940078010 arimidex Drugs 0.000 description 4
- 229940087620 aromasin Drugs 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 125000004966 cyanoalkyl group Chemical group 0.000 description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 4
- 125000004212 difluorophenyl group Chemical group 0.000 description 4
- 229940082789 erbitux Drugs 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 229960000255 exemestane Drugs 0.000 description 4
- 229940087476 femara Drugs 0.000 description 4
- 125000001153 fluoro group Chemical group F* 0.000 description 4
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 4
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 4
- 125000001841 imino group Chemical group [H]N=* 0.000 description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 4
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 description 4
- 229960003881 letrozole Drugs 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- ZDZOTLJHXYCWBA-BSEPLHNVSA-N molport-006-823-826 Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-BSEPLHNVSA-N 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 229950008835 neratinib Drugs 0.000 description 4
- JWNPDZNEKVCWMY-VQHVLOKHSA-N neratinib Chemical compound C=12C=C(NC(=O)\C=C\CN(C)C)C(OCC)=CC2=NC=C(C#N)C=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 JWNPDZNEKVCWMY-VQHVLOKHSA-N 0.000 description 4
- HHZIURLSWUIHRB-UHFFFAOYSA-N nilotinib Chemical compound C1=NC(C)=CN1C1=CC(NC(=O)C=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 HHZIURLSWUIHRB-UHFFFAOYSA-N 0.000 description 4
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 description 4
- 125000003145 oxazol-4-yl group Chemical group O1C=NC(=C1)* 0.000 description 4
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 230000011664 signaling Effects 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 4
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 4
- WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 4
- 229960005267 tositumomab Drugs 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- 230000004614 tumor growth Effects 0.000 description 4
- 229940094060 tykerb Drugs 0.000 description 4
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 3
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 3
- KUFRQPKVAWMTJO-QSTRRNJOSA-N 17-dmag Chemical compound N1C(=O)\C(C)=C/C=C\[C@@H](OC)[C@H](OC(N)=O)\C(C)=C/[C@@H](C)[C@@H](O)[C@H](OC)C[C@@H](C)CC2=C(NCCN(C)C)C(=O)C=C1C2=O KUFRQPKVAWMTJO-QSTRRNJOSA-N 0.000 description 3
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 3
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 3
- RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 3
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 3
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical group C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 3
- ANTISGAVDLDNTA-UHFFFAOYSA-N 2-methoxyquinazolin-4-amine Chemical compound C1=CC=CC2=NC(OC)=NC(N)=C21 ANTISGAVDLDNTA-UHFFFAOYSA-N 0.000 description 3
- JBIHMFNMKHDTEE-UHFFFAOYSA-N 3,4,6,7,8,8a-hexahydro-2h-pyrrolo[1,2-a]pyrazin-1-one Chemical compound O=C1NCCN2CCCC12 JBIHMFNMKHDTEE-UHFFFAOYSA-N 0.000 description 3
- XLZYKTYMLBOINK-UHFFFAOYSA-N 3-(4-hydroxybenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)C=2C=CC(O)=CC=2)=C1 XLZYKTYMLBOINK-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 3
- XXJWYDDUDKYVKI-UHFFFAOYSA-N 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline Chemical compound COC1=CC2=C(OC=3C(=C4C=C(C)NC4=CC=3)F)N=CN=C2C=C1OCCCN1CCCC1 XXJWYDDUDKYVKI-UHFFFAOYSA-N 0.000 description 3
- RJWBTWIBUIGANW-UHFFFAOYSA-N 4-chlorobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-N 0.000 description 3
- PHOLLAGTGGRDBH-UHFFFAOYSA-N 4-methyl-8h-pyrido[2,3-d]pyrimidin-7-one Chemical compound N1C(=O)C=CC2=C1N=CN=C2C PHOLLAGTGGRDBH-UHFFFAOYSA-N 0.000 description 3
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 3
- NIFBNIANYCOETB-UHFFFAOYSA-N 8-methyl-n-(2-phenylethyl)-8-azabicyclo[3.2.1]octan-3-amine Chemical compound CN1C(C2)CCC1CC2NCCC1=CC=CC=C1 NIFBNIANYCOETB-UHFFFAOYSA-N 0.000 description 3
- 208000001446 Anaplastic Thyroid Carcinoma Diseases 0.000 description 3
- 206010002240 Anaplastic thyroid cancer Diseases 0.000 description 3
- QULDDKSCVCJTPV-UHFFFAOYSA-N BIIB021 Chemical compound COC1=C(C)C=NC(CN2C3=NC(N)=NC(Cl)=C3N=C2)=C1C QULDDKSCVCJTPV-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 3
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Chemical group OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 201000008808 Fibrosarcoma Diseases 0.000 description 3
- VWUXBMIQPBEWFH-WCCTWKNTSA-N Fulvestrant Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC2=C1 VWUXBMIQPBEWFH-WCCTWKNTSA-N 0.000 description 3
- 101710113436 GTPase KRas Proteins 0.000 description 3
- JRZJKWGQFNTSRN-UHFFFAOYSA-N Geldanamycin Natural products C1C(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)CCC=C(C)C(=O)NC2=CC(=O)C(OC)=C1C2=O JRZJKWGQFNTSRN-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Chemical group OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 3
- 108010069236 Goserelin Proteins 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 239000002067 L01XE06 - Dasatinib Substances 0.000 description 3
- UIARLYUEJFELEN-LROUJFHJSA-N LSM-1231 Chemical compound C12=C3N4C5=CC=CC=C5C3=C3C(=O)NCC3=C2C2=CC=CC=C2N1[C@]1(C)[C@](CO)(O)C[C@H]4O1 UIARLYUEJFELEN-LROUJFHJSA-N 0.000 description 3
- 108010000817 Leuprolide Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Chemical group OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 3
- 150000001204 N-oxides Chemical class 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- 108091007960 PI3Ks Proteins 0.000 description 3
- 102000014160 PTEN Phosphohydrolase Human genes 0.000 description 3
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 3
- 206010033701 Papillary thyroid cancer Diseases 0.000 description 3
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 206010043276 Teratoma Diseases 0.000 description 3
- IWEQQRMGNVVKQW-OQKDUQJOSA-N Toremifene citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 IWEQQRMGNVVKQW-OQKDUQJOSA-N 0.000 description 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 125000005083 alkoxyalkoxy group Chemical group 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 150000001408 amides Chemical group 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 230000000573 anti-seizure effect Effects 0.000 description 3
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 3
- 229940092714 benzenesulfonic acid Drugs 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 3
- 230000036983 biotransformation Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- 229960004117 capecitabine Drugs 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 229960005243 carmustine Drugs 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 229960002412 cediranib Drugs 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 125000000068 chlorophenyl group Chemical group 0.000 description 3
- 235000013985 cinnamic acid Nutrition 0.000 description 3
- 229930016911 cinnamic acid Natural products 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 238000002681 cryosurgery Methods 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 229960000684 cytarabine Drugs 0.000 description 3
- 229960003901 dacarbazine Drugs 0.000 description 3
- 229960002448 dasatinib Drugs 0.000 description 3
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 3
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical group CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 3
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 229940043168 fareston Drugs 0.000 description 3
- 206010016629 fibroma Diseases 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 235000011087 fumaric acid Nutrition 0.000 description 3
- 125000002541 furyl group Chemical group 0.000 description 3
- QTQAWLPCGQOSGP-GBTDJJJQSA-N geldanamycin Chemical compound N1C(=O)\C(C)=C/C=C\[C@@H](OC)[C@H](OC(N)=O)\C(C)=C/[C@@H](C)[C@@H](O)[C@H](OC)C[C@@H](C)CC2=C(OC)C(=O)C=C1C2=O QTQAWLPCGQOSGP-GBTDJJJQSA-N 0.000 description 3
- 229960000578 gemtuzumab Drugs 0.000 description 3
- 239000000174 gluconic acid Chemical group 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Chemical group 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 229960002913 goserelin Drugs 0.000 description 3
- 201000011066 hemangioma Diseases 0.000 description 3
- 229940022353 herceptin Drugs 0.000 description 3
- 229960001001 ibritumomab tiuxetan Drugs 0.000 description 3
- 125000002883 imidazolyl group Chemical group 0.000 description 3
- 238000000099 in vitro assay Methods 0.000 description 3
- 229940079322 interferon Drugs 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 3
- 229960004338 leuprorelin Drugs 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 229960002510 mandelic acid Drugs 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 3
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 230000002611 ovarian Effects 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 3
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 125000003373 pyrazinyl group Chemical group 0.000 description 3
- 125000003226 pyrazolyl group Chemical group 0.000 description 3
- 125000002098 pyridazinyl group Chemical group 0.000 description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 description 3
- 125000000168 pyrrolyl group Chemical group 0.000 description 3
- 229940107700 pyruvic acid Drugs 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 229960004622 raloxifene Drugs 0.000 description 3
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 3
- 239000008117 stearic acid Chemical group 0.000 description 3
- 238000011476 stem cell transplantation Methods 0.000 description 3
- 229960001052 streptozocin Drugs 0.000 description 3
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- AYUNIORJHRXIBJ-TXHRRWQRSA-N tanespimycin Chemical compound N1C(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)CC2=C(NCC=C)C(=O)C=C1C2=O AYUNIORJHRXIBJ-TXHRRWQRSA-N 0.000 description 3
- 229950007866 tanespimycin Drugs 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 3
- 125000000335 thiazolyl group Chemical group 0.000 description 3
- 208000030045 thyroid gland papillary carcinoma Diseases 0.000 description 3
- 208000019179 thyroid gland undifferentiated (anaplastic) carcinoma Diseases 0.000 description 3
- XFCLJVABOIYOMF-QPLCGJKRSA-N toremifene Chemical compound C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 XFCLJVABOIYOMF-QPLCGJKRSA-N 0.000 description 3
- 229960005026 toremifene Drugs 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- SVNJBEMPMKWDCO-KCHLEUMXSA-N (2s)-2-[[(2s)-3-carboxy-2-[[2-[[(2s)-5-(diaminomethylideneamino)-2-[[4-oxo-4-[[4-(4-oxo-8-phenylchromen-2-yl)morpholin-4-ium-4-yl]methoxy]butanoyl]amino]pentanoyl]amino]acetyl]amino]propanoyl]amino]-3-hydroxypropanoate Chemical compound C=1C(=O)C2=CC=CC(C=3C=CC=CC=3)=C2OC=1[N+]1(COC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C([O-])=O)CCOCC1 SVNJBEMPMKWDCO-KCHLEUMXSA-N 0.000 description 2
- SWDZPNJZKUGIIH-QQTULTPQSA-N (5z)-n-ethyl-5-(4-hydroxy-6-oxo-3-propan-2-ylcyclohexa-2,4-dien-1-ylidene)-4-[4-(morpholin-4-ylmethyl)phenyl]-2h-1,2-oxazole-3-carboxamide Chemical compound O1NC(C(=O)NCC)=C(C=2C=CC(CN3CCOCC3)=CC=2)\C1=C1/C=C(C(C)C)C(O)=CC1=O SWDZPNJZKUGIIH-QQTULTPQSA-N 0.000 description 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 2
- LEDWWWTZELHRQW-SNAWJCMRSA-N (e)-3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-enoic acid Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(\C=C\C(O)=O)=NNC=3N=CN=2)CC1 LEDWWWTZELHRQW-SNAWJCMRSA-N 0.000 description 2
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 2
- JTTIOYHBNXDJOD-UHFFFAOYSA-N 2,4,6-triaminopyrimidine Chemical compound NC1=CC(N)=NC(N)=N1 JTTIOYHBNXDJOD-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- SYYMNUFXRFAELA-BTQNPOSSSA-N 4-[4-[[(1r)-1-phenylethyl]amino]-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenol;hydrobromide Chemical compound Br.N([C@H](C)C=1C=CC=CC=1)C(C=1C=2)=NC=NC=1NC=2C1=CC=C(O)C=C1 SYYMNUFXRFAELA-BTQNPOSSSA-N 0.000 description 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 2
- BUROJSBIWGDYCN-GAUTUEMISA-N AP 23573 Chemical compound C1C[C@@H](OP(C)(C)=O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 BUROJSBIWGDYCN-GAUTUEMISA-N 0.000 description 2
- 108010012934 Albumin-Bound Paclitaxel Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 201000003076 Angiosarcoma Diseases 0.000 description 2
- 101100297694 Arabidopsis thaliana PIP2-7 gene Proteins 0.000 description 2
- 229940124204 C-kit inhibitor Drugs 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 239000005461 Canertinib Substances 0.000 description 2
- 239000012623 DNA damaging agent Substances 0.000 description 2
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 2
- MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 description 2
- 208000032612 Glial tumor Diseases 0.000 description 2
- 206010018338 Glioma Diseases 0.000 description 2
- 208000001258 Hemangiosarcoma Diseases 0.000 description 2
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 2
- 101100079846 Homo sapiens NEU1 gene Proteins 0.000 description 2
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 2
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 2
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 2
- XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 2
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 239000005536 L01XE08 - Nilotinib Substances 0.000 description 2
- 239000003798 L01XE11 - Pazopanib Substances 0.000 description 2
- 208000018142 Leiomyosarcoma Diseases 0.000 description 2
- GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000034578 Multiple myelomas Diseases 0.000 description 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
- 229910003827 NRaRb Inorganic materials 0.000 description 2
- TUVCWJQQGGETHL-UHFFFAOYSA-N PI-103 Chemical compound OC1=CC=CC(C=2N=C3C4=CC=CN=C4OC3=C(N3CCOCC3)N=2)=C1 TUVCWJQQGGETHL-UHFFFAOYSA-N 0.000 description 2
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical group N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 2
- 101100456541 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MEC3 gene Proteins 0.000 description 2
- 101100483663 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) UFD1 gene Proteins 0.000 description 2
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 2
- 102100028760 Sialidase-1 Human genes 0.000 description 2
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 2
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 description 2
- 102100022596 Tyrosine-protein kinase ABL1 Human genes 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 2
- 208000008383 Wilms tumor Diseases 0.000 description 2
- ZUSWDTWYONAOPH-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]hydrazine;hydrochloride Chemical group [Cl-].[NH3+]NC1=CC=CC=C1C(F)(F)F ZUSWDTWYONAOPH-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 125000005090 alkenylcarbonyl group Chemical group 0.000 description 2
- 125000005193 alkenylcarbonyloxy group Chemical group 0.000 description 2
- 125000004450 alkenylene group Chemical group 0.000 description 2
- 125000005084 alkoxyalkylaminoalkyl group Chemical group 0.000 description 2
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 2
- 125000003418 alkyl amino alkoxy group Chemical group 0.000 description 2
- 125000000278 alkyl amino alkyl group Chemical group 0.000 description 2
- 125000004949 alkyl amino carbonyl amino group Chemical group 0.000 description 2
- 125000005195 alkyl amino carbonyloxy group Chemical group 0.000 description 2
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000009167 androgen deprivation therapy Methods 0.000 description 2
- 229940045799 anthracyclines and related substance Drugs 0.000 description 2
- 230000000340 anti-metabolite Effects 0.000 description 2
- 229940044684 anti-microtubule agent Drugs 0.000 description 2
- 229940100197 antimetabolite Drugs 0.000 description 2
- 239000002256 antimetabolite Substances 0.000 description 2
- 238000003782 apoptosis assay Methods 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 229960003005 axitinib Drugs 0.000 description 2
- RITAVMQDGBJQJZ-FMIVXFBMSA-N axitinib Chemical compound CNC(=O)C1=CC=CC=C1SC1=CC=C(C(\C=C\C=2N=CC=CC=2)=NN2)C2=C1 RITAVMQDGBJQJZ-FMIVXFBMSA-N 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- 208000002458 carcinoid tumor Diseases 0.000 description 2
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 2
- 229960004630 chlorambucil Drugs 0.000 description 2
- 239000000460 chlorine Chemical group 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 229960000975 daunorubicin Drugs 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 125000004984 dialkylaminoalkoxy group Chemical group 0.000 description 2
- 125000005202 dialkylaminocarbonyloxy group Chemical group 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- 239000003534 dna topoisomerase inhibitor Substances 0.000 description 2
- 229960000390 fludarabine Drugs 0.000 description 2
- GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 description 2
- 229960004421 formestane Drugs 0.000 description 2
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 208000010749 gastric carcinoma Diseases 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000005113 hydroxyalkoxy group Chemical group 0.000 description 2
- 229960003685 imatinib mesylate Drugs 0.000 description 2
- YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 description 2
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 229940043355 kinase inhibitor Drugs 0.000 description 2
- 201000010260 leiomyoma Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229960002247 lomustine Drugs 0.000 description 2
- 229950005069 luminespib Drugs 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 229950008001 matuzumab Drugs 0.000 description 2
- 229960004961 mechlorethamine Drugs 0.000 description 2
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 2
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 2
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 2
- 229960001924 melphalan Drugs 0.000 description 2
- 206010027191 meningioma Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 2
- WCUWHUUPGXCMMQ-UHFFFAOYSA-N morpholine-4-carboximidamide Chemical compound NC(=N)N1CCOCC1 WCUWHUUPGXCMMQ-UHFFFAOYSA-N 0.000 description 2
- ONDPWWDPQDCQNJ-UHFFFAOYSA-N n-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;phosphoric acid Chemical compound OP(O)(O)=O.OP(O)(O)=O.C=1C=C2C(C)(C)CNC2=CC=1NC(=O)C1=CC=CN=C1NCC1=CC=NC=C1 ONDPWWDPQDCQNJ-UHFFFAOYSA-N 0.000 description 2
- LBWFXVZLPYTWQI-IPOVEDGCSA-N n-[2-(diethylamino)ethyl]-5-[(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C LBWFXVZLPYTWQI-IPOVEDGCSA-N 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- 229940086322 navelbine Drugs 0.000 description 2
- 229960001346 nilotinib Drugs 0.000 description 2
- 229950010203 nimotuzumab Drugs 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 201000008968 osteosarcoma Diseases 0.000 description 2
- 125000001715 oxadiazolyl group Chemical group 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- CUIHSIWYWATEQL-UHFFFAOYSA-N pazopanib Chemical compound C1=CC2=C(C)N(C)N=C2C=C1N(C)C(N=1)=CC=NC=1NC1=CC=C(C)C(S(N)(=O)=O)=C1 CUIHSIWYWATEQL-UHFFFAOYSA-N 0.000 description 2
- 229960000639 pazopanib Drugs 0.000 description 2
- 229950006299 pelitinib Drugs 0.000 description 2
- QOFFJEBXNKRSPX-ZDUSSCGKSA-N pemetrexed Chemical compound C1=N[C]2NC(N)=NC(=O)C2=C1CCC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QOFFJEBXNKRSPX-ZDUSSCGKSA-N 0.000 description 2
- 229960005079 pemetrexed Drugs 0.000 description 2
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 2
- SZFPYBIJACMNJV-UHFFFAOYSA-N perifosine Chemical compound CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1 SZFPYBIJACMNJV-UHFFFAOYSA-N 0.000 description 2
- 229950010632 perifosine Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- RLZZZVKAURTHCP-UHFFFAOYSA-N phenanthrene-3,4-diol Chemical compound C1=CC=C2C3=C(O)C(O)=CC=C3C=CC2=C1 RLZZZVKAURTHCP-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Chemical group 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
- 229960004618 prednisone Drugs 0.000 description 2
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 2
- 229960000624 procarbazine Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000005522 programmed cell death Effects 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 2
- 125000004944 pyrazin-3-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 2
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 2
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 2
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 229940124617 receptor tyrosine kinase inhibitor Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052701 rubidium Inorganic materials 0.000 description 2
- 229950003647 semaxanib Drugs 0.000 description 2
- WUWDLXZGHZSWQZ-WQLSENKSSA-N semaxanib Chemical compound N1C(C)=CC(C)=C1\C=C/1C2=CC=CC=C2NC\1=O WUWDLXZGHZSWQZ-WQLSENKSSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 201000000498 stomach carcinoma Diseases 0.000 description 2
- 125000005415 substituted alkoxy group Chemical group 0.000 description 2
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 2
- 229940034785 sutent Drugs 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- UXXQOJXBIDBUAC-UHFFFAOYSA-N tandutinib Chemical compound COC1=CC2=C(N3CCN(CC3)C(=O)NC=3C=CC(OC(C)C)=CC=3)N=CN=C2C=C1OCCCN1CCCCC1 UXXQOJXBIDBUAC-UHFFFAOYSA-N 0.000 description 2
- 229940120982 tarceva Drugs 0.000 description 2
- 229960000235 temsirolimus Drugs 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
- 229960003087 tioguanine Drugs 0.000 description 2
- 229940044693 topoisomerase inhibitor Drugs 0.000 description 2
- 125000001425 triazolyl group Chemical group 0.000 description 2
- 229950000578 vatalanib Drugs 0.000 description 2
- YCOYDOIWSSHVCK-UHFFFAOYSA-N vatalanib Chemical compound C1=CC(Cl)=CC=C1NC(C1=CC=CC=C11)=NN=C1CC1=CC=NC=C1 YCOYDOIWSSHVCK-UHFFFAOYSA-N 0.000 description 2
- CILBMBUYJCWATM-PYGJLNRPSA-N vinorelbine ditartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC CILBMBUYJCWATM-PYGJLNRPSA-N 0.000 description 2
- HJONXIJNTCIJTH-UHFFFAOYSA-N (2-chloropyridin-3-yl)-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]methanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C=3C(=NC=CC=3)Cl)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HJONXIJNTCIJTH-UHFFFAOYSA-N 0.000 description 1
- SKUORLYLDDJDMD-VWLOTQADSA-N (2s)-1-benzyl-n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]pyrrolidine-2-carboxamide Chemical compound C([C@H]1C(=O)NC2=CC=C(C=C2)OC=2C=CN=C3C=C(C(=CC3=2)OC)OC)CCN1CC1=CC=CC=C1 SKUORLYLDDJDMD-VWLOTQADSA-N 0.000 description 1
- YAIQLSGJDFUANQ-QMMMGPOBSA-N (2s)-2-(benzylamino)propanamide Chemical compound NC(=O)[C@H](C)NCC1=CC=CC=C1 YAIQLSGJDFUANQ-QMMMGPOBSA-N 0.000 description 1
- YXTKHLHCVFUPPT-YYFJYKOTSA-N (2s)-2-[[4-[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;(1r,2r)-1,2-dimethanidylcyclohexane;5-fluoro-1h-pyrimidine-2,4-dione;oxalic acid;platinum(2+) Chemical compound [Pt+2].OC(=O)C(O)=O.[CH2-][C@@H]1CCCC[C@H]1[CH2-].FC1=CNC(=O)NC1=O.C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 YXTKHLHCVFUPPT-YYFJYKOTSA-N 0.000 description 1
- XDEHMKQLKPZERH-BYPYZUCNSA-N (2s)-2-amino-3-methylbutanamide Chemical compound CC(C)[C@H](N)C(N)=O XDEHMKQLKPZERH-BYPYZUCNSA-N 0.000 description 1
- MHFUWOIXNMZFIW-WNQIDUERSA-N (2s)-2-hydroxypropanoic acid;n-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide Chemical compound C[C@H](O)C(O)=O.C1CN(C)CCN1C1=CC(NC2=NNC(C)=C2)=NC(SC=2C=CC(NC(=O)C3CC3)=CC=2)=N1 MHFUWOIXNMZFIW-WNQIDUERSA-N 0.000 description 1
- SYLHDCKBBWIRTH-UHFFFAOYSA-N (4-butylphenyl)-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]methanone Chemical compound C1=CC(CCCC)=CC=C1C(=O)N1CC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)OCC1 SYLHDCKBBWIRTH-UHFFFAOYSA-N 0.000 description 1
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 1
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 description 1
- PGROYXXCSUBAOJ-UHFFFAOYSA-N (6-chloropyridin-3-yl)-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]methanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C=3C=NC(Cl)=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PGROYXXCSUBAOJ-UHFFFAOYSA-N 0.000 description 1
- KTADNURCUXHCJM-LBPRGKRZSA-N (6s)-6-[[4-(3,4-dichloro-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-dimethylpiperazin-2-one Chemical compound N1=CN=C2C=C(OC[C@H]3N(C(=O)CN(C)C3)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1F KTADNURCUXHCJM-LBPRGKRZSA-N 0.000 description 1
- ZPNSUJMOMIXELJ-NSHDSACASA-N (6s)-6-[[4-(3,4-dichloro-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-4-methylpiperazin-2-one Chemical compound N1=CN=C2C=C(OC[C@H]3NC(=O)CN(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1F ZPNSUJMOMIXELJ-NSHDSACASA-N 0.000 description 1
- ICKYQMYVKOGDAJ-LBPRGKRZSA-N (6s)-6-[[4-(4-bromo-3-chloro-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-dimethylpiperazin-2-one Chemical compound N1=CN=C2C=C(OC[C@H]3N(C(=O)CN(C)C3)C)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1F ICKYQMYVKOGDAJ-LBPRGKRZSA-N 0.000 description 1
- AAWZYZGJDOSLSU-NSHDSACASA-N (6s)-6-[[4-(4-bromo-3-chloro-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-4-methylpiperazin-2-one Chemical compound N1=CN=C2C=C(OC[C@H]3NC(=O)CN(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1F AAWZYZGJDOSLSU-NSHDSACASA-N 0.000 description 1
- MWWSFMDVAYGXBV-MYPASOLCSA-N (7r,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride Chemical compound Cl.O([C@@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-MYPASOLCSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- IJBZFRMMDXVGCU-SNAWJCMRSA-N (e)-3-[4-[4-[5-[2,3-difluoro-2-(fluoromethyl)propoxy]-2-methyl-3-(2-pyrrolidin-1-ylethylamino)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-enoic acid Chemical compound C1=C(OCC(F)(CF)CF)C=C(N2CCN(CC2)C=2C=3C(\C=C\C(O)=O)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 IJBZFRMMDXVGCU-SNAWJCMRSA-N 0.000 description 1
- FQPXLXBETNISGH-VOTSOKGWSA-N (e)-3-[4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-enoic acid Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(\C=C\C(O)=O)=NNC=3N=CN=2)C(C)=C1CCCN1CCCC1 FQPXLXBETNISGH-VOTSOKGWSA-N 0.000 description 1
- XLOVPKCQAPHUKK-UHFFFAOYSA-N 1,2,3,4,4a,5,8,8a-octahydronaphthalene Chemical compound C1C=CCC2CCCCC21 XLOVPKCQAPHUKK-UHFFFAOYSA-N 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- CPDVUYTVYREKJG-UHFFFAOYSA-N 1,3-benzodioxol-5-yl-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]methanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C=3C=C4OCOC4=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 CPDVUYTVYREKJG-UHFFFAOYSA-N 0.000 description 1
- ROKURXRPRCIPKT-UHFFFAOYSA-N 1-(3-chlorophenyl)-4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-n-(2-morpholin-4-ylethyl)piperazine-2-carboxamide Chemical compound C=12C(CC)=NNC2=NC=NC=1N(C1)CCN(C=2C=C(Cl)C=CC=2)C1C(=O)NCCN1CCOCC1 ROKURXRPRCIPKT-UHFFFAOYSA-N 0.000 description 1
- LFFNFWLFYKQSNU-UHFFFAOYSA-N 1-(3-chlorophenyl)-n-[2-(dimethylamino)ethyl]-4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazine-2-carboxamide Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1C(=O)NCCN(C)C)CCN1C1=CC=CC(Cl)=C1 LFFNFWLFYKQSNU-UHFFFAOYSA-N 0.000 description 1
- PWMWNFMRSKOCEY-UHFFFAOYSA-N 1-Phenyl-1,2-ethanediol Chemical compound OCC(O)C1=CC=CC=C1 PWMWNFMRSKOCEY-UHFFFAOYSA-N 0.000 description 1
- YYJBPBRJPNTFPS-UHFFFAOYSA-N 1-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-1-(4-chlorophenyl)-4-(dimethylamino)butan-1-ol Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(O)(CCCN(C)C)C1=CC=C(Cl)C=C1 YYJBPBRJPNTFPS-UHFFFAOYSA-N 0.000 description 1
- WCJPMEFJDSKAHZ-UHFFFAOYSA-N 1-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-1-(4-fluorophenyl)-n-methyl-n-(pyridin-2-ylmethyl)methanamine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(C=1C=CC(F)=CC=1)N(C)CC1=CC=CC=N1 WCJPMEFJDSKAHZ-UHFFFAOYSA-N 0.000 description 1
- VEUAGFBTUOWMGS-UHFFFAOYSA-N 1-[2-[2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylphenyl]phenoxy]ethyl]pyrrolidine-2,5-dione Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C1=CC=CC=C1OCCN1C(=O)CCC1=O VEUAGFBTUOWMGS-UHFFFAOYSA-N 0.000 description 1
- FEBOQCZDPJAXJB-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-oxazepan-4-yl]ethanone Chemical compound N1=CN=C2C=C(OCC3OCCCN(C3)C(C)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 FEBOQCZDPJAXJB-UHFFFAOYSA-N 0.000 description 1
- AENQVVCMBGUAQO-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]ethanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(C)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 AENQVVCMBGUAQO-UHFFFAOYSA-N 0.000 description 1
- IKBSEBRGSVFUHM-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]-4,4,4-trifluorobutan-1-one Chemical compound C1=C(C(=O)CCC(F)(F)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 IKBSEBRGSVFUHM-UHFFFAOYSA-N 0.000 description 1
- JEWJTXCLTYTKGJ-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]ethanone Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)C)=CC=1NCCN1CCCC1 JEWJTXCLTYTKGJ-UHFFFAOYSA-N 0.000 description 1
- DCNODYHFBSBLGN-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]pentan-1-one Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)CCCC)=CC=1NCCN1CCCC1 DCNODYHFBSBLGN-UHFFFAOYSA-N 0.000 description 1
- DEJZGAXRKVTAOI-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]propan-1-one Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)CC)=CC=1NCCN1CCCC1 DEJZGAXRKVTAOI-UHFFFAOYSA-N 0.000 description 1
- JPGSIPPBCGKIIU-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(2-pyrrolidin-1-ylethylamino)phenyl]butan-1-one Chemical compound C=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)CCC)=CC=1NCCN1CCCC1 JPGSIPPBCGKIIU-UHFFFAOYSA-N 0.000 description 1
- NWBMPJUVBNMTAZ-UHFFFAOYSA-N 1-[3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]pentan-1-one Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(CC)=NNC=3N=CN=2)=CC(C(=O)CCCC)=CC=1NCCN1CCCC1 NWBMPJUVBNMTAZ-UHFFFAOYSA-N 0.000 description 1
- YGRIEMSMFNEFKK-UHFFFAOYSA-N 1-[3-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-4-ethylpiperazin-1-yl]ethanone Chemical compound CCN1CCN(C(C)=O)CC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC YGRIEMSMFNEFKK-UHFFFAOYSA-N 0.000 description 1
- HPIIDXXXXRXUCH-UHFFFAOYSA-N 1-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]isoquinoline Chemical compound C1=CC=C2C(N3CCN(CC3)C=3N=CN=C4NN=C(C=34)CC)=NC=CC2=C1 HPIIDXXXXRXUCH-UHFFFAOYSA-N 0.000 description 1
- FGOBYJLJQMACOY-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-3-(2-phenylacetyl)imidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C1=O)CCN1C(=O)CC1=CC=CC=C1 FGOBYJLJQMACOY-UHFFFAOYSA-N 0.000 description 1
- CTMKMZYTPUDEDG-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]piperidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N1CCCCC1=O CTMKMZYTPUDEDG-UHFFFAOYSA-N 0.000 description 1
- MPSSICBWBJYDLF-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]pyrrolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N1CCCC1=O MPSSICBWBJYDLF-UHFFFAOYSA-N 0.000 description 1
- BWMAIJPCEMKYSE-UHFFFAOYSA-N 1-[4-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 BWMAIJPCEMKYSE-UHFFFAOYSA-N 0.000 description 1
- TZFORYKWKFKQQB-UHFFFAOYSA-N 1-[5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methoxyphenyl]-n,n-dimethylmethanamine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC(CN(C)C)=C1OC TZFORYKWKFKQQB-UHFFFAOYSA-N 0.000 description 1
- BIJCHRXRGHEMQV-UHFFFAOYSA-N 1-[[1-(3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methyl]-1-[2-(dimethylamino)ethyl]urea Chemical compound BrC1=NNC2=NC=NC(=C21)N2CCC(CC2)C(N(C(=O)N)CCN(C)C)C2=CC=C(C=C2)Cl BIJCHRXRGHEMQV-UHFFFAOYSA-N 0.000 description 1
- QYNFFYUKWKXYAZ-UHFFFAOYSA-N 1-benzyl-3-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]imidazolidin-2-one;1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]imidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N1CCNC1=O.C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C1=O)CCN1CC1=CC=CC=C1 QYNFFYUKWKXYAZ-UHFFFAOYSA-N 0.000 description 1
- PYCRBAYIHZFPMZ-UHFFFAOYSA-N 1-benzyl-3-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-n'-(4-fluorophenyl)azetidine-3,3-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C(C1)(C(N)=O)CN1CC1=CC=CC=C1 PYCRBAYIHZFPMZ-UHFFFAOYSA-N 0.000 description 1
- SNKDCTFPQUHAPR-UHFFFAOYSA-N 1-fluoropyrimidine-2,4-dione Chemical compound FN1C=CC(=O)NC1=O SNKDCTFPQUHAPR-UHFFFAOYSA-N 0.000 description 1
- HYVJXVJIRRULOF-UHFFFAOYSA-N 1-n'-(4-fluorophenyl)-1-n'-[4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxy-2-methylphenyl]cyclopropane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1OC(C=C1C)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 HYVJXVJIRRULOF-UHFFFAOYSA-N 0.000 description 1
- JKVKPIDJOYBNPM-UHFFFAOYSA-N 1-n'-(4-fluorophenyl)-1-n'-[4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]cyclopropane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1OC(C=C1)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 JKVKPIDJOYBNPM-UHFFFAOYSA-N 0.000 description 1
- WPIPKIAGFZSDSI-UHFFFAOYSA-N 1-n'-[3-fluoro-4-[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 WPIPKIAGFZSDSI-UHFFFAOYSA-N 0.000 description 1
- CPKPGNLKKANZNM-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxy-2-methylsulfanylquinolin-4-yl)oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC(SC)=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 CPKPGNLKKANZNM-UHFFFAOYSA-N 0.000 description 1
- HQVQFFLTAGZOPN-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 HQVQFFLTAGZOPN-UHFFFAOYSA-N 0.000 description 1
- NOSCGNWOQNYCFS-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3,5-trifluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1F)F)=C(F)C=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 NOSCGNWOQNYCFS-UHFFFAOYSA-N 0.000 description 1
- IEYGZGOCKSTJQZ-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-difluorophenyl]-1-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC(F)=C1NC(=O)C1(C(=O)NC=2C=CC(F)=CC=2)CC1 IEYGZGOCKSTJQZ-UHFFFAOYSA-N 0.000 description 1
- KMEFSPDLCSTMFN-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3,5-difluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=C(F)C=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 KMEFSPDLCSTMFN-UHFFFAOYSA-N 0.000 description 1
- FKZMHDRGYUCWJX-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 FKZMHDRGYUCWJX-UHFFFAOYSA-N 0.000 description 1
- NDHROUHEJNSAQB-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-2-methylphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC(C)=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 NDHROUHEJNSAQB-UHFFFAOYSA-N 0.000 description 1
- IOXIGWWVCMOUGW-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-n'-[2-(morpholin-4-ylmethyl)phenyl]cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C(=CC=CC=1)CN1CCOCC1)C(=O)C1(C(N)=O)CC1 IOXIGWWVCMOUGW-UHFFFAOYSA-N 0.000 description 1
- HOEYPVNEHIDTAP-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-n'-[2-(piperidin-1-ylmethyl)phenyl]cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C(=CC=CC=1)CN1CCCCC1)C(=O)C1(C(N)=O)CC1 HOEYPVNEHIDTAP-UHFFFAOYSA-N 0.000 description 1
- KBPSFNZVQAYUGT-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-n'-phenylcyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C=CC=CC=1)C(=O)C1(C(N)=O)CC1 KBPSFNZVQAYUGT-UHFFFAOYSA-N 0.000 description 1
- OLCZWPWSTBMVMG-UHFFFAOYSA-N 1-n'-[4-(7-chloroquinolin-4-yl)oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=1C=C(F)C=CC=1N(C=1C=C(F)C(OC=2C3=CC=C(Cl)C=C3N=CC=2)=CC=1)C(=O)C1(C(=O)N)CC1 OLCZWPWSTBMVMG-UHFFFAOYSA-N 0.000 description 1
- NDNPLKPDGDRJDL-UHFFFAOYSA-N 1-n'-[4-(7-chloroquinolin-4-yl)oxyphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=1C=C(F)C=CC=1N(C=1C=CC(OC=2C3=CC=C(Cl)C=C3N=CC=2)=CC=1)C(=O)C1(C(=O)N)CC1 NDNPLKPDGDRJDL-UHFFFAOYSA-N 0.000 description 1
- MULHNDJNEMHOQX-UHFFFAOYSA-N 1-n'-[4-[7-[2-(diethylamino)ethoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclobutane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OCCN(CC)CC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CCC1 MULHNDJNEMHOQX-UHFFFAOYSA-N 0.000 description 1
- GINNKDVFQLUMEX-UHFFFAOYSA-N 1-n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-1-n'-(2-phenylethyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C(=O)C1(CC1)C(N)=O)CCC1=CC=CC=C1 GINNKDVFQLUMEX-UHFFFAOYSA-N 0.000 description 1
- QZJQIUNVMJLQMT-UHFFFAOYSA-N 1-n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-1-n'-(4-fluorophenyl)cyclobutane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CCC1 QZJQIUNVMJLQMT-UHFFFAOYSA-N 0.000 description 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- UZURTQHPMXADGG-UHFFFAOYSA-N 2,3,3a,4,7,7a-hexahydro-1h-indene Chemical compound C1C=CCC2CCCC21 UZURTQHPMXADGG-UHFFFAOYSA-N 0.000 description 1
- PHXGAJLBHUUAKB-UHFFFAOYSA-N 2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound O1CCC2OCCC21 PHXGAJLBHUUAKB-UHFFFAOYSA-N 0.000 description 1
- AGBUHYGWJRLISC-UHFFFAOYSA-N 2,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-1-one Chemical compound C1CCCC2C(=O)NCCN21 AGBUHYGWJRLISC-UHFFFAOYSA-N 0.000 description 1
- 125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 1
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical group COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 description 1
- 125000003070 2-(2-chlorophenyl)ethyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- XNWJPKXDERVJBQ-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]ethanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)CC=3C=CC(Cl)=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 XNWJPKXDERVJBQ-UHFFFAOYSA-N 0.000 description 1
- ABBADGFSRBWENF-UHFFFAOYSA-N 2-[(3-bromo-5-tert-butyl-4-hydroxyphenyl)methylidene]propanedinitrile Chemical compound CC(C)(C)C1=CC(C=C(C#N)C#N)=CC(Br)=C1O ABBADGFSRBWENF-UHFFFAOYSA-N 0.000 description 1
- DKERJQDWDPTFNJ-NRFANRHFSA-N 2-[(r)-(4-chlorophenyl)-[1-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]methoxy]-n,n-dimethylethanamine Chemical compound C1([C@H](OCCN(C)C)C2CCN(CC2)C=2N=CN=C3NN=C(C=23)CC)=CC=C(Cl)C=C1 DKERJQDWDPTFNJ-NRFANRHFSA-N 0.000 description 1
- SXDXUUULDWGCHS-FQEVSTJZSA-N 2-[(r)-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methoxy]-n,n-diethylethanamine Chemical compound C1([C@@H](C2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)OCCN(CC)CC)=CC=C(Cl)C=C1 SXDXUUULDWGCHS-FQEVSTJZSA-N 0.000 description 1
- HITKNPGYVMWQBV-SFHVURJKSA-N 2-[(r)-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methoxy]-n,n-dimethylethanamine Chemical compound C1([C@@H](C2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)OCCN(C)C)=CC=C(Cl)C=C1 HITKNPGYVMWQBV-SFHVURJKSA-N 0.000 description 1
- VDNKDMALAXYLFZ-UHFFFAOYSA-N 2-[2-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]ethoxy]ethanol Chemical compound N1=CN=C2C=C(OCC3OCCN(CCOCCO)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 VDNKDMALAXYLFZ-UHFFFAOYSA-N 0.000 description 1
- HENKTRFJYRXSTF-UHFFFAOYSA-N 2-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-1-phenylethanone Chemical compound N1=CN=C2C=C(OCC3OCCN(CC(=O)C=4C=CC=CC=4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HENKTRFJYRXSTF-UHFFFAOYSA-N 0.000 description 1
- PYAFRFDCPSOBJI-UHFFFAOYSA-N 2-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]ethanol Chemical compound N1=CN=C2C=C(OCC3OCCN(CCO)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PYAFRFDCPSOBJI-UHFFFAOYSA-N 0.000 description 1
- ANPOOPNQKGKSJT-UHFFFAOYSA-N 2-[2-chloro-4-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-methylphenoxy]-n,n-dimethylethanamine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=C(OCCN(C)C)C=C1C ANPOOPNQKGKSJT-UHFFFAOYSA-N 0.000 description 1
- FBSCDUASAGWKMV-UHFFFAOYSA-N 2-[2-chloro-5-(trifluoromethyl)phenyl]-n-[6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-1,3-benzothiazol-2-yl]acetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2NC(=O)CC1=CC(C(F)(F)F)=CC=C1Cl FBSCDUASAGWKMV-UHFFFAOYSA-N 0.000 description 1
- YTWXXVFTSISDIU-UHFFFAOYSA-N 2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]phenoxy]-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 YTWXXVFTSISDIU-UHFFFAOYSA-N 0.000 description 1
- QACFEEHLDHOROZ-UHFFFAOYSA-N 2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]phenoxy]-n-cyclopropylacetamide Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C(C=1)=CC=CC=1OCC(=O)NC1CC1 QACFEEHLDHOROZ-UHFFFAOYSA-N 0.000 description 1
- SGXWCNICGLRKLH-UHFFFAOYSA-N 2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]phenoxy]-n-ethylacetamide Chemical compound CCNC(=O)COC1=CC=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 SGXWCNICGLRKLH-UHFFFAOYSA-N 0.000 description 1
- UGBZDDLNHZCSGD-UHFFFAOYSA-N 2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]pyrazin-2-yl]oxy-n,n-dimethylethanamine Chemical compound CN(C)CCOC1=NC=CN=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 UGBZDDLNHZCSGD-UHFFFAOYSA-N 0.000 description 1
- YDCPJETYANMVFW-UHFFFAOYSA-N 2-[3-[4-[1-tert-butyl-3-(trifluoromethyl)pyrazolo[3,4-d]pyrimidin-4-yl]piperazin-1-yl]-5-chloro-2-methylphenoxy]-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NN(C=3N=CN=2)C(C)(C)C)C(F)(F)F)=C1C YDCPJETYANMVFW-UHFFFAOYSA-N 0.000 description 1
- LQLOZXZBBRYWKZ-UHFFFAOYSA-N 2-[3-chloro-5-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]phenoxy]-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(CC)=NNC=3N=CN=2)=C1 LQLOZXZBBRYWKZ-UHFFFAOYSA-N 0.000 description 1
- MVXPRNNRMIKVJP-UHFFFAOYSA-N 2-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyanilino]-2-oxoacetic acid Chemical compound C1=CN=C2C=C(OCC3CCN(C)CC3)C(OC)=CC2=C1OC1=CC=C(NC(=O)C(O)=O)C=C1F MVXPRNNRMIKVJP-UHFFFAOYSA-N 0.000 description 1
- ZREYJYHNHLWXMG-UHFFFAOYSA-N 2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-3,5,6-trifluoro-n-(3-methylbutyl)pyridin-4-amine Chemical compound CC(C)CCNC1=C(F)C(F)=NC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1F ZREYJYHNHLWXMG-UHFFFAOYSA-N 0.000 description 1
- BYPWKEYKDJFHMZ-UHFFFAOYSA-N 2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n,n-diethylpyrimidin-4-amine Chemical compound CCN(CC)C1=CC=NC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=N1 BYPWKEYKDJFHMZ-UHFFFAOYSA-N 0.000 description 1
- NIRBINYWIWLAKJ-UHFFFAOYSA-N 2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n,n-dimethylacetamide Chemical compound C1CN(CC(=O)N(C)C)CCN1C1=NC=NC2=C1C(Br)=NN2 NIRBINYWIWLAKJ-UHFFFAOYSA-N 0.000 description 1
- FGJILWGYJYHNBB-UHFFFAOYSA-N 2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-pyridin-2-ylacetamide Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC(=O)NC1=CC=CC=N1 FGJILWGYJYHNBB-UHFFFAOYSA-N 0.000 description 1
- HXUGITZLWUIORI-UHFFFAOYSA-N 2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]benzonitrile Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC=C1C#N HXUGITZLWUIORI-UHFFFAOYSA-N 0.000 description 1
- DJMBORBQCHGPTO-UHFFFAOYSA-N 2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]pyridine-3-carbonitrile Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=NC=CC=C1C#N DJMBORBQCHGPTO-UHFFFAOYSA-N 0.000 description 1
- ACYZJWLNTOYYEJ-UHFFFAOYSA-N 2-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]pyridine-3-carboxamide Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=NC=CC=C1C(N)=O ACYZJWLNTOYYEJ-UHFFFAOYSA-N 0.000 description 1
- JJPWYGOOLUCARP-UHFFFAOYSA-N 2-[5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methoxyphenoxy]-n,n-dimethylethanamine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC(OCCN(C)C)=C1OC JJPWYGOOLUCARP-UHFFFAOYSA-N 0.000 description 1
- ZQWOIHWHSIPTIE-UHFFFAOYSA-N 2-[5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylphenoxy]-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(CC)=NNC=3N=CN=2)=C1C ZQWOIHWHSIPTIE-UHFFFAOYSA-N 0.000 description 1
- VEMYRWOPVSXONW-UHFFFAOYSA-N 2-[5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylphenoxy]-n,n-dimethylethanamine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC(OCCN(C)C)=C1C VEMYRWOPVSXONW-UHFFFAOYSA-N 0.000 description 1
- UFNIERATEHAXDW-UHFFFAOYSA-N 2-[[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-fluorophenyl)methoxy]-n,n-dimethylethanamine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(OCCN(C)C)C1=CC=C(F)C=C1 UFNIERATEHAXDW-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SIQBRKREBNRFFZ-UHFFFAOYSA-N 2-amino-6-(3-chlorophenyl)-8-ethyl-4-methylpyrido[2,3-d]pyrimidin-7-one Chemical compound O=C1N(CC)C2=NC(N)=NC(C)=C2C=C1C1=CC=CC(Cl)=C1 SIQBRKREBNRFFZ-UHFFFAOYSA-N 0.000 description 1
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- MVPBFQKBNPPHJD-UHFFFAOYSA-N 2-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-fluoro-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1Cl)=CC(F)=CC=1NCCN1CCCC1 MVPBFQKBNPPHJD-UHFFFAOYSA-N 0.000 description 1
- HRQVYTNMNDWJAQ-UHFFFAOYSA-N 2-chloro-4-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-methylphenol Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=C(O)C=C1C HRQVYTNMNDWJAQ-UHFFFAOYSA-N 0.000 description 1
- HWIIAAVGRHKSOJ-UHFFFAOYSA-N 2-chloro-6,7-dimethoxyquinazolin-4-amine Chemical compound ClC1=NC(N)=C2C=C(OC)C(OC)=CC2=N1 HWIIAAVGRHKSOJ-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 229940013085 2-diethylaminoethanol Drugs 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- GELMWIVBBPAMIO-UHFFFAOYSA-N 2-methylbutan-2-amine Chemical compound CCC(C)(C)N GELMWIVBBPAMIO-UHFFFAOYSA-N 0.000 description 1
- FJNLCHNQVJVCPY-UHFFFAOYSA-N 2-n-methoxy-2-n-methyl-4-n,6-n-dipropyl-1,3,5-triazine-2,4,6-triamine Chemical compound CCCNC1=NC(NCCC)=NC(N(C)OC)=N1 FJNLCHNQVJVCPY-UHFFFAOYSA-N 0.000 description 1
- 125000004638 2-oxopiperazinyl group Chemical group O=C1N(CCNC1)* 0.000 description 1
- 125000004637 2-oxopiperidinyl group Chemical group O=C1N(CCCC1)* 0.000 description 1
- DYPTZRBONBKVSC-UHFFFAOYSA-N 2-thiophen-2-yl-8H-pyrido[2,3-d]pyrimidin-7-one Chemical compound N1=C2NC(=O)C=CC2=CN=C1C1=CC=CS1 DYPTZRBONBKVSC-UHFFFAOYSA-N 0.000 description 1
- NDMPLJNOPCLANR-UHFFFAOYSA-N 3,4-dihydroxy-15-(4-hydroxy-18-methoxycarbonyl-5,18-seco-ibogamin-18-yl)-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 NDMPLJNOPCLANR-UHFFFAOYSA-N 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 1
- IHRWZYGUYZIWKE-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=C5OCOC5=CC=4)=NNC=3N=CN=2)CC1 IHRWZYGUYZIWKE-UHFFFAOYSA-N 0.000 description 1
- QHAZYBSNQRTYDK-UHFFFAOYSA-N 3-(3h-benzimidazol-5-yl)-2-benzyl-3-hydroxyisoindol-1-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3N=CNC3=CC=2)N1CC1=CC=CC=C1 QHAZYBSNQRTYDK-UHFFFAOYSA-N 0.000 description 1
- RCPMWFKCKLHIEK-UHFFFAOYSA-N 3-(azetidin-3-ylidenemethyl)-4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=C4CNC4)=NNC=3N=CN=2)CC1 RCPMWFKCKLHIEK-UHFFFAOYSA-N 0.000 description 1
- SMJDOACCIIQIIV-GOSISDBHSA-N 3-[(2r)-4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-2-(hydroxymethyl)piperazin-1-yl]-4-methyl-n-phenylbenzamide Chemical compound C1=C(N2[C@H](CN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)CO)C(C)=CC=C1C(=O)NC1=CC=CC=C1 SMJDOACCIIQIIV-GOSISDBHSA-N 0.000 description 1
- WLEVNSDEDNVUGR-INIZCTEOSA-N 3-[(2s)-4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-2-methylpiperazin-1-yl]-4-methyl-n-phenylbenzamide Chemical compound C([C@@H]1C)N(C=2C=3C(Br)=NNC=3N=CN=2)CCN1C(C(=CC=1)C)=CC=1C(=O)NC1=CC=CC=C1 WLEVNSDEDNVUGR-INIZCTEOSA-N 0.000 description 1
- HFSKPUQIDUCLHN-UHFFFAOYSA-N 3-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-3-oxopropanoic acid Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)CC(O)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HFSKPUQIDUCLHN-UHFFFAOYSA-N 0.000 description 1
- UIODCBCHOOHDBJ-UHFFFAOYSA-N 3-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]butan-2-one Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(C)C(C)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 UIODCBCHOOHDBJ-UHFFFAOYSA-N 0.000 description 1
- DLMKOVRFSWGSNZ-UHFFFAOYSA-N 3-[2-chloro-4-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-methylphenoxy]-n,n-dimethylpropan-1-amine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=C(OCCCN(C)C)C=C1C DLMKOVRFSWGSNZ-UHFFFAOYSA-N 0.000 description 1
- IKUFFDDVPUPTCG-UHFFFAOYSA-N 3-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-chloro-2-methylphenoxy]-n,n-diethylpropan-1-amine Chemical compound CCN(CC)CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C IKUFFDDVPUPTCG-UHFFFAOYSA-N 0.000 description 1
- SQMYBMIVKNUFRI-UHFFFAOYSA-N 3-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-chloro-2-methylphenyl]-n,n-diethylpropan-1-amine Chemical compound CCN(CC)CCCC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C SQMYBMIVKNUFRI-UHFFFAOYSA-N 0.000 description 1
- ASLBGEXQSXSLDI-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-2-oxopiperazin-1-yl]-4-methyl-n-phenylbenzamide Chemical compound C1=C(N2C(CN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=O)C(C)=CC=C1C(=O)NC1=CC=CC=C1 ASLBGEXQSXSLDI-UHFFFAOYSA-N 0.000 description 1
- XOOIIPHBBUZFOP-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-chloro-5-fluoro-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound ClC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(F)=CC=1NCCN1CCCC1 XOOIIPHBBUZFOP-UHFFFAOYSA-N 0.000 description 1
- AJWFNKDUKOFVSO-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(2-phenylethynyl)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(C#CC=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 AJWFNKDUKOFVSO-UHFFFAOYSA-N 0.000 description 1
- HGCQHRUBKWVKHA-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC1=NOC(C=2C=C(C(C)=C(NCCN3CCCC3)C=2)N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=N1 HGCQHRUBKWVKHA-UHFFFAOYSA-N 0.000 description 1
- WDWOGDISXRDAPH-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(3-methylbutoxy)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OCCC(C)C)=CC=1NCCN1CCCC1 WDWOGDISXRDAPH-UHFFFAOYSA-N 0.000 description 1
- BKZVKDVSFQWXCI-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(oxolan-2-ylmethoxy)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2OCCC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 BKZVKDVSFQWXCI-UHFFFAOYSA-N 0.000 description 1
- YWUIVMBLSSVYOU-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-methylsulfonyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(S(C)(=O)=O)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 YWUIVMBLSSVYOU-UHFFFAOYSA-N 0.000 description 1
- IHQZZYDEVZEHEN-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-phenyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(C=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 IHQZZYDEVZEHEN-UHFFFAOYSA-N 0.000 description 1
- CQAFUDZJKLZILE-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-propoxy-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OCCC)=CC=1NCCN1CCCC1 CQAFUDZJKLZILE-UHFFFAOYSA-N 0.000 description 1
- FQCOMPCVEBMBGQ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)-5-(1,3-thiazol-2-yl)aniline Chemical compound C1=C(C=2SC=CN=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 FQCOMPCVEBMBGQ-UHFFFAOYSA-N 0.000 description 1
- CXWRIIBHGFNKAV-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)-5-(2,2,2-trifluoroethoxy)aniline Chemical compound C1=C(OCC(F)(F)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 CXWRIIBHGFNKAV-UHFFFAOYSA-N 0.000 description 1
- FRSGTYFDKGJXNW-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)-5-(3,3,3-trifluoropropoxy)aniline Chemical compound C1=C(OCCC(F)(F)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 FRSGTYFDKGJXNW-UHFFFAOYSA-N 0.000 description 1
- OTROXNUGLUHDPM-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)-5-(4,4,4-trifluoro-1,1-dimethoxybutyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(CCC(F)(F)F)(OC)OC)=CC=1NCCN1CCCC1 OTROXNUGLUHDPM-UHFFFAOYSA-N 0.000 description 1
- DAGQTIZIUNGONJ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzoic acid Chemical compound C1=C(C(O)=O)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 DAGQTIZIUNGONJ-UHFFFAOYSA-N 0.000 description 1
- CSWJHPQUGVGBIV-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-n-phenyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound C1=C(C(=O)NC=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 CSWJHPQUGVGBIV-UHFFFAOYSA-N 0.000 description 1
- HJFUGUJMYAFXJJ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-n-phenylbenzamide Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C(=O)NC1=CC=CC=C1 HJFUGUJMYAFXJJ-UHFFFAOYSA-N 0.000 description 1
- UUQNWWDBXQLKPN-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-n-propan-2-yl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)NC(C)C)=CC=1NCCN1CCCC1 UUQNWWDBXQLKPN-UHFFFAOYSA-N 0.000 description 1
- QNWLCNHMFYUSEU-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-n-pyridin-3-yl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound C1=C(C(=O)NC=2C=NC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 QNWLCNHMFYUSEU-UHFFFAOYSA-N 0.000 description 1
- OSZJZLURIWBTMR-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 OSZJZLURIWBTMR-UHFFFAOYSA-N 0.000 description 1
- ZFGPLQJDDUAPLD-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(1,1-difluorobutyl)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(F)(F)CCC)=CC=1NCCN1CCCC1 ZFGPLQJDDUAPLD-UHFFFAOYSA-N 0.000 description 1
- DRFKNPFAXPCTQG-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(2,2-dimethylpropoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC(C)(C)C)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 DRFKNPFAXPCTQG-UHFFFAOYSA-N 0.000 description 1
- HROXMNKAOQUZSJ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(2-fluoro-2-methylpropoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC(C)(C)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 HROXMNKAOQUZSJ-UHFFFAOYSA-N 0.000 description 1
- FNHNYWBZBHUBPV-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(2-methoxyethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OCCOC)=CC=1NCCN1CCCC1 FNHNYWBZBHUBPV-UHFFFAOYSA-N 0.000 description 1
- YBPFAYRBOUOWEW-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(3,3-dimethylbut-1-ynyl)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(C#CC(C)(C)C)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 YBPFAYRBOUOWEW-UHFFFAOYSA-N 0.000 description 1
- BZWINHLDUBAFJC-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(3,3-dimethylbutyl)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(CCC(C)(C)C)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 BZWINHLDUBAFJC-UHFFFAOYSA-N 0.000 description 1
- MZMMBFATXSYGDE-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(cyclobutylmethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2CCC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 MZMMBFATXSYGDE-UHFFFAOYSA-N 0.000 description 1
- OFIYBNFGPNSUBZ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(cyclohexylmethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2CCCCC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 OFIYBNFGPNSUBZ-UHFFFAOYSA-N 0.000 description 1
- IYGKFXLAHMDZHD-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(cyclopentylmethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2CCCC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 IYGKFXLAHMDZHD-UHFFFAOYSA-N 0.000 description 1
- GMJSCDCMWJNAQQ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(cyclopropylmethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2CC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 GMJSCDCMWJNAQQ-UHFFFAOYSA-N 0.000 description 1
- GIBOSPRQHDUWQU-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(difluoromethoxymethyl)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(COC(F)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 GIBOSPRQHDUWQU-UHFFFAOYSA-N 0.000 description 1
- LDUJWILZFQEFOV-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-[2,3-difluoro-2-(fluoromethyl)propoxy]-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC(F)(CF)CF)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 LDUJWILZFQEFOV-UHFFFAOYSA-N 0.000 description 1
- QQHQZRLEXUVJBO-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-[2-(dimethylamino)ethylamino]-4-methyl-n-phenylbenzamide Chemical compound C=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C(C)C(NCCN(C)C)=CC=1C(=O)NC1=CC=CC=C1 QQHQZRLEXUVJBO-UHFFFAOYSA-N 0.000 description 1
- SUHQXAOVYOYYQL-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-[2-(dimethylamino)ethylamino]-4-methyl-n-propan-2-ylbenzamide Chemical compound CC(C)NC(=O)C1=CC(NCCN(C)C)=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 SUHQXAOVYOYYQL-UHFFFAOYSA-N 0.000 description 1
- NFYLJFNABIOBQQ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-butoxy-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OCCCC)=CC=1NCCN1CCCC1 NFYLJFNABIOBQQ-UHFFFAOYSA-N 0.000 description 1
- IFJNCEJQABLDMF-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-chloro-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(Cl)=CC=1NCCN1CCCC1 IFJNCEJQABLDMF-UHFFFAOYSA-N 0.000 description 1
- PYBBUIDGGUYWIF-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-ethyl-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(CC)=CC=1NCCN1CCCC1 PYBBUIDGGUYWIF-UHFFFAOYSA-N 0.000 description 1
- LYDIYXALBYBXDU-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-ethylsulfonyl-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(S(=O)(=O)CC)=CC=1NCCN1CCCC1 LYDIYXALBYBXDU-UHFFFAOYSA-N 0.000 description 1
- TZMWLSHRKGZJIJ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-fluoro-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 TZMWLSHRKGZJIJ-UHFFFAOYSA-N 0.000 description 1
- UQPLUMXNXTZQMI-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-methoxy-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OC)=CC=1NCCN1CCCC1 UQPLUMXNXTZQMI-UHFFFAOYSA-N 0.000 description 1
- WCYZKEXUAINNCJ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n,4-dimethyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)NC)=CC=1NCCN1CCCC1 WCYZKEXUAINNCJ-UHFFFAOYSA-N 0.000 description 1
- SUPTVDNUUOFKOU-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n,4-dimethylbenzamide Chemical compound CNC(=O)C1=CC=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 SUPTVDNUUOFKOU-UHFFFAOYSA-N 0.000 description 1
- XIQYNIPNCGZIBX-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n,n,4-trimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 XIQYNIPNCGZIBX-UHFFFAOYSA-N 0.000 description 1
- WKWKPUVHYAQHRB-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-(2-chlorophenyl)-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound C1=C(C(=O)NC=2C(=CC=CC=2)Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 WKWKPUVHYAQHRB-UHFFFAOYSA-N 0.000 description 1
- ZBDHUMHGEAVULE-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-(4-chlorophenyl)-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound C1=C(C(=O)NC=2C=CC(Cl)=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 ZBDHUMHGEAVULE-UHFFFAOYSA-N 0.000 description 1
- SIODQEWTENYBSI-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-[2-(dimethylamino)ethyl]-4-methylbenzamide Chemical compound CN(C)CCNC(=O)C1=CC=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 SIODQEWTENYBSI-UHFFFAOYSA-N 0.000 description 1
- DLSVCPCULIRHJL-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-ethyl-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)NCC)=CC=1NCCN1CCCC1 DLSVCPCULIRHJL-UHFFFAOYSA-N 0.000 description 1
- WAVPGOFELRXLDK-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-methoxy-n,4-dimethyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)N(C)OC)=CC=1NCCN1CCCC1 WAVPGOFELRXLDK-UHFFFAOYSA-N 0.000 description 1
- KFEZLXHRIQNJQO-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-tert-butyl-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound C1=C(C(=O)NC(C)(C)C)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 KFEZLXHRIQNJQO-UHFFFAOYSA-N 0.000 description 1
- ZYNKXHMLHGWMFA-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]pyrazine-2-carbonitrile Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=NC=CN=C1C#N ZYNKXHMLHGWMFA-UHFFFAOYSA-N 0.000 description 1
- LWZBMXSUTVCFDI-UHFFFAOYSA-N 3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(2-methylpropoxy)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(OCC(C)C)=CC=1NCCN1CCCC1 LWZBMXSUTVCFDI-UHFFFAOYSA-N 0.000 description 1
- VGZTWRCQVSHEPS-UHFFFAOYSA-N 3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-phenylmethoxy-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C(=C(NCCN1CCCC1)C=1)C)=CC=1OCC1=CC=CC=C1 VGZTWRCQVSHEPS-UHFFFAOYSA-N 0.000 description 1
- UBLLVZQZRNGUJQ-UHFFFAOYSA-N 3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-fluoro-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(F)=CC=1NCCN1CCCC1 UBLLVZQZRNGUJQ-UHFFFAOYSA-N 0.000 description 1
- SVAZQZBAUSXFFJ-UHFFFAOYSA-N 3-[4-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-6-chloro-5-methylpyrimidin-2-yl]oxy-n,n-diethylpropan-1-amine Chemical compound CCN(CC)CCCOC1=NC(Cl)=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=N1 SVAZQZBAUSXFFJ-UHFFFAOYSA-N 0.000 description 1
- ZRENRORAOHMBRV-UHFFFAOYSA-N 3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]-n,n-diethylprop-2-yn-1-amine Chemical compound C=12C(C#CCN(CC)CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C ZRENRORAOHMBRV-UHFFFAOYSA-N 0.000 description 1
- CDYHYTPKRKNVFO-UHFFFAOYSA-N 3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]-n,n-diethylpropan-1-amine Chemical compound C=12C(CCCN(CC)CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C CDYHYTPKRKNVFO-UHFFFAOYSA-N 0.000 description 1
- HBAHCSKBUFIZHI-UHFFFAOYSA-N 3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]aniline Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=C(N)C=CC=4)=NNC=3N=CN=2)CC1 HBAHCSKBUFIZHI-UHFFFAOYSA-N 0.000 description 1
- OSZPLABAQXTERJ-UHFFFAOYSA-N 3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]benzoic acid Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=C(C=CC=4)C(O)=O)=NNC=3N=CN=2)CC1 OSZPLABAQXTERJ-UHFFFAOYSA-N 0.000 description 1
- DUZXKKRUOUCQRH-UHFFFAOYSA-N 3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]phenol Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=C(O)C=CC=4)=NNC=3N=CN=2)CC1 DUZXKKRUOUCQRH-UHFFFAOYSA-N 0.000 description 1
- FVTGZBCGLSOVNH-UHFFFAOYSA-N 3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-yn-1-ol Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C#CCO)=NNC=3N=CN=2)CC1 FVTGZBCGLSOVNH-UHFFFAOYSA-N 0.000 description 1
- MMMKUWNVQFPSJD-UHFFFAOYSA-N 3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]propan-1-ol Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(CCCO)=NNC=3N=CN=2)CC1 MMMKUWNVQFPSJD-UHFFFAOYSA-N 0.000 description 1
- UGTLNWHSTJEXDT-UHFFFAOYSA-N 3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]propanoic acid Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(CCC(O)=O)=NNC=3N=CN=2)CC1 UGTLNWHSTJEXDT-UHFFFAOYSA-N 0.000 description 1
- FFEQLBRPPNNIIS-UHFFFAOYSA-N 3-[4-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]phenoxy]-n,n-dimethylpropan-1-amine Chemical compound C1=CC(OCCCN(C)C)=CC=C1C1=NNC2=NC=NC(N3CCN(CC3)C=3C(=CC=C(Cl)C=3)C)=C12 FFEQLBRPPNNIIS-UHFFFAOYSA-N 0.000 description 1
- RZCJHYLETSBGLY-UHFFFAOYSA-N 3-[5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylphenoxy]-n,n-diethylpropan-1-amine Chemical compound CCN(CC)CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(CC)=NNC=3N=CN=2)=C1C RZCJHYLETSBGLY-UHFFFAOYSA-N 0.000 description 1
- BPORTURMMAXOII-UHFFFAOYSA-N 3-[5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylphenyl]-n,n-dimethylprop-2-yn-1-amine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC(C#CCN(C)C)=C1C BPORTURMMAXOII-UHFFFAOYSA-N 0.000 description 1
- URKNKOFMKSTDIG-UHFFFAOYSA-N 3-[[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methoxy]-n,n-dimethylpropan-1-amine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(OCCCN(C)C)C1=CC=C(Cl)C=C1 URKNKOFMKSTDIG-UHFFFAOYSA-N 0.000 description 1
- ITZRTIPTIGXEDC-UHFFFAOYSA-N 3-benzyl-4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(CC=4C=CC=CC=4)=NNC=3N=CN=2)CC1 ITZRTIPTIGXEDC-UHFFFAOYSA-N 0.000 description 1
- MYZBUJRZUJOUNX-UHFFFAOYSA-N 3-benzyl-n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1,2,4-oxadiazol-5-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(ON=1)=NC=1CC1=CC=CC=C1 MYZBUJRZUJOUNX-UHFFFAOYSA-N 0.000 description 1
- SJZSTPJFVIJFGX-UHFFFAOYSA-N 3-bromo-4-(4-butan-2-ylpiperazin-1-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C(C)CC)CCN1C1=NC=NC2=C1C(Br)=NN2 SJZSTPJFVIJFGX-UHFFFAOYSA-N 0.000 description 1
- CMNVIOXBVGGMHC-UHFFFAOYSA-N 3-bromo-4-(4-phenylpiperazin-1-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC=C1 CMNVIOXBVGGMHC-UHFFFAOYSA-N 0.000 description 1
- BNTQQSCEOKZDMO-UHFFFAOYSA-N 3-bromo-4-(4-pyrazin-2-ylpiperazin-1-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CN=CC=N1 BNTQQSCEOKZDMO-UHFFFAOYSA-N 0.000 description 1
- QAZBUEIOUQSTLE-UHFFFAOYSA-N 3-bromo-4-(4-pyridin-2-ylpiperazin-1-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC=N1 QAZBUEIOUQSTLE-UHFFFAOYSA-N 0.000 description 1
- ZNZOVFHYHATGSO-UHFFFAOYSA-N 3-bromo-4-(4-pyrimidin-2-ylpiperazin-1-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=NC=CC=N1 ZNZOVFHYHATGSO-UHFFFAOYSA-N 0.000 description 1
- KHQIGQVSEDRIKJ-LLVKDONJSA-N 3-bromo-4-[(3r)-4-(5-chloro-2-methylphenyl)-3-methylpiperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C([C@H]1C)N(C=2C=3C(Br)=NNC=3N=CN=2)CCN1C1=CC(Cl)=CC=C1C KHQIGQVSEDRIKJ-LLVKDONJSA-N 0.000 description 1
- KHQIGQVSEDRIKJ-NSHDSACASA-N 3-bromo-4-[(3s)-4-(5-chloro-2-methylphenyl)-3-methylpiperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C([C@@H]1C)N(C=2C=3C(Br)=NNC=3N=CN=2)CCN1C1=CC(Cl)=CC=C1C KHQIGQVSEDRIKJ-NSHDSACASA-N 0.000 description 1
- AVFPOWPKUSYREA-NSHDSACASA-N 3-bromo-4-[(3s)-4-[(4-chlorophenyl)methyl]-3-methylpiperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C([C@@H]1C)N(C=2C=3C(Br)=NNC=3N=CN=2)CCN1CC1=CC=C(Cl)C=C1 AVFPOWPKUSYREA-NSHDSACASA-N 0.000 description 1
- HXDBVSLKASWNMX-UHFFFAOYSA-N 3-bromo-4-[3-methyl-4-(3-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCN1C1=CC=CC(C)=C1 HXDBVSLKASWNMX-UHFFFAOYSA-N 0.000 description 1
- FXIUWVNFYZNXCK-UHFFFAOYSA-N 3-bromo-4-[4-(1-phenylethyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCN1C(C)C1=CC=CC=C1 FXIUWVNFYZNXCK-UHFFFAOYSA-N 0.000 description 1
- FGCOCAPHCRJCOP-UHFFFAOYSA-N 3-bromo-4-[4-(1h-imidazol-2-ylmethyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC1=NC=CN1 FGCOCAPHCRJCOP-UHFFFAOYSA-N 0.000 description 1
- HVADNQGYIAOGEP-UHFFFAOYSA-N 3-bromo-4-[4-(2,3-dichlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1Cl HVADNQGYIAOGEP-UHFFFAOYSA-N 0.000 description 1
- RLQHIEAYRBMRRQ-UHFFFAOYSA-N 3-bromo-4-[4-(2,4-dichlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC(Cl)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 RLQHIEAYRBMRRQ-UHFFFAOYSA-N 0.000 description 1
- OTFFWCPPHHIFJB-UHFFFAOYSA-N 3-bromo-4-[4-(2,4-dimethoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC(OC)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 OTFFWCPPHHIFJB-UHFFFAOYSA-N 0.000 description 1
- GWRUURCRUCYCEF-UHFFFAOYSA-N 3-bromo-4-[4-(2,5-dichlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC=C(Cl)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 GWRUURCRUCYCEF-UHFFFAOYSA-N 0.000 description 1
- ZXVQZHJGOFVOMR-UHFFFAOYSA-N 3-bromo-4-[4-(2,5-difluorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound FC1=CC=C(F)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 ZXVQZHJGOFVOMR-UHFFFAOYSA-N 0.000 description 1
- QKVBHDNWWHXBKQ-UHFFFAOYSA-N 3-bromo-4-[4-(2,6-dimethylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=CC(C)=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 QKVBHDNWWHXBKQ-UHFFFAOYSA-N 0.000 description 1
- DWTODKDOZLKTNN-UHFFFAOYSA-N 3-bromo-4-[4-(2-ethylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CCC1=CC=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 DWTODKDOZLKTNN-UHFFFAOYSA-N 0.000 description 1
- CQXAPCMYRSTDGK-UHFFFAOYSA-N 3-bromo-4-[4-(2-methoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC=CC=C1N1CCN(C=2C3=C(Br)NN=C3N=CN=2)CC1 CQXAPCMYRSTDGK-UHFFFAOYSA-N 0.000 description 1
- QVHUJIKBEWFVFM-UHFFFAOYSA-N 3-bromo-4-[4-(2-thiophen-2-ylethyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CCC1=CC=CS1 QVHUJIKBEWFVFM-UHFFFAOYSA-N 0.000 description 1
- PZENQFNUARUTTQ-UHFFFAOYSA-N 3-bromo-4-[4-(3,4-dichlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 PZENQFNUARUTTQ-UHFFFAOYSA-N 0.000 description 1
- XOTIGRBKZQTNHN-UHFFFAOYSA-N 3-bromo-4-[4-(3,4-difluorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(F)C(F)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 XOTIGRBKZQTNHN-UHFFFAOYSA-N 0.000 description 1
- IGLANVDJAXSNRA-UHFFFAOYSA-N 3-bromo-4-[4-(3,4-dimethylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(C)C(C)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 IGLANVDJAXSNRA-UHFFFAOYSA-N 0.000 description 1
- VUOHNLSILKQOGZ-UHFFFAOYSA-N 3-bromo-4-[4-(3,5-dichlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 VUOHNLSILKQOGZ-UHFFFAOYSA-N 0.000 description 1
- NMMXPVBLDKUDAW-UHFFFAOYSA-N 3-bromo-4-[4-(3,5-dimethoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 NMMXPVBLDKUDAW-UHFFFAOYSA-N 0.000 description 1
- YKAMPLLTQDGYHQ-UHFFFAOYSA-N 3-bromo-4-[4-(3-chloro-4-fluorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C(F)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 YKAMPLLTQDGYHQ-UHFFFAOYSA-N 0.000 description 1
- NJUZQTKLBLLKNB-UHFFFAOYSA-N 3-bromo-4-[4-(3-chlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 NJUZQTKLBLLKNB-UHFFFAOYSA-N 0.000 description 1
- XKKYDENFHXAFLA-UHFFFAOYSA-N 3-bromo-4-[4-(3-methoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 XKKYDENFHXAFLA-UHFFFAOYSA-N 0.000 description 1
- AJETWHHIDCIIFF-UHFFFAOYSA-N 3-bromo-4-[4-(3-methoxypyrazin-2-yl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=NC=CN=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 AJETWHHIDCIIFF-UHFFFAOYSA-N 0.000 description 1
- DZRWGEXSVGWXND-UHFFFAOYSA-N 3-bromo-4-[4-(3-pyrrolidin-1-ylpropyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CCCN1CCCC1 DZRWGEXSVGWXND-UHFFFAOYSA-N 0.000 description 1
- GJFGRMNSKDWZCR-UHFFFAOYSA-N 3-bromo-4-[4-(4-bromophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=C(Br)C=C1 GJFGRMNSKDWZCR-UHFFFAOYSA-N 0.000 description 1
- JUTQDMDUNSWDQG-UHFFFAOYSA-N 3-bromo-4-[4-(4-chlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(Cl)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 JUTQDMDUNSWDQG-UHFFFAOYSA-N 0.000 description 1
- OARRIXBHAFQNGW-UHFFFAOYSA-N 3-bromo-4-[4-(4-ethoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(OCC)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 OARRIXBHAFQNGW-UHFFFAOYSA-N 0.000 description 1
- CONWTRAMVJTTNB-UHFFFAOYSA-N 3-bromo-4-[4-(4-fluorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(F)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 CONWTRAMVJTTNB-UHFFFAOYSA-N 0.000 description 1
- CMSOTWVWWGTOCD-UHFFFAOYSA-N 3-bromo-4-[4-(4-nitrophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 CMSOTWVWWGTOCD-UHFFFAOYSA-N 0.000 description 1
- MJTYOEDASCWGNL-UHFFFAOYSA-N 3-bromo-4-[4-(4-phenylmethoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C(C=C1)=CC=C1OCC1=CC=CC=C1 MJTYOEDASCWGNL-UHFFFAOYSA-N 0.000 description 1
- VXOGMIMOLDTFBZ-UHFFFAOYSA-N 3-bromo-4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 VXOGMIMOLDTFBZ-UHFFFAOYSA-N 0.000 description 1
- UHFJAAIQMNTTLB-UHFFFAOYSA-N 3-bromo-4-[4-(6,7,8,9-tetrahydro-5h-benzo[7]annulen-5-yl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CCCC2=CC=CC=C2C1N(CC1)CCN1C1=C2C(Br)=NNC2=NC=N1 UHFJAAIQMNTTLB-UHFFFAOYSA-N 0.000 description 1
- XLCNXEYUWASVJX-UHFFFAOYSA-N 3-bromo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC1=CC=CN=C1 XLCNXEYUWASVJX-UHFFFAOYSA-N 0.000 description 1
- RRBKPVSGXLWUHU-UHFFFAOYSA-N 3-bromo-4-[4-(pyridin-4-ylmethyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC1=CC=NC=C1 RRBKPVSGXLWUHU-UHFFFAOYSA-N 0.000 description 1
- SCYVHSCNZKLRPR-UHFFFAOYSA-N 3-bromo-4-[4-[(10-chloroanthracen-9-yl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C12=CC=CC=C2C(Cl)=C(C=CC=C2)C2=C1CN1CCN(C=2C3=C(Br)NN=C3N=CN=2)CC1 SCYVHSCNZKLRPR-UHFFFAOYSA-N 0.000 description 1
- FWLVVIROQGNWOM-UHFFFAOYSA-N 3-bromo-4-[4-[(2-bromophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC1=CC=CC=C1Br FWLVVIROQGNWOM-UHFFFAOYSA-N 0.000 description 1
- BDYYYDWHUCJFDQ-UHFFFAOYSA-N 3-bromo-4-[4-[(2-chloro-6-fluorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound FC1=CC=CC(Cl)=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 BDYYYDWHUCJFDQ-UHFFFAOYSA-N 0.000 description 1
- ZBWZJXSVLQNKPE-UHFFFAOYSA-N 3-bromo-4-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 ZBWZJXSVLQNKPE-UHFFFAOYSA-N 0.000 description 1
- OYDSLMICYSWZKX-UHFFFAOYSA-N 3-bromo-4-[4-[(3,4-dichlorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 OYDSLMICYSWZKX-UHFFFAOYSA-N 0.000 description 1
- SFANFKCYVDEBSW-UHFFFAOYSA-N 3-bromo-4-[4-[(4,6-dimethoxypyrimidin-2-yl)-phenylmethyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC(OC)=NC(C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C=2C=CC=CC=2)=N1 SFANFKCYVDEBSW-UHFFFAOYSA-N 0.000 description 1
- MZVPHNWNBHOGLG-UHFFFAOYSA-N 3-bromo-4-[4-[(4,6-dimethoxypyrimidin-2-yl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC(OC)=NC(CN2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=N1 MZVPHNWNBHOGLG-UHFFFAOYSA-N 0.000 description 1
- CKGYQQRHPXDSBD-UHFFFAOYSA-N 3-bromo-4-[4-[(4-bromophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC1=CC=C(Br)C=C1 CKGYQQRHPXDSBD-UHFFFAOYSA-N 0.000 description 1
- AEMXXZPJJCZOLU-UHFFFAOYSA-N 3-bromo-4-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(Cl)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 AEMXXZPJJCZOLU-UHFFFAOYSA-N 0.000 description 1
- OQRVEBZUVHZJJN-UHFFFAOYSA-N 3-bromo-4-[4-[(4-fluorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(F)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 OQRVEBZUVHZJJN-UHFFFAOYSA-N 0.000 description 1
- PWBOLVFJDQVVCX-UHFFFAOYSA-N 3-bromo-4-[4-[(4-methoxyphenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(OC)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 PWBOLVFJDQVVCX-UHFFFAOYSA-N 0.000 description 1
- CJVLNYANWJPSNK-UHFFFAOYSA-N 3-bromo-4-[4-[(4-phenylmethoxyphenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC(C=C1)=CC=C1OCC1=CC=CC=C1 CJVLNYANWJPSNK-UHFFFAOYSA-N 0.000 description 1
- QJMAXBSLZHUROH-UHFFFAOYSA-N 3-bromo-4-[4-[(4-phenylphenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC(C=C1)=CC=C1C1=CC=CC=C1 QJMAXBSLZHUROH-UHFFFAOYSA-N 0.000 description 1
- DYGAFJNIWKKLRO-UHFFFAOYSA-N 3-bromo-4-[4-[2-chloro-5-[2-(2-pyrrolidin-1-ylethoxy)phenyl]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(Cl)=CC=C1C1=CC=CC=C1OCCN1CCCC1 DYGAFJNIWKKLRO-UHFFFAOYSA-N 0.000 description 1
- RAQLRASZPYFRHR-UHFFFAOYSA-N 3-bromo-4-[4-[2-chloro-5-[4-fluoro-2-(2-pyrrolidin-1-ylethoxy)phenyl]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=1C(F)=CC=C(C=2C=C(C(Cl)=CC=2)N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C=1OCCN1CCCC1 RAQLRASZPYFRHR-UHFFFAOYSA-N 0.000 description 1
- DCAOYMUUNJOKSB-UHFFFAOYSA-N 3-bromo-4-[4-[2-methyl-5-(2-methylpropoxy)-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OCC(C)C)=CC=1CCCN1CCCC1 DCAOYMUUNJOKSB-UHFFFAOYSA-N 0.000 description 1
- WBNGOBJGEOGHKO-UHFFFAOYSA-N 3-bromo-4-[4-[2-methyl-5-[2-(2-pyrrolidin-1-ylethoxy)phenyl]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C1=CC=CC=C1OCCN1CCCC1 WBNGOBJGEOGHKO-UHFFFAOYSA-N 0.000 description 1
- APSONKVXTVHOIR-UHFFFAOYSA-N 3-bromo-4-[4-[2-methyl-5-[3-(2-pyrrolidin-1-ylethoxy)phenyl]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C(C=1)=CC=CC=1OCCN1CCCC1 APSONKVXTVHOIR-UHFFFAOYSA-N 0.000 description 1
- GZQAOQAIVFTXBT-UHFFFAOYSA-N 3-bromo-4-[4-[2-methyl-5-phenyl-3-(3-pyridin-1-ium-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(C=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCC[N+]1=CC=CC=C1 GZQAOQAIVFTXBT-UHFFFAOYSA-N 0.000 description 1
- JZMNQCWLQJMJJQ-UHFFFAOYSA-N 3-bromo-4-[4-[3-(2-piperidin-1-ylethoxy)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C(C=1)=CC=CC=1OCCN1CCCCC1 JZMNQCWLQJMJJQ-UHFFFAOYSA-N 0.000 description 1
- GHUFQOINANIXTK-UHFFFAOYSA-N 3-bromo-4-[4-[3-(2-piperidin-1-ylethoxy)pyrazin-2-yl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=NC=CN=C1OCCN1CCCCC1 GHUFQOINANIXTK-UHFFFAOYSA-N 0.000 description 1
- JLMAYHBMKURLET-UHFFFAOYSA-N 3-bromo-4-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound FC(F)(F)C1=CC=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 JLMAYHBMKURLET-UHFFFAOYSA-N 0.000 description 1
- ULNFDXASZYQCIC-UHFFFAOYSA-N 3-bromo-4-[4-[3-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound FC(F)(F)C1=CC=CN=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 ULNFDXASZYQCIC-UHFFFAOYSA-N 0.000 description 1
- DGKZAYJXHQGDRL-UHFFFAOYSA-N 3-bromo-4-[4-[3-[(3-methylphenyl)methoxy]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=CC(COC=2C=C(C=CC=2)N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 DGKZAYJXHQGDRL-UHFFFAOYSA-N 0.000 description 1
- WSFCJBDCDVWWPR-UHFFFAOYSA-N 3-bromo-4-[4-[3-bromo-5-[2,3-difluoro-2-(fluoromethyl)propoxy]-2-methylphenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=C(Br)C=C(OCC(F)(CF)CF)C=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 WSFCJBDCDVWWPR-UHFFFAOYSA-N 0.000 description 1
- VBHFWMSSEZZUDB-UHFFFAOYSA-N 3-bromo-4-[4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC(C(F)(F)F)=CN=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 VBHFWMSSEZZUDB-UHFFFAOYSA-N 0.000 description 1
- WTRRDUPRZHYBMD-UHFFFAOYSA-N 3-bromo-4-[4-[4-(furan-2-yl)pyrimidin-2-yl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C(N=1)=NC=CC=1C1=CC=CO1 WTRRDUPRZHYBMD-UHFFFAOYSA-N 0.000 description 1
- RQVHKXWGBFPZNU-UHFFFAOYSA-N 3-bromo-4-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(C(F)(F)F)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 RQVHKXWGBFPZNU-UHFFFAOYSA-N 0.000 description 1
- GTOPXVPNCNNXLW-UHFFFAOYSA-N 3-bromo-4-[4-[4-(trifluoromethyl)pyrimidin-2-yl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound FC(F)(F)C1=CC=NC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=N1 GTOPXVPNCNNXLW-UHFFFAOYSA-N 0.000 description 1
- UQXOTKGBLBLLEJ-UHFFFAOYSA-N 3-bromo-4-[4-[4-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C=C1OCCN1CCCC1 UQXOTKGBLBLLEJ-UHFFFAOYSA-N 0.000 description 1
- FDYRBFONKISFFU-UHFFFAOYSA-N 3-bromo-4-[4-[4-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C=C1CCCN1CCCC1 FDYRBFONKISFFU-UHFFFAOYSA-N 0.000 description 1
- RNWDPKPXTBMPLU-UHFFFAOYSA-N 3-bromo-4-[4-[5-(3,4-difluorophenyl)-4-fluoro-2-methylphenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC(F)=C1C1=CC=C(F)C(F)=C1 RNWDPKPXTBMPLU-UHFFFAOYSA-N 0.000 description 1
- JBRKDJZHLSVLLA-UHFFFAOYSA-N 3-bromo-4-[4-[5-[2,3-difluoro-2-(fluoromethyl)propoxy]-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(OCC(F)(CF)CF)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCCN1CCCC1 JBRKDJZHLSVLLA-UHFFFAOYSA-N 0.000 description 1
- UOALCMPNVGOVDK-UHFFFAOYSA-N 3-bromo-4-[4-[5-[2,3-difluoro-2-(fluoromethyl)propoxy]-2-methylphenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(OCC(F)(CF)CF)C=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 UOALCMPNVGOVDK-UHFFFAOYSA-N 0.000 description 1
- NCUIHEKCQCSDGR-UHFFFAOYSA-N 3-bromo-4-[4-[5-[3-fluoro-2-(2-pyrrolidin-1-ylethoxy)phenyl]-2-methylphenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C1=CC=CC(F)=C1OCCN1CCCC1 NCUIHEKCQCSDGR-UHFFFAOYSA-N 0.000 description 1
- JHITWGOEXOEWQD-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-(2-piperidin-1-ylethoxy)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1OCCN1CCCCC1 JHITWGOEXOEWQD-UHFFFAOYSA-N 0.000 description 1
- XPZWAIMVIPQEMM-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1OCCN1CCCC1 XPZWAIMVIPQEMM-UHFFFAOYSA-N 0.000 description 1
- VIDMYEJOBBYUIX-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-(3-piperidin-1-ylpropoxy)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1OCCCN1CCCCC1 VIDMYEJOBBYUIX-UHFFFAOYSA-N 0.000 description 1
- BKEGNPFOPJZHEG-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-(3-piperidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCCN1CCCCC1 BKEGNPFOPJZHEG-UHFFFAOYSA-N 0.000 description 1
- NHBAOYDFPBHMMK-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropoxy)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1OCCCN1CCCC1 NHBAOYDFPBHMMK-UHFFFAOYSA-N 0.000 description 1
- QTGCAQPANBHFRY-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCCN1CCCC1 QTGCAQPANBHFRY-UHFFFAOYSA-N 0.000 description 1
- MGZUHAQRVCAGIQ-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-[(1-methylpiperidin-4-yl)methoxy]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCC1COC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C MGZUHAQRVCAGIQ-UHFFFAOYSA-N 0.000 description 1
- BXUHUHGWLOFGKA-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C BXUHUHGWLOFGKA-UHFFFAOYSA-N 0.000 description 1
- PGMCBJLKJSZOQM-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C PGMCBJLKJSZOQM-UHFFFAOYSA-N 0.000 description 1
- AYSQAXKKEIXBFU-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propyl]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCCC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C AYSQAXKKEIXBFU-UHFFFAOYSA-N 0.000 description 1
- RZIMJZUGEXCLDX-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-3-[2-(4-ethylpiperazin-1-yl)ethoxy]-2-methylphenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C RZIMJZUGEXCLDX-UHFFFAOYSA-N 0.000 description 1
- UZQJMNDBBURGNW-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-3-[3-(4-ethylpiperazin-1-yl)propoxy]-2-methylphenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C UZQJMNDBBURGNW-UHFFFAOYSA-N 0.000 description 1
- JRCOATCNMDGXOI-UHFFFAOYSA-N 3-bromo-4-[4-[5-fluoro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCCN1CCCC1 JRCOATCNMDGXOI-UHFFFAOYSA-N 0.000 description 1
- DYGVLMVRHYPKPH-UHFFFAOYSA-N 3-bromo-4-[4-[[5-(4-chlorophenyl)furan-2-yl]methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(Cl)=CC=C1C(O1)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 DYGVLMVRHYPKPH-UHFFFAOYSA-N 0.000 description 1
- LVCUTRIUEIMSSN-UHFFFAOYSA-N 3-bromo-5-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-n-phenylbenzamide Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C(Br)C=C1C(=O)NC1=CC=CC=C1 LVCUTRIUEIMSSN-UHFFFAOYSA-N 0.000 description 1
- RQVCBFVLFOELEY-UHFFFAOYSA-N 3-bromo-5-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-n-phenylbenzamide Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C(=C(Br)C=1)C)=CC=1C(=O)NC1=CC=CC=C1 RQVCBFVLFOELEY-UHFFFAOYSA-N 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- ZUGWVLCGKRAMCK-UHFFFAOYSA-N 3-ethyl-4-(4-phenylpiperazin-1-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC=C1 ZUGWVLCGKRAMCK-UHFFFAOYSA-N 0.000 description 1
- ABCLBFFJWCINQC-UHFFFAOYSA-N 3-ethyl-4-[4-(3-methoxy-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC(OC)=C1C ABCLBFFJWCINQC-UHFFFAOYSA-N 0.000 description 1
- DSUZVNZHENWVEH-UHFFFAOYSA-N 3-ethyl-4-[4-(3-methoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC(OC)=C1 DSUZVNZHENWVEH-UHFFFAOYSA-N 0.000 description 1
- HYDOMGRCFKLOMU-UHFFFAOYSA-N 3-ethyl-4-[4-[4-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(C(F)(F)F)=CC=N1 HYDOMGRCFKLOMU-UHFFFAOYSA-N 0.000 description 1
- JLEIRAYWBMNMKU-UHFFFAOYSA-N 3-ethylpentan-3-amine Chemical compound CCC(N)(CC)CC JLEIRAYWBMNMKU-UHFFFAOYSA-N 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- NQGUYIIGRJFWGT-UHFFFAOYSA-N 3-methyl-4-[4-(2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(C)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC=C1C NQGUYIIGRJFWGT-UHFFFAOYSA-N 0.000 description 1
- CVMGWJJUNNHKEO-UHFFFAOYSA-N 3-methyl-4-[4-[4-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(C)=NNC2=NC=NC=1N(CC1)CCN1C(C=1)=CC=C(C)C=1OCCN1CCCC1 CVMGWJJUNNHKEO-UHFFFAOYSA-N 0.000 description 1
- MATIWBMCPVBIJK-UHFFFAOYSA-N 3-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-n'-(4-fluorophenyl)azetidine-3,3-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CNC1 MATIWBMCPVBIJK-UHFFFAOYSA-N 0.000 description 1
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 description 1
- OXKGFXZLEVBMRZ-UHFFFAOYSA-N 4-(2-cyclohexylethyl)-2-[[4-[(3,4-dichlorophenyl)methyl]-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-oxazepane Chemical compound N1=CN=C2C=C(OCC3OCCCN(CCC4CCCCC4)C3)C(OC)=CC2=C1CC1=CC=C(Cl)C(Cl)=C1 OXKGFXZLEVBMRZ-UHFFFAOYSA-N 0.000 description 1
- YIZQSXLPFSEWNO-UHFFFAOYSA-N 4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-1-(5-chloro-2-methylphenyl)piperazin-2-one Chemical compound CC1=CC=C(Cl)C=C1N1C(=O)CN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 YIZQSXLPFSEWNO-UHFFFAOYSA-N 0.000 description 1
- SXKQDCIDBSRHGY-UHFFFAOYSA-N 4-(3-chlorophenyl)-1-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-n-methylpiperazine-2-carboxamide Chemical compound C=12C(CC)=NNC2=NC=NC=1N(C(C1)C(=O)NC)CCN1C1=CC=CC(Cl)=C1 SXKQDCIDBSRHGY-UHFFFAOYSA-N 0.000 description 1
- AUVRRQMRYIPLIZ-UHFFFAOYSA-N 4-(4-benzylpiperazin-1-yl)-3-bromo-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC1=CC=CC=C1 AUVRRQMRYIPLIZ-UHFFFAOYSA-N 0.000 description 1
- RPGYWHYWENYQGY-UHFFFAOYSA-N 4-(4-phenylpiperazin-1-yl)-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C=2C=3C=NNC=3N=CN=2)CCN1C1=CC=CC=C1 RPGYWHYWENYQGY-UHFFFAOYSA-N 0.000 description 1
- YOMXRYXICGNVKI-UHFFFAOYSA-N 4-(4-phenylpiperazin-1-yl)-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CCN1C1=CC=CC=C1 YOMXRYXICGNVKI-UHFFFAOYSA-N 0.000 description 1
- LTCFSMLHPAQRAW-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoro-n-(3-phenylpropyl)benzenesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1S(=O)(=O)NCCCC1=CC=CC=C1 LTCFSMLHPAQRAW-UHFFFAOYSA-N 0.000 description 1
- OOGRHMWWVSLRGA-UHFFFAOYSA-N 4-(cyclohexylmethyl)-2-[[4-[(3,4-dichlorophenyl)methyl]-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-oxazepane Chemical compound N1=CN=C2C=C(OCC3OCCCN(CC4CCCCC4)C3)C(OC)=CC2=C1CC1=CC=C(Cl)C(Cl)=C1 OOGRHMWWVSLRGA-UHFFFAOYSA-N 0.000 description 1
- GVQGFWPYHOLEEM-UHFFFAOYSA-N 4-[(6,7-dimethoxyquinolin-4-yl)amino]-n-(3-phenylpropyl)benzamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1NC(C=C1)=CC=C1C(=O)NCCCC1=CC=CC=C1 GVQGFWPYHOLEEM-UHFFFAOYSA-N 0.000 description 1
- GWRSATNRNFYMDI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound FC=1C=C(NC=2N=C3N(C4CCCC4)CC(F)(F)C(=O)N(C)C3=CN=2)C(OC)=CC=1C(=O)NC1CCN(C)CC1 GWRSATNRNFYMDI-UHFFFAOYSA-N 0.000 description 1
- BDOGXIABZYTOLP-UHFFFAOYSA-N 4-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-4-(4-chlorophenyl)-n,n-dimethylbutan-1-amine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(CCCN(C)C)C1=CC=C(Cl)C=C1 BDOGXIABZYTOLP-UHFFFAOYSA-N 0.000 description 1
- TVFXHYIMTMBBRN-UHFFFAOYSA-N 4-[2-[2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylphenyl]phenoxy]ethyl]morpholine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C1=CC=CC=C1OCCN1CCOCC1 TVFXHYIMTMBBRN-UHFFFAOYSA-N 0.000 description 1
- DBHLLUYXGVGCBT-UHFFFAOYSA-N 4-[2-[2-chloro-4-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]phenoxy]ethyl]morpholine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=C1Cl)=CC=C1OCCN1CCOCC1 DBHLLUYXGVGCBT-UHFFFAOYSA-N 0.000 description 1
- VGARQGDBXVXNBU-UHFFFAOYSA-N 4-[2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-chloro-2-methylphenoxy]ethyl]morpholine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1OCCN1CCOCC1 VGARQGDBXVXNBU-UHFFFAOYSA-N 0.000 description 1
- UROLKIGIZGADHV-UHFFFAOYSA-N 4-[2-[4-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]phenoxy]ethyl]morpholine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=CC(OCCN5CCOCC5)=CC=4)=NNC=3N=CN=2)CC1 UROLKIGIZGADHV-UHFFFAOYSA-N 0.000 description 1
- DDSNBPYIVBWXGB-UHFFFAOYSA-N 4-[2-[5-chloro-2-methyl-3-[4-[3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidin-4-yl]piperazin-1-yl]phenoxy]ethyl]morpholine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1OCCN1CCOCC1 DDSNBPYIVBWXGB-UHFFFAOYSA-N 0.000 description 1
- SDTLVFOPJADHPB-UHFFFAOYSA-N 4-[2-[5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylphenoxy]ethyl]morpholine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCN1CCOCC1 SDTLVFOPJADHPB-UHFFFAOYSA-N 0.000 description 1
- MJEAPPCIXUQHHX-UHFFFAOYSA-N 4-[2-fluoro-4-[2-phenylethyl(2-phenylethylsulfamoyl)amino]phenoxy]-6,7-dimethoxyquinoline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(S(=O)(=O)NCCC=1C=CC=CC=1)CCC1=CC=CC=C1 MJEAPPCIXUQHHX-UHFFFAOYSA-N 0.000 description 1
- MFCRUXWKACGBRB-UHFFFAOYSA-N 4-[3-[2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylphenyl]phenoxy]propyl]morpholine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C1=CC=CC=C1OCCCN1CCOCC1 MFCRUXWKACGBRB-UHFFFAOYSA-N 0.000 description 1
- XYOGGDREGYYWPA-UHFFFAOYSA-N 4-[3-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-chloro-2-methylphenyl]propyl]morpholine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCCN1CCOCC1 XYOGGDREGYYWPA-UHFFFAOYSA-N 0.000 description 1
- RKQYJHUYDPMEBV-UHFFFAOYSA-N 4-[3-[5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylphenoxy]propyl]morpholine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCCN1CCOCC1 RKQYJHUYDPMEBV-UHFFFAOYSA-N 0.000 description 1
- ISQYTURYBKUOTA-UHFFFAOYSA-N 4-[3-[5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylphenyl]propyl]morpholine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1CCCN1CCOCC1 ISQYTURYBKUOTA-UHFFFAOYSA-N 0.000 description 1
- UODYUPMNTWUFNK-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-3-bromo-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C2OCOC2=CC(CN2CCN(CC2)C=2N=CN=C3NN=C(C=23)Br)=C1 UODYUPMNTWUFNK-UHFFFAOYSA-N 0.000 description 1
- UQLMPDRFVRHEEC-UHFFFAOYSA-N 4-[4-(2,5-difluorophenyl)piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(F)=CC=C1F UQLMPDRFVRHEEC-UHFFFAOYSA-N 0.000 description 1
- YRKKQVKSWQLXBZ-UHFFFAOYSA-N 4-[4-(2-chlorophenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound ClC1=CC=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 YRKKQVKSWQLXBZ-UHFFFAOYSA-N 0.000 description 1
- IBXALBYOWBTGRR-UHFFFAOYSA-N 4-[4-(2-fluorophenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound FC1=CC=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 IBXALBYOWBTGRR-UHFFFAOYSA-N 0.000 description 1
- PNKDJCFGTHLQCJ-UHFFFAOYSA-N 4-[4-(2-methoxyphenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound COC1=CC=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 PNKDJCFGTHLQCJ-UHFFFAOYSA-N 0.000 description 1
- HWUXRXXIRBYCNK-UHFFFAOYSA-N 4-[4-(2-methylphenyl)piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=CC=C1N1CCN(C=2C=3C=NNC=3N=CN=2)CC1 HWUXRXXIRBYCNK-UHFFFAOYSA-N 0.000 description 1
- CTJVUQNXXFJPAN-UHFFFAOYSA-N 4-[4-(2-methylphenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound CC1=CC=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 CTJVUQNXXFJPAN-UHFFFAOYSA-N 0.000 description 1
- OIQHXDDUNABRJN-UHFFFAOYSA-N 4-[4-(3,6-dimethylpyrazin-2-yl)piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=NC(C)=CN=C1C OIQHXDDUNABRJN-UHFFFAOYSA-N 0.000 description 1
- ZTTZSXXHUDNUPX-UHFFFAOYSA-N 4-[4-(3-bromo-2-chloro-5-fluorophenyl)piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(F)=CC(Br)=C1Cl ZTTZSXXHUDNUPX-UHFFFAOYSA-N 0.000 description 1
- KNOFIZHBESOPPI-UHFFFAOYSA-N 4-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-(trifluoromethyl)quinoline Chemical compound C1=CC=CC2=NC(C(F)(F)F)=CC(N3CCN(CC3)C=3C=4C(Br)=NNC=4N=CN=3)=C21 KNOFIZHBESOPPI-UHFFFAOYSA-N 0.000 description 1
- YIDPQUCBGBVPJQ-UHFFFAOYSA-N 4-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylquinoline Chemical compound C1=CC=CC2=NC(C)=CC(N3CCN(CC3)C=3C=4C(Br)=NNC=4N=CN=3)=C21 YIDPQUCBGBVPJQ-UHFFFAOYSA-N 0.000 description 1
- TXVYVJXMZMPYMX-UHFFFAOYSA-N 4-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]benzonitrile Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=C(C#N)C=C1 TXVYVJXMZMPYMX-UHFFFAOYSA-N 0.000 description 1
- LVOGLFHZHNTLSS-UHFFFAOYSA-N 4-[4-(3-bromo-5-chloro-2-methylphenyl)piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound CC1=C(Br)C=C(Cl)C=C1N1CCN(C=2C=3C=NNC=3N=C(N)N=2)CC1 LVOGLFHZHNTLSS-UHFFFAOYSA-N 0.000 description 1
- BQQTTYBDFMEOIC-UHFFFAOYSA-N 4-[4-(3-chloro-5-methoxyphenyl)piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC(OC)=C1 BQQTTYBDFMEOIC-UHFFFAOYSA-N 0.000 description 1
- ZIYLOLUWFBWXIH-UHFFFAOYSA-N 4-[4-(3-chlorophenyl)-1,4-diazepan-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCCN1C1=CC=CC(Cl)=C1 ZIYLOLUWFBWXIH-UHFFFAOYSA-N 0.000 description 1
- LCGMENDABLGZBC-UHFFFAOYSA-N 4-[4-(3-chlorophenyl)piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC=CC(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)=C1 LCGMENDABLGZBC-UHFFFAOYSA-N 0.000 description 1
- XATAOMSNDMSGSO-UHFFFAOYSA-N 4-[4-(3-chlorophenyl)piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC(Cl)=C1 XATAOMSNDMSGSO-UHFFFAOYSA-N 0.000 description 1
- YXAQKJOQSNRGHK-UHFFFAOYSA-N 4-[4-(3-chlorophenyl)piperazin-1-yl]-3-methyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(C)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC(Cl)=C1 YXAQKJOQSNRGHK-UHFFFAOYSA-N 0.000 description 1
- WUWSJZJZLJLZJJ-UHFFFAOYSA-N 4-[4-(3-chlorophenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound ClC1=CC=CC(N2CCN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 WUWSJZJZLJLZJJ-UHFFFAOYSA-N 0.000 description 1
- BVGJVMGHJXIGBN-UHFFFAOYSA-N 4-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-6,7-dimethoxyquinazoline Chemical compound COC1=C(OC)C=C2C(N3CCN(CC3)C=3N=CN=C4NN=C(C=34)CC)=NC=NC2=C1 BVGJVMGHJXIGBN-UHFFFAOYSA-N 0.000 description 1
- FWECWZKFGBIJMK-UHFFFAOYSA-N 4-[4-(3-methoxyphenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound COC1=CC=CC(N2CCN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 FWECWZKFGBIJMK-UHFFFAOYSA-N 0.000 description 1
- BKUPEAMZZKHYFG-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1=CC(Cl)=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 BKUPEAMZZKHYFG-UHFFFAOYSA-N 0.000 description 1
- MGAUNJWDDNBFEB-UHFFFAOYSA-N 4-[4-(4-fluorophenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1=CC(F)=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 MGAUNJWDDNBFEB-UHFFFAOYSA-N 0.000 description 1
- AAICARCSHFYCBL-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 AAICARCSHFYCBL-UHFFFAOYSA-N 0.000 description 1
- TZRRXZFUOZMLHU-UHFFFAOYSA-N 4-[4-(5-chloro-2-methoxyphenyl)piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1OC TZRRXZFUOZMLHU-UHFFFAOYSA-N 0.000 description 1
- WENXGABSSNOICL-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C=NNC=3N=C(N)N=2)CC1 WENXGABSSNOICL-UHFFFAOYSA-N 0.000 description 1
- OJSJVZOGAFBPJE-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C=NNC=3N=CN=2)CC1 OJSJVZOGAFBPJE-UHFFFAOYSA-N 0.000 description 1
- UWHHNRRWMAAGMX-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(1,2,3,6-tetrahydropyridin-4-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4CCNCC=4)=NNC=3N=CN=2)CC1 UWHHNRRWMAAGMX-UHFFFAOYSA-N 0.000 description 1
- JDRLXIDHAYBNRM-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(2-methoxyethoxymethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(COCCOC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C JDRLXIDHAYBNRM-UHFFFAOYSA-N 0.000 description 1
- RFBBUGWLRAJCHK-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(2-methoxyphenyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC=CC=C1C1=NNC2=NC=NC(N3CCN(CC3)C=3C(=CC=C(Cl)C=3)C)=C12 RFBBUGWLRAJCHK-UHFFFAOYSA-N 0.000 description 1
- WSHLJCGMVSJNMB-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(2-methylpropyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC(C)C)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C WSHLJCGMVSJNMB-UHFFFAOYSA-N 0.000 description 1
- WSQDXQLVVHANFN-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(3-chloropyridin-4-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C(=CN=CC=4)Cl)=NNC=3N=CN=2)CC1 WSQDXQLVVHANFN-UHFFFAOYSA-N 0.000 description 1
- VVEVCMUDDUYAPL-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(3-fluoropyridin-4-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C(=CN=CC=4)F)=NNC=3N=CN=2)CC1 VVEVCMUDDUYAPL-UHFFFAOYSA-N 0.000 description 1
- ZKJQPYPFCFCZHX-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(3-methoxyphenyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC=CC(C=2C3=C(N4CCN(CC4)C=4C(=CC=C(Cl)C=4)C)N=CN=C3NN=2)=C1 ZKJQPYPFCFCZHX-UHFFFAOYSA-N 0.000 description 1
- OFGPMXXPBQRGQG-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(3-methylbut-2-enyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC=C(C)C)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C OFGPMXXPBQRGQG-UHFFFAOYSA-N 0.000 description 1
- BMZLXAUYUKVRBT-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(3-phenylmethoxyphenyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=C(OCC=5C=CC=CC=5)C=CC=4)=NNC=3N=CN=2)CC1 BMZLXAUYUKVRBT-UHFFFAOYSA-N 0.000 description 1
- WGCZFRRJTKPHPH-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(3-pyrrolidin-1-ylprop-1-ynyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C#CCN4CCCC4)=NNC=3N=CN=2)CC1 WGCZFRRJTKPHPH-UHFFFAOYSA-N 0.000 description 1
- WSDIKTCRDBJNEZ-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(3-pyrrolidin-1-ylpropyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(CCCN4CCCC4)=NNC=3N=CN=2)CC1 WSDIKTCRDBJNEZ-UHFFFAOYSA-N 0.000 description 1
- WXIKPYIDNAJYKS-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(4-fluorophenyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=CC(F)=CC=4)=NNC=3N=CN=2)CC1 WXIKPYIDNAJYKS-UHFFFAOYSA-N 0.000 description 1
- HEMUMKTZPWGNKZ-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(4-methoxyphenyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(OC)=CC=C1C1=NNC2=NC=NC(N3CCN(CC3)C=3C(=CC=C(Cl)C=3)C)=C12 HEMUMKTZPWGNKZ-UHFFFAOYSA-N 0.000 description 1
- JKYFXFLTMOYKHE-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(4-methylphenyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(C)=CC=C1C1=NNC2=NC=NC(N3CCN(CC3)C=3C(=CC=C(Cl)C=3)C)=C12 JKYFXFLTMOYKHE-UHFFFAOYSA-N 0.000 description 1
- PEXFLFCCUBQENE-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(4-methylpiperazin-1-yl)-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1C1=NNC2=NC=NC(N3CCN(CC3)C=3C(=CC=C(Cl)C=3)C)=C12 PEXFLFCCUBQENE-UHFFFAOYSA-N 0.000 description 1
- SABZWXMHVIATPL-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(4-phenoxyphenyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=CC(OC=5C=CC=CC=5)=CC=4)=NNC=3N=CN=2)CC1 SABZWXMHVIATPL-UHFFFAOYSA-N 0.000 description 1
- WGLZMPRVECRUGN-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(piperidin-4-ylmethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(CC4CCNCC4)=NNC=3N=CN=2)CC1 WGLZMPRVECRUGN-UHFFFAOYSA-N 0.000 description 1
- BXXGWPDHOXTRRE-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)CC1 BXXGWPDHOXTRRE-UHFFFAOYSA-N 0.000 description 1
- MVAPPIZCVCEAMZ-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-[3-(4-methylpiperazin-1-yl)prop-1-ynyl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CC#CC1=NNC2=NC=NC(N3CCN(CC3)C=3C(=CC=C(Cl)C=3)C)=C12 MVAPPIZCVCEAMZ-UHFFFAOYSA-N 0.000 description 1
- QZPJJGRIIWFHNP-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-[4-(piperidin-4-ylmethoxy)phenyl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=CC(OCC5CCNCC5)=CC=4)=NNC=3N=CN=2)CC1 QZPJJGRIIWFHNP-UHFFFAOYSA-N 0.000 description 1
- IYFFGVGWWQJVFY-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C IYFFGVGWWQJVFY-UHFFFAOYSA-N 0.000 description 1
- HGNLAXAYDKLPAN-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-methyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(C)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C HGNLAXAYDKLPAN-UHFFFAOYSA-N 0.000 description 1
- QMRYFQJVJSUZLY-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-methyl-6-phenyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(C)=NNC2=NC(C=2C=CC=CC=2)=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C QMRYFQJVJSUZLY-UHFFFAOYSA-N 0.000 description 1
- DBBPQRUDHSGXGI-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-phenyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=CC=CC=4)=NNC=3N=CN=2)CC1 DBBPQRUDHSGXGI-UHFFFAOYSA-N 0.000 description 1
- NNMOENYDTWNVJF-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-piperazin-1-yl-1h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(N4CCNCC4)=NNC=3N=CN=2)CC1 NNMOENYDTWNVJF-UHFFFAOYSA-N 0.000 description 1
- GVPKPIYHQSAUFM-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-propan-2-yl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(C(C)C)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C GVPKPIYHQSAUFM-UHFFFAOYSA-N 0.000 description 1
- KFJYAVVIRNQQKI-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-propyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CCC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C KFJYAVVIRNQQKI-UHFFFAOYSA-N 0.000 description 1
- LRXQPIKTVGCSCD-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-pyridin-4-yl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=CN=CC=4)=NNC=3N=CN=2)CC1 LRXQPIKTVGCSCD-UHFFFAOYSA-N 0.000 description 1
- BQVOBOKTPDRMQV-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-thiophen-2-yl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4SC=CC=4)=NNC=3N=CN=2)CC1 BQVOBOKTPDRMQV-UHFFFAOYSA-N 0.000 description 1
- CUTHWLLCENKSGW-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-6-ethyl-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C=NNC2=NC(CC)=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C CUTHWLLCENKSGW-UHFFFAOYSA-N 0.000 description 1
- PRVDHIXOOBBJFD-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-6-methyl-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C=NNC2=NC(C)=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C PRVDHIXOOBBJFD-UHFFFAOYSA-N 0.000 description 1
- PZPHGLIZCQICOD-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-6-propan-2-yl-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C=NNC2=NC(C(C)C)=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C PZPHGLIZCQICOD-UHFFFAOYSA-N 0.000 description 1
- SFSIFSMOSDIXGP-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-n-phenyl-2h-pyrazolo[3,4-d]pyrimidin-3-amine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(NC=4C=CC=CC=4)=NNC=3N=CN=2)CC1 SFSIFSMOSDIXGP-UHFFFAOYSA-N 0.000 description 1
- VUZSRKURYLGNGT-UHFFFAOYSA-N 4-[4-(5-chloro-3-methoxy-2-methylphenyl)piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC(OC)=C1C VUZSRKURYLGNGT-UHFFFAOYSA-N 0.000 description 1
- MYAYFLXJENQGNP-UHFFFAOYSA-N 4-[4-(5-chloro-4-methoxy-2-methylphenyl)piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=C(OC)C=C1C MYAYFLXJENQGNP-UHFFFAOYSA-N 0.000 description 1
- MXHFMCMHQFKAME-UHFFFAOYSA-N 4-[4-[2-chloro-5-(trifluoromethyl)phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(C(F)(F)F)=CC=C1Cl MXHFMCMHQFKAME-UHFFFAOYSA-N 0.000 description 1
- MOWCFUDCJQIYNA-UHFFFAOYSA-N 4-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound FC(F)(F)C1=CC=CC(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)=C1 MOWCFUDCJQIYNA-UHFFFAOYSA-N 0.000 description 1
- YISGVHBBSBDPLQ-UHFFFAOYSA-N 4-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound FC(F)(F)C1=CC=CC(N2CCN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 YISGVHBBSBDPLQ-UHFFFAOYSA-N 0.000 description 1
- BJVXKHFOWCDPLN-UHFFFAOYSA-N 4-[4-[3-chloro-4-(2-piperidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=C1Cl)=CC=C1OCCN1CCCCC1 BJVXKHFOWCDPLN-UHFFFAOYSA-N 0.000 description 1
- PBHIIIVVBPIJSN-UHFFFAOYSA-N 4-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2H-pyrazolo[3,4-d]pyrimidin-3-yl]phenol Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=CC(O)=CC=4)=NNC=3N=CN=2)CC1 PBHIIIVVBPIJSN-UHFFFAOYSA-N 0.000 description 1
- BWDRROCFMQDWRM-UHFFFAOYSA-N 4-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]benzonitrile Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=CC(=CC=4)C#N)=NNC=3N=CN=2)CC1 BWDRROCFMQDWRM-UHFFFAOYSA-N 0.000 description 1
- PHMKLEPFJAIHGK-UHFFFAOYSA-N 4-[4-[4-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)C=C1OCCN1CCCC1 PHMKLEPFJAIHGK-UHFFFAOYSA-N 0.000 description 1
- JFIJGHSUNBWBAL-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-piperidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCN1CCCCC1 JFIJGHSUNBWBAL-UHFFFAOYSA-N 0.000 description 1
- SWUHHIRFMYRIJB-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)C(C)=C1OCCN1CCCC1 SWUHHIRFMYRIJB-UHFFFAOYSA-N 0.000 description 1
- UPRIVIWOZLARIH-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-(2-methylpropyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC(C)C)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCN1CCCC1 UPRIVIWOZLARIH-UHFFFAOYSA-N 0.000 description 1
- AQZAQRSOINDPNL-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-cyclopropyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(C4CC4)=NNC=3N=CN=2)C(C)=C1OCCN1CCCC1 AQZAQRSOINDPNL-UHFFFAOYSA-N 0.000 description 1
- VAPICOZQFYVJCT-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCN1CCCC1 VAPICOZQFYVJCT-UHFFFAOYSA-N 0.000 description 1
- WMDNCMBKBRUWNI-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-methyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(C)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCN1CCCC1 WMDNCMBKBRUWNI-UHFFFAOYSA-N 0.000 description 1
- IXFLVBJXEDPMNN-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-propan-2-yl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(C(C)C)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCN1CCCC1 IXFLVBJXEDPMNN-UHFFFAOYSA-N 0.000 description 1
- XBGWSDJSVVDITQ-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-piperidin-1-ylpropoxy)phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1OCCCN1CCCCC1 XBGWSDJSVVDITQ-UHFFFAOYSA-N 0.000 description 1
- BYGOXDLLNRNBPG-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-piperidin-1-ylpropoxy)phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCCN1CCCCC1 BYGOXDLLNRNBPG-UHFFFAOYSA-N 0.000 description 1
- HFMZMDXFDNLWCB-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-piperidin-1-ylpropyl)phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1CCCN1CCCCC1 HFMZMDXFDNLWCB-UHFFFAOYSA-N 0.000 description 1
- CCMZHPLGQJCYTC-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-piperidin-1-ylpropyl)phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1CCCN1CCCCC1 CCMZHPLGQJCYTC-UHFFFAOYSA-N 0.000 description 1
- YNEHNQLNJHUVNL-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropoxy)phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1OCCCN1CCCC1 YNEHNQLNJHUVNL-UHFFFAOYSA-N 0.000 description 1
- MUVXQJBLKUTUPZ-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropoxy)phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCCN1CCCC1 MUVXQJBLKUTUPZ-UHFFFAOYSA-N 0.000 description 1
- MAWNYUYBGKUWRX-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)C(C)=C1CCCN1CCCC1 MAWNYUYBGKUWRX-UHFFFAOYSA-N 0.000 description 1
- ASGJAACMIIQVBB-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1CCCN1CCCC1 ASGJAACMIIQVBB-UHFFFAOYSA-N 0.000 description 1
- KWKGHSHSXVOIQU-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1CCCN1CCCC1 KWKGHSHSXVOIQU-UHFFFAOYSA-N 0.000 description 1
- WPMSKZBISRKCCA-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[(1-methylpiperidin-4-yl)methoxy]phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCC1CCN(C)CC1 WPMSKZBISRKCCA-UHFFFAOYSA-N 0.000 description 1
- DARRPJUVNRFGQX-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[2-(1-methylpiperidin-4-yl)ethoxy]phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCC1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C DARRPJUVNRFGQX-UHFFFAOYSA-N 0.000 description 1
- XCOVTQGGVHMDFB-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[2-(1-methylpiperidin-4-yl)ethoxy]phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCC1CCN(C)CC1 XCOVTQGGVHMDFB-UHFFFAOYSA-N 0.000 description 1
- MREHXQMHLRHSEM-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C MREHXQMHLRHSEM-UHFFFAOYSA-N 0.000 description 1
- XCFTYDOZRKVXNM-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCN1CCN(C)CC1 XCFTYDOZRKVXNM-UHFFFAOYSA-N 0.000 description 1
- RHHDBYUITDSZOI-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCCN1CCN(C)CC1 RHHDBYUITDSZOI-UHFFFAOYSA-N 0.000 description 1
- UIIOSEYTZDZNAG-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propyl]phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCCC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C UIIOSEYTZDZNAG-UHFFFAOYSA-N 0.000 description 1
- WYQXCFRWJKGILM-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propyl]phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1CCCN1CCN(C)CC1 WYQXCFRWJKGILM-UHFFFAOYSA-N 0.000 description 1
- IEGMLOPFLQNVPN-UHFFFAOYSA-N 4-[4-[5-chloro-3-[2-(4-ethylpiperazin-1-yl)ethoxy]-2-methylphenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C IEGMLOPFLQNVPN-UHFFFAOYSA-N 0.000 description 1
- DZFNNPOBVMURRI-UHFFFAOYSA-N 4-[4-[5-chloro-3-[2-(4-ethylpiperazin-1-yl)ethoxy]-2-methylphenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(CC)=NNC=3N=CN=2)=C1C DZFNNPOBVMURRI-UHFFFAOYSA-N 0.000 description 1
- ORHSSASUVVWACH-UHFFFAOYSA-N 4-[4-[5-chloro-3-[3-(4-ethylpiperazin-1-yl)propoxy]-2-methylphenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C ORHSSASUVVWACH-UHFFFAOYSA-N 0.000 description 1
- AFQIYWYPUWYCCT-UHFFFAOYSA-N 4-[4-[5-chloro-3-[3-(4-ethylpiperazin-1-yl)propoxy]-2-methylphenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(CC)=NNC=3N=CN=2)=C1C AFQIYWYPUWYCCT-UHFFFAOYSA-N 0.000 description 1
- FRYZXWBIDBKNTC-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N1CC2CC1CN2C1=CC=CC(Cl)=C1 FRYZXWBIDBKNTC-UHFFFAOYSA-N 0.000 description 1
- ZEGDVMSZKIZCEO-UHFFFAOYSA-N 4-[5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylphenyl]morpholine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1N1CCOCC1 ZEGDVMSZKIZCEO-UHFFFAOYSA-N 0.000 description 1
- IQZYTWZJCLWWMX-UHFFFAOYSA-N 4-[[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]methyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 IQZYTWZJCLWWMX-UHFFFAOYSA-N 0.000 description 1
- BLPHPXYTDDFZER-UHFFFAOYSA-N 4-[[4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-n'-cyanopiperidine-1-carboximidamide Chemical compound N1=CN=C2C=C(OCC3CCN(CC3)C(N)=NC#N)C(OC)=CC2=C1NC1=CC=C(Br)C=C1F BLPHPXYTDDFZER-UHFFFAOYSA-N 0.000 description 1
- ABUNOQPWPPKFEJ-UHFFFAOYSA-N 4-[[[[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-fluorophenyl)methyl]-methylamino]methyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1CN(C)C(C=1C=CC(F)=CC=1)C1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 ABUNOQPWPPKFEJ-UHFFFAOYSA-N 0.000 description 1
- BQZSITGLBLNHBE-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-3-(4-methylphenyl)sulfonylimidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C(N1S(=O)(=O)C=2C=CC(C)=CC=2)=O)CC1CC1=CC=CC=C1 BQZSITGLBLNHBE-UHFFFAOYSA-N 0.000 description 1
- DFFYYHCIQMERJE-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]imidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C(N1)=O)CC1CC1=CC=CC=C1 DFFYYHCIQMERJE-UHFFFAOYSA-N 0.000 description 1
- VWIYIAHIOHEFJL-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1,3-diazinan-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C(N1)=O)CCC1CC1=CC=CC=C1 VWIYIAHIOHEFJL-UHFFFAOYSA-N 0.000 description 1
- TWIBKSKGAXIZLL-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(4-methylphenyl)sulfonylimidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C(N1S(=O)(=O)C=2C=CC(C)=CC=2)=O)CC1CC1=CC=CC=C1 TWIBKSKGAXIZLL-UHFFFAOYSA-N 0.000 description 1
- XQALDUDLHLHAOH-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]imidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C(N1)=O)CC1CC1=CC=CC=C1 XQALDUDLHLHAOH-UHFFFAOYSA-N 0.000 description 1
- OJFCYUGKFBRLDI-UHFFFAOYSA-N 4-benzyl-n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-4,5-dihydro-1,3-oxazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(OC1)=NC1CC1=CC=CC=C1 OJFCYUGKFBRLDI-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- 125000005986 4-piperidonyl group Chemical group 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- VATKWVNDCITFEB-UHFFFAOYSA-N 5-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,3-thiazol-4-yl]-2-hydroxybenzamide Chemical compound N1=CN=C2C=C(OCC=3SC=C(N=3)C=3C=C(C(O)=CC=3)C(N)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 VATKWVNDCITFEB-UHFFFAOYSA-N 0.000 description 1
- CNANJBQGWVKXDT-UHFFFAOYSA-N 5-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC1=CC=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C=C1NCCN1CCCC1 CNANJBQGWVKXDT-UHFFFAOYSA-N 0.000 description 1
- IDPUKCWIGUEADI-UHFFFAOYSA-N 5-[bis(2-chloroethyl)amino]uracil Chemical compound ClCCN(CCCl)C1=CNC(=O)NC1=O IDPUKCWIGUEADI-UHFFFAOYSA-N 0.000 description 1
- 125000004539 5-benzimidazolyl group Chemical group N1=CNC2=C1C=CC(=C2)* 0.000 description 1
- PHHJAFUIIRWPQI-UHFFFAOYSA-N 5-bromo-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylaniline Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Br)=CC(N)=C1C PHHJAFUIIRWPQI-UHFFFAOYSA-N 0.000 description 1
- JTLPCDMHGTVANG-UHFFFAOYSA-N 5-chloro-2-methyl-3-[4-(1h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 JTLPCDMHGTVANG-UHFFFAOYSA-N 0.000 description 1
- ASTYUTBLDLIZJL-UHFFFAOYSA-N 5-chloro-2-methyl-3-[4-(3-methyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=12C(C)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1NCCN1CCCC1 ASTYUTBLDLIZJL-UHFFFAOYSA-N 0.000 description 1
- CABOYHXJYNGXSR-UHFFFAOYSA-N 5-chloro-2-methyl-3-[4-(3-propan-2-yl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=12C(C(C)C)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1NCCN1CCCC1 CABOYHXJYNGXSR-UHFFFAOYSA-N 0.000 description 1
- WVSOMLBCFGPONC-UHFFFAOYSA-N 5-chloro-2-methyl-3-[4-[3-(2-methylpropyl)-2h-pyrazolo[3,4-d]pyrimidin-4-yl]piperazin-1-yl]-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=12C(CC(C)C)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1NCCN1CCCC1 WVSOMLBCFGPONC-UHFFFAOYSA-N 0.000 description 1
- OGKBRMWNHGMVFX-UHFFFAOYSA-N 5-chloro-2-methyl-n-(2-pyrrolidin-1-ylethyl)-3-[4-[3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidin-4-yl]piperazin-1-yl]aniline Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1NCCN1CCCC1 OGKBRMWNHGMVFX-UHFFFAOYSA-N 0.000 description 1
- ICZBXKGLNSAERJ-UHFFFAOYSA-N 5-chloro-3-[4-(3-cyclopropyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(C4CC4)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 ICZBXKGLNSAERJ-UHFFFAOYSA-N 0.000 description 1
- MYIRXQMHGQHKKB-UHFFFAOYSA-N 5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1NCCN1CCCC1 MYIRXQMHGQHKKB-UHFFFAOYSA-N 0.000 description 1
- JGUKUPRLVDSOPK-UHFFFAOYSA-N 5-chloro-n-[2-(dimethylamino)ethyl]-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methoxybenzamide Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC(C(=O)NCCN(C)C)=C1OC JGUKUPRLVDSOPK-UHFFFAOYSA-N 0.000 description 1
- IPSGJJMTWOHXNA-UHFFFAOYSA-N 5-fluoro-2-methyl-n-(2-pyrrolidin-1-ylethyl)-3-[4-[3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidin-4-yl]piperazin-1-yl]aniline Chemical compound C1=C(F)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1NCCN1CCCC1 IPSGJJMTWOHXNA-UHFFFAOYSA-N 0.000 description 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 description 1
- UMLXGVVBPHXNCX-UHFFFAOYSA-N 6-(2-benzyl-1-hydroxy-3-oxoisoindol-1-yl)-n-methyl-1h-benzimidazole-2-carboxamide Chemical compound C=1C=C2NC(C(=O)NC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=CC=C1 UMLXGVVBPHXNCX-UHFFFAOYSA-N 0.000 description 1
- PDJBXTTYRLDGSW-UHFFFAOYSA-N 6-(2-butyl-1-hydroxy-3-oxoisoindol-1-yl)-4h-1,4-benzoxazin-3-one Chemical compound O1CC(=O)NC2=CC(C3(O)C4=CC=CC=C4C(=O)N3CCCC)=CC=C21 PDJBXTTYRLDGSW-UHFFFAOYSA-N 0.000 description 1
- AFIYYGFBBBNREQ-UHFFFAOYSA-N 6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-1,3-benzothiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC2=C1N=C(N)S2 AFIYYGFBBBNREQ-UHFFFAOYSA-N 0.000 description 1
- MGAGAOYTZWXURQ-UHFFFAOYSA-N 6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-n-(2-phenoxyethyl)-1,3-benzothiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2NCCOC1=CC=CC=C1 MGAGAOYTZWXURQ-UHFFFAOYSA-N 0.000 description 1
- OKSQZLCYDQAKJK-UHFFFAOYSA-N 6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-n-(2-piperidin-1-ylethyl)-1,3-benzothiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2NCCN1CCCCC1 OKSQZLCYDQAKJK-UHFFFAOYSA-N 0.000 description 1
- ICATZJCTIMGZSE-UHFFFAOYSA-N 6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-n-(2-pyrrolidin-1-ylethyl)-1,3-benzothiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2NCCN1CCCC1 ICATZJCTIMGZSE-UHFFFAOYSA-N 0.000 description 1
- YTHCCOCZRQGJEZ-UHFFFAOYSA-N 6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-n-[[3-(trifluoromethyl)phenyl]methyl]-1,3-benzothiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2NCC1=CC=CC(C(F)(F)F)=C1 YTHCCOCZRQGJEZ-UHFFFAOYSA-N 0.000 description 1
- ISXYCOVIHXIWQD-UHFFFAOYSA-N 6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-n-methyl-n-(2-phenylethyl)-1,3-benzothiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2N(C)CCC1=CC=CC=C1 ISXYCOVIHXIWQD-UHFFFAOYSA-N 0.000 description 1
- RQKDRBJZIZMTJK-UHFFFAOYSA-N 6-[1-hydroxy-2-(3-iodophenyl)-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC(I)=C1 RQKDRBJZIZMTJK-UHFFFAOYSA-N 0.000 description 1
- ZYJMLXUONVRHHX-UHFFFAOYSA-N 6-[1-hydroxy-2-(3-methoxyphenyl)-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound COC1=CC=CC(N2C(C3=CC=CC=C3C2=O)(O)C=2C=C3NC(=O)COC3=CC=2)=C1 ZYJMLXUONVRHHX-UHFFFAOYSA-N 0.000 description 1
- DZCBRTBEXDTPDC-UHFFFAOYSA-N 6-[1-hydroxy-2-(3-methylphenyl)-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound CC1=CC=CC(N2C(C3=CC=CC=C3C2=O)(O)C=2C=C3NC(=O)COC3=CC=2)=C1 DZCBRTBEXDTPDC-UHFFFAOYSA-N 0.000 description 1
- IHHUCXRAMDFEAC-UHFFFAOYSA-N 6-[1-hydroxy-2-(3-nitrophenyl)-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC([N+]([O-])=O)=C1 IHHUCXRAMDFEAC-UHFFFAOYSA-N 0.000 description 1
- LGGRHPOWHSUTQV-UHFFFAOYSA-N 6-[1-hydroxy-2-(4-methylphenyl)-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound C1=CC(C)=CC=C1N1C(C=2C=C3NC(=O)COC3=CC=2)(O)C2=CC=CC=C2C1=O LGGRHPOWHSUTQV-UHFFFAOYSA-N 0.000 description 1
- OGZILHKYGPBSCN-UHFFFAOYSA-N 6-[1-hydroxy-2-[(2-methoxyphenyl)methyl]-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound COC1=CC=CC=C1CN1C(C=2C=C3NC(=O)COC3=CC=2)(O)C2=CC=CC=C2C1=O OGZILHKYGPBSCN-UHFFFAOYSA-N 0.000 description 1
- IVRIHMKFJQECLE-UHFFFAOYSA-N 6-[1-hydroxy-2-[(3-iodophenyl)methyl]-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=CC(I)=C1 IVRIHMKFJQECLE-UHFFFAOYSA-N 0.000 description 1
- DZMHPXFZEYWNCN-UHFFFAOYSA-N 6-[1-hydroxy-2-[(3-nitrophenyl)methyl]-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=CC([N+]([O-])=O)=C1 DZMHPXFZEYWNCN-UHFFFAOYSA-N 0.000 description 1
- MOCPTAAWOLXJLR-UHFFFAOYSA-N 6-[1-hydroxy-2-[(4-methylphenyl)methyl]-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound C1=CC(C)=CC=C1CN1C(C=2C=C3NC(=O)COC3=CC=2)(O)C2=CC=CC=C2C1=O MOCPTAAWOLXJLR-UHFFFAOYSA-N 0.000 description 1
- SGLPYYZGNOHNTK-UHFFFAOYSA-N 6-[1-hydroxy-3-oxo-2-(2-phenylethyl)isoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CCC1=CC=CC=C1 SGLPYYZGNOHNTK-UHFFFAOYSA-N 0.000 description 1
- JZWBUQUSKAZPJJ-UHFFFAOYSA-N 6-[1-hydroxy-3-oxo-2-(3-phenylpropyl)isoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CCCC1=CC=CC=C1 JZWBUQUSKAZPJJ-UHFFFAOYSA-N 0.000 description 1
- ZORRHPHSEMTNSF-UHFFFAOYSA-N 6-[1-hydroxy-3-oxo-2-(3-propan-2-ylphenyl)isoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound CC(C)C1=CC=CC(N2C(C3=CC=CC=C3C2=O)(O)C=2C=C3NC(=O)COC3=CC=2)=C1 ZORRHPHSEMTNSF-UHFFFAOYSA-N 0.000 description 1
- HEBSEJYDCRBKHO-UHFFFAOYSA-N 6-[2-(3,4-dichlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=C(Cl)C(Cl)=C1 HEBSEJYDCRBKHO-UHFFFAOYSA-N 0.000 description 1
- OIIZNSUWICCJEB-UHFFFAOYSA-N 6-[2-(3,4-difluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=C(F)C(F)=C1 OIIZNSUWICCJEB-UHFFFAOYSA-N 0.000 description 1
- WZKUZUWJZRNLDA-UHFFFAOYSA-N 6-[2-(3-bromophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC(Br)=C1 WZKUZUWJZRNLDA-UHFFFAOYSA-N 0.000 description 1
- NPMXBHGHCRPSIO-UHFFFAOYSA-N 6-[2-(3-chlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC(Cl)=C1 NPMXBHGHCRPSIO-UHFFFAOYSA-N 0.000 description 1
- FHABBMMGGOBOLS-UHFFFAOYSA-N 6-[2-(3-fluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC(F)=C1 FHABBMMGGOBOLS-UHFFFAOYSA-N 0.000 description 1
- BOYORSYSOCEJAM-UHFFFAOYSA-N 6-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)benzoyl]-4h-1,4-benzoxazin-3-one Chemical compound C=1C=C2OCC(=O)NC2=CC=1C(=O)C1=CC=CC=C1C(ON=1)=NC=1C1=CC=CC=C1 BOYORSYSOCEJAM-UHFFFAOYSA-N 0.000 description 1
- XVIOTDHIXUDJOH-UHFFFAOYSA-N 6-[2-(4-chlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=C(Cl)C=C1 XVIOTDHIXUDJOH-UHFFFAOYSA-N 0.000 description 1
- WVHOOARJHLELEM-UHFFFAOYSA-N 6-[2-[(2-bromophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=CC=C1Br WVHOOARJHLELEM-UHFFFAOYSA-N 0.000 description 1
- XHIJBRPSFSRZFD-UHFFFAOYSA-N 6-[2-[(2-chlorophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=CC=C1Cl XHIJBRPSFSRZFD-UHFFFAOYSA-N 0.000 description 1
- VLLZSGCPCSKMMY-UHFFFAOYSA-N 6-[2-[(2-fluorophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=CC=C1F VLLZSGCPCSKMMY-UHFFFAOYSA-N 0.000 description 1
- JSMIWUUKHVQDRY-UHFFFAOYSA-N 6-[2-[(3-bromophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=CC(Br)=C1 JSMIWUUKHVQDRY-UHFFFAOYSA-N 0.000 description 1
- MCSQGGVPYHUPET-UHFFFAOYSA-N 6-[2-[(3-chlorophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=CC(Cl)=C1 MCSQGGVPYHUPET-UHFFFAOYSA-N 0.000 description 1
- KDTAQSMAQLUPGB-UHFFFAOYSA-N 6-[2-[(3-fluorophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=CC(F)=C1 KDTAQSMAQLUPGB-UHFFFAOYSA-N 0.000 description 1
- PRFRFUUDXFZJBY-UHFFFAOYSA-N 6-[2-[(4-chlorophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=C(Cl)C=C1 PRFRFUUDXFZJBY-UHFFFAOYSA-N 0.000 description 1
- SBWPMGUCBLOOTR-UHFFFAOYSA-N 6-[2-[(5-bromo-2-fluorophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC(Br)=CC=C1F SBWPMGUCBLOOTR-UHFFFAOYSA-N 0.000 description 1
- FUZOXHWXAYGCHT-UHFFFAOYSA-N 6-[2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]pyrimidin-4-yl]-4h-1,4-benzoxazin-3-one Chemical compound O1CC(=O)NC2=CC(C=3C=CN=C(N=3)N3CCN(CC3)C=3N=CN=C4NN=C(C=34)Br)=CC=C21 FUZOXHWXAYGCHT-UHFFFAOYSA-N 0.000 description 1
- LZFVWERIFXVTMC-UHFFFAOYSA-N 6-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]hexan-1-ol Chemical compound N1=CN=C2C=C(OCC3OCCN(CCCCCCO)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 LZFVWERIFXVTMC-UHFFFAOYSA-N 0.000 description 1
- CEQBNUJPFJXLFR-UHFFFAOYSA-N 6-[2-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=C(Cl)C(C(F)(F)F)=C1 CEQBNUJPFJXLFR-UHFFFAOYSA-N 0.000 description 1
- KDYPEARPZJFJBV-UHFFFAOYSA-N 6-[4-(2-chlorophenyl)piperazin-1-yl]-7h-purine Chemical compound ClC1=CC=CC=C1N1CCN(C=2C=3NC=NC=3N=CN=2)CC1 KDYPEARPZJFJBV-UHFFFAOYSA-N 0.000 description 1
- ZMJKIUCPJALXPF-UHFFFAOYSA-N 6-[4-(2-fluorophenyl)piperazin-1-yl]-7h-purine Chemical compound FC1=CC=CC=C1N1CCN(C=2C=3NC=NC=3N=CN=2)CC1 ZMJKIUCPJALXPF-UHFFFAOYSA-N 0.000 description 1
- KWLXRQFZEOGTIH-UHFFFAOYSA-N 6-[4-(2-methoxyphenyl)piperazin-1-yl]-7h-purine Chemical compound COC1=CC=CC=C1N1CCN(C=2C=3NC=NC=3N=CN=2)CC1 KWLXRQFZEOGTIH-UHFFFAOYSA-N 0.000 description 1
- MWRLTPXFGZXUKB-UHFFFAOYSA-N 6-[4-(2-methylphenyl)piperazin-1-yl]-7h-purine Chemical compound CC1=CC=CC=C1N1CCN(C=2C=3N=CNC=3N=CN=2)CC1 MWRLTPXFGZXUKB-UHFFFAOYSA-N 0.000 description 1
- GOSAHYKJGHXFIT-UHFFFAOYSA-N 6-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-3,5-difluoro-4-n-(3-methylbutyl)-2-n-(2-pyrrolidin-1-ylethyl)pyridine-2,4-diamine Chemical compound N=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C(F)C(NCCC(C)C)=C(F)C=1NCCN1CCCC1 GOSAHYKJGHXFIT-UHFFFAOYSA-N 0.000 description 1
- IQFNNPBWPNNACU-UHFFFAOYSA-N 6-[4-(4-chlorophenyl)piperazin-1-yl]-7h-purine Chemical compound C1=CC(Cl)=CC=C1N1CCN(C=2C=3N=CNC=3N=CN=2)CC1 IQFNNPBWPNNACU-UHFFFAOYSA-N 0.000 description 1
- MBRQCVJHJOVNLO-UHFFFAOYSA-N 6-[4-(4-fluorophenyl)piperazin-1-yl]-7h-purine Chemical compound C1=CC(F)=CC=C1N1CCN(C=2C=3NC=NC=3N=CN=2)CC1 MBRQCVJHJOVNLO-UHFFFAOYSA-N 0.000 description 1
- ICAARADRKONXBF-UHFFFAOYSA-N 6-[4-(4-methoxyphenyl)piperazin-1-yl]-7h-purine Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=3NC=NC=3N=CN=2)CC1 ICAARADRKONXBF-UHFFFAOYSA-N 0.000 description 1
- AQKCWTXVJVQGDX-UHFFFAOYSA-N 6-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-7h-purine Chemical compound FC(F)(F)C1=CC=CC(N2CCN(CC2)C=2C=3NC=NC=3N=CN=2)=C1 AQKCWTXVJVQGDX-UHFFFAOYSA-N 0.000 description 1
- NWWPZALFLBATKW-UHFFFAOYSA-N 6-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-3,3,4-trimethylmorpholin-2-one Chemical compound N1=CN=C2C=C(OCC3OC(=O)C(C)(C)N(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 NWWPZALFLBATKW-UHFFFAOYSA-N 0.000 description 1
- TWMPXXRMSJFJSY-UHFFFAOYSA-N 6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]-n-(3,4,5-trichlorophenyl)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC(Cl)=C(Cl)C(Cl)=C1 TWMPXXRMSJFJSY-UHFFFAOYSA-N 0.000 description 1
- TZOPEIOUJFXKQZ-UHFFFAOYSA-N 7-(1,3-benzothiazol-2-ylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC4=CC=CC=C4N=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 TZOPEIOUJFXKQZ-UHFFFAOYSA-N 0.000 description 1
- HLDHNATWCDWAML-UHFFFAOYSA-N 7-(2,1,3-benzothiadiazol-4-ylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C4=NSN=C4C=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HLDHNATWCDWAML-UHFFFAOYSA-N 0.000 description 1
- BDXLOYXFMUPOIW-UHFFFAOYSA-N 7-(2,1,3-benzoxadiazol-5-ylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3=CC4=NON=C4C=C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 BDXLOYXFMUPOIW-UHFFFAOYSA-N 0.000 description 1
- WYZCWZRHCBLLRQ-UHFFFAOYSA-N 7-(2-cyclohexylethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCCC3CCCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 WYZCWZRHCBLLRQ-UHFFFAOYSA-N 0.000 description 1
- GOTKNVOMZNDPKT-UHFFFAOYSA-N 7-(cyclobutylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3CCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 GOTKNVOMZNDPKT-UHFFFAOYSA-N 0.000 description 1
- SDPXNCYWHLAZJC-UHFFFAOYSA-N 7-(cyclopropylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3CC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 SDPXNCYWHLAZJC-UHFFFAOYSA-N 0.000 description 1
- YETQQFMHUDZVIA-UHFFFAOYSA-N 7-[(3,5-dibromophenyl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C=C(Br)C=C(Br)C=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 YETQQFMHUDZVIA-UHFFFAOYSA-N 0.000 description 1
- WRVHLDXCHAGIMA-UHFFFAOYSA-N 7-[(4-butyl-1,4-oxazepan-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound C1N(CCCC)CCCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC WRVHLDXCHAGIMA-UHFFFAOYSA-N 0.000 description 1
- CHESBDRRLQCAEW-UHFFFAOYSA-N 7-[(4-butylmorpholin-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound C1N(CCCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC CHESBDRRLQCAEW-UHFFFAOYSA-N 0.000 description 1
- CKIBKYNCWLLXRU-UHFFFAOYSA-N 7-[(4-butylsulfonylmorpholin-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound C1N(S(=O)(=O)CCCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC CKIBKYNCWLLXRU-UHFFFAOYSA-N 0.000 description 1
- YJHVTCUKZLXENT-UHFFFAOYSA-N 7-[(4-cyclobutylmorpholin-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C3CCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 YJHVTCUKZLXENT-UHFFFAOYSA-N 0.000 description 1
- JZVGJCJOXIONNM-UHFFFAOYSA-N 7-[(4-cyclopentylmorpholin-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C3CCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 JZVGJCJOXIONNM-UHFFFAOYSA-N 0.000 description 1
- QQGZOWNAHJAXCG-UHFFFAOYSA-N 7-[(5-chloro-1-benzothiophen-3-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C4=CC(Cl)=CC=C4SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QQGZOWNAHJAXCG-UHFFFAOYSA-N 0.000 description 1
- ZCRLDBQMLFBFFN-UHFFFAOYSA-N 7-[(5-chloro-1-methyl-3-phenylpyrazol-4-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C(=NN(C)C=3Cl)C=3C=CC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ZCRLDBQMLFBFFN-UHFFFAOYSA-N 0.000 description 1
- TUQBWKPRXZNXMC-UHFFFAOYSA-N 7-[(6-chloropyridin-3-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C=NC(Cl)=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 TUQBWKPRXZNXMC-UHFFFAOYSA-N 0.000 description 1
- JJQTYTQYXOULRB-UXPWSPDFSA-N 7-[[(3ar,6s,6as)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@@H]3[C@H]4OCC[C@H]4OC3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1 JJQTYTQYXOULRB-UXPWSPDFSA-N 0.000 description 1
- OUEOJFCFMCXADD-PLACYPQZSA-N 7-[[(3r,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=C(Br)C(Cl)=C1 OUEOJFCFMCXADD-PLACYPQZSA-N 0.000 description 1
- PDTLXTDXRUZIGN-PDDAWLJDSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-6-methoxy-n-(2,3,4-trichlorophenyl)quinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1Cl PDTLXTDXRUZIGN-PDDAWLJDSA-N 0.000 description 1
- ZNTUEQOGCBDJQV-PDDAWLJDSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-6-methoxy-n-(2,3,4-trifluorophenyl)quinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(F)C(F)=C1F ZNTUEQOGCBDJQV-PDDAWLJDSA-N 0.000 description 1
- GESHUZBGGLGNGZ-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-6-methoxy-n-(2,4,5-trifluorophenyl)quinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC(F)=C(F)C=C1F GESHUZBGGLGNGZ-YFMMTPMMSA-N 0.000 description 1
- SYTDXYNETZANOI-PTLICHBZSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-6-methoxy-n-(2,4,6-trifluorophenyl)quinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=C(F)C=C(F)C=C1F SYTDXYNETZANOI-PTLICHBZSA-N 0.000 description 1
- XVPSLKGHDHFMEM-PTLICHBZSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-6-methoxy-n-(3,4,5-trichlorophenyl)quinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC(Cl)=C(Cl)C(Cl)=C1 XVPSLKGHDHFMEM-PTLICHBZSA-N 0.000 description 1
- VPMFDTGNFBVOSP-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(Cl)C=C1Cl VPMFDTGNFBVOSP-YFMMTPMMSA-N 0.000 description 1
- PBZBHUPNRAUVJF-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2,4-difluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(F)C=C1F PBZBHUPNRAUVJF-YFMMTPMMSA-N 0.000 description 1
- IXUDYVHGCQIEDJ-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2,5-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC(Cl)=CC=C1Cl IXUDYVHGCQIEDJ-YFMMTPMMSA-N 0.000 description 1
- KNQFEIWYUMJEJW-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2,5-difluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC(F)=CC=C1F KNQFEIWYUMJEJW-YFMMTPMMSA-N 0.000 description 1
- WFNAULMUNPRODX-PTLICHBZSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2,6-difluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=C(F)C=CC=C1F WFNAULMUNPRODX-PTLICHBZSA-N 0.000 description 1
- HJOMYFVOXGNASK-PTLICHBZSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2-bromo-4,6-difluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=C(F)C=C(F)C=C1Br HJOMYFVOXGNASK-PTLICHBZSA-N 0.000 description 1
- IVTMGIFJCKLZRO-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2-bromo-4-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(F)C=C1Br IVTMGIFJCKLZRO-YFMMTPMMSA-N 0.000 description 1
- NAOSUZSDORYMKP-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2-bromophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=CC=C1Br NAOSUZSDORYMKP-YFMMTPMMSA-N 0.000 description 1
- UQJWQNWEZPXTRQ-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2-chloro-4-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(F)C=C1Cl UQJWQNWEZPXTRQ-YFMMTPMMSA-N 0.000 description 1
- UIELDVYKNRNSEM-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2-chlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=CC=C1Cl UIELDVYKNRNSEM-YFMMTPMMSA-N 0.000 description 1
- GNBFLDHHHUBBFG-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=CC=C1F GNBFLDHHHUBBFG-YFMMTPMMSA-N 0.000 description 1
- CQIIIEIHBWOUOM-PDDAWLJDSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1F CQIIIEIHBWOUOM-PDDAWLJDSA-N 0.000 description 1
- ZDHUWTTUQHECMO-FCDRMGDPSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ZDHUWTTUQHECMO-FCDRMGDPSA-N 0.000 description 1
- HZOGQCYCMSFESW-FCDRMGDPSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3,4-difluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(F)C(F)=C1 HZOGQCYCMSFESW-FCDRMGDPSA-N 0.000 description 1
- NWWJHGTVZUZRMP-FCDRMGDPSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3,5-difluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC(F)=CC(F)=C1 NWWJHGTVZUZRMP-FCDRMGDPSA-N 0.000 description 1
- MBPRKKURYAKGON-XXMUNEJQSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3,5-dimethylphenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC(C)=CC(C)=C1 MBPRKKURYAKGON-XXMUNEJQSA-N 0.000 description 1
- PFBDUGXDPNHKAM-IDCXYZFESA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3-bromo-4-methylphenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(C)C(Br)=C1 PFBDUGXDPNHKAM-IDCXYZFESA-N 0.000 description 1
- HAVVSQSFGAQFOW-FCDRMGDPSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3-bromophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=CC(Br)=C1 HAVVSQSFGAQFOW-FCDRMGDPSA-N 0.000 description 1
- QKKRTUHQIAZEDD-PDDAWLJDSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3-chloro-2,4-difluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(F)C(Cl)=C1F QKKRTUHQIAZEDD-PDDAWLJDSA-N 0.000 description 1
- GBVHHGINCYVVRZ-GISJFGRKSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=CC(Cl)=C1F GBVHHGINCYVVRZ-GISJFGRKSA-N 0.000 description 1
- RJGUQSMXHFQXPD-PLBGURBNSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3-chloro-2-methylphenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=CC(Cl)=C1C RJGUQSMXHFQXPD-PLBGURBNSA-N 0.000 description 1
- VQRNHLREZMWHGF-FCDRMGDPSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3-chloro-4-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(F)C(Cl)=C1 VQRNHLREZMWHGF-FCDRMGDPSA-N 0.000 description 1
- DJXUANYGYXJJAE-FCDRMGDPSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(3-chlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=CC(Cl)=C1 DJXUANYGYXJJAE-FCDRMGDPSA-N 0.000 description 1
- RNMZCDDYUSJWBE-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(4,5-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC(Cl)=C(Cl)C=C1F RNMZCDDYUSJWBE-YFMMTPMMSA-N 0.000 description 1
- UUPSSROUZJUAGT-PDDAWLJDSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(4-bromo-2,3-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1Cl UUPSSROUZJUAGT-PDDAWLJDSA-N 0.000 description 1
- UOXGDSKFAKYBGU-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(Br)C=C1F UOXGDSKFAKYBGU-YFMMTPMMSA-N 0.000 description 1
- HQHKCYQAKIHFNI-PDDAWLJDSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1F HQHKCYQAKIHFNI-PDDAWLJDSA-N 0.000 description 1
- YALKSQBVLCYSFM-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(4-bromo-5-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC(Cl)=C(Br)C=C1F YALKSQBVLCYSFM-YFMMTPMMSA-N 0.000 description 1
- YXCHYSQVLDVUOJ-FCDRMGDPSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(4-chlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(Cl)C=C1 YXCHYSQVLDVUOJ-FCDRMGDPSA-N 0.000 description 1
- FSNXDZZUWFZSPA-FCDRMGDPSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(4-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(F)C=C1 FSNXDZZUWFZSPA-FCDRMGDPSA-N 0.000 description 1
- IUKSUNXUYRVVIQ-YFMMTPMMSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-(5-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC(Cl)=CC=C1F IUKSUNXUYRVVIQ-YFMMTPMMSA-N 0.000 description 1
- PSMXKRAQDFGMBM-FCDRMGDPSA-N 7-[[(3r,3as,6r,6ar)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-n-[4-fluoro-3-(trifluoromethyl)phenyl]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@H]3[C@@H]4OC[C@@H](F)[C@@H]4OC3)C(OC)=CC2=C1NC1=CC=C(F)C(C(F)(F)F)=C1 PSMXKRAQDFGMBM-FCDRMGDPSA-N 0.000 description 1
- RVMLSAUWFLLGAT-FNAHDJPLSA-N 7-[[(3s,3ar,6s,6ar)-3-ethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OCC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=C(Br)C(Cl)=C1 RVMLSAUWFLLGAT-FNAHDJPLSA-N 0.000 description 1
- KURAWEFNNHDHOM-ZCLUNYJNSA-N 7-[[(3s,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=C(Cl)C(Cl)=C1F KURAWEFNNHDHOM-ZCLUNYJNSA-N 0.000 description 1
- ZAMYFBONNUIDDG-UWHLTILDSA-N 7-[[(3s,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=C(Cl)C(Cl)=C1 ZAMYFBONNUIDDG-UWHLTILDSA-N 0.000 description 1
- GAKPIAPJVGZESM-FNAHDJPLSA-N 7-[[(3s,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(3-bromo-2-methylphenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=CC(Br)=C1C GAKPIAPJVGZESM-FNAHDJPLSA-N 0.000 description 1
- SJEYKCLWHCAMQL-ZCLUNYJNSA-N 7-[[(3s,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(3-chloro-2,4-difluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=C(F)C(Cl)=C1F SJEYKCLWHCAMQL-ZCLUNYJNSA-N 0.000 description 1
- MBKCHTMJAMAWPC-FMWKFLBASA-N 7-[[(3s,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(3-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=CC(Cl)=C1F MBKCHTMJAMAWPC-FMWKFLBASA-N 0.000 description 1
- FDJOKRBUPKWJTB-UWHLTILDSA-N 7-[[(3s,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(4,5-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC(Cl)=C(Cl)C=C1F FDJOKRBUPKWJTB-UWHLTILDSA-N 0.000 description 1
- ZLFBWBUGVAULCA-ZCLUNYJNSA-N 7-[[(3s,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(4-bromo-2,3-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=C(Br)C(Cl)=C1Cl ZLFBWBUGVAULCA-ZCLUNYJNSA-N 0.000 description 1
- BVPDJKPURONCRY-ZCLUNYJNSA-N 7-[[(3s,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=C(Br)C(Cl)=C1F BVPDJKPURONCRY-ZCLUNYJNSA-N 0.000 description 1
- OUEOJFCFMCXADD-UWHLTILDSA-N 7-[[(3s,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=C(Br)C(Cl)=C1 OUEOJFCFMCXADD-UWHLTILDSA-N 0.000 description 1
- UUILILXZMGYNLD-UWHLTILDSA-N 7-[[(3s,3ar,6s,6ar)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-n-(4-bromo-5-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound O([C@@H]1[C@H]2OC[C@@H]([C@H]2OC1)OC)C(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC(Cl)=C(Br)C=C1F UUILILXZMGYNLD-UWHLTILDSA-N 0.000 description 1
- OGNKTNDFGPEFFD-PWRODBHTSA-N 7-[[(3s,3as,6ar)-6-methylidene-2,3,3a,6a-tetrahydrofuro[3,2-b]furan-3-yl]oxy]-n-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@@H]3[C@@H]4[C@@H](C(CO4)=C)OC3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1 OGNKTNDFGPEFFD-PWRODBHTSA-N 0.000 description 1
- BDVHNGIDDSJCCD-UHFFFAOYSA-N 7-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(N=3)C=3C=CC(Cl)=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 BDVHNGIDDSJCCD-UHFFFAOYSA-N 0.000 description 1
- GVQHNFSUVYXILE-UHFFFAOYSA-N 7-[[4-(2-cyclohexylethyl)morpholin-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CCC4CCCCC4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 GVQHNFSUVYXILE-UHFFFAOYSA-N 0.000 description 1
- PFWWSXZJVNFSKD-UHFFFAOYSA-N 7-[[4-(3-chloropropylsulfonyl)morpholin-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)S(=O)(=O)CCCCl)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PFWWSXZJVNFSKD-UHFFFAOYSA-N 0.000 description 1
- KPUHDJMEVYIACF-UHFFFAOYSA-N 7-[[4-(cyclohexylmethyl)morpholin-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CC4CCCCC4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KPUHDJMEVYIACF-UHFFFAOYSA-N 0.000 description 1
- XNADADUSWUFNQO-UHFFFAOYSA-N 7-[[4-(cyclopropylmethyl)-1,4-oxazepan-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCCN(CC4CC4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 XNADADUSWUFNQO-UHFFFAOYSA-N 0.000 description 1
- MNXNBCHIKSVTIG-UHFFFAOYSA-N 7-[[4-(cyclopropylmethyl)morpholin-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CC4CC4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 MNXNBCHIKSVTIG-UHFFFAOYSA-N 0.000 description 1
- IAULTELZJHNXGT-GORDUTHDSA-N 7-[[4-[(e)-3-bromoprop-2-enyl]morpholin-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C\C=C\Br)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 IAULTELZJHNXGT-GORDUTHDSA-N 0.000 description 1
- QEIAACVSNFOMGZ-UHFFFAOYSA-N 7-[[4-chloro-2-(trifluoromethyl)quinolin-6-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C=C4C(Cl)=CC(=NC4=CC=3)C(F)(F)F)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QEIAACVSNFOMGZ-UHFFFAOYSA-N 0.000 description 1
- SNZSSCZJMVIOCR-UHFFFAOYSA-N 7-azabicyclo[2.2.1]heptane Chemical compound C1CC2CCC1N2 SNZSSCZJMVIOCR-UHFFFAOYSA-N 0.000 description 1
- VOQVXZHQBTXEHV-UHFFFAOYSA-N 7-cyclopentyloxy-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OC3CCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 VOQVXZHQBTXEHV-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 206010001233 Adenoma benign Diseases 0.000 description 1
- 108090000644 Angiozyme Proteins 0.000 description 1
- 229930091051 Arenine Natural products 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 206010073106 Bone giant cell tumour malignant Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- IZDHDILLHRXXCP-UHFFFAOYSA-N C1CN(C)CCN1C1=CN=C(N)N=C1N Chemical compound C1CN(C)CCN1C1=CN=C(N)N=C1N IZDHDILLHRXXCP-UHFFFAOYSA-N 0.000 description 1
- 102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
- 108010065524 CD52 Antigen Proteins 0.000 description 1
- RMVPLSSKKGJMDZ-UHFFFAOYSA-N COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)S(=O)(=O)N(CCCC1=CC=CC=C1)C)F.C1(=CC=CC=C1)CCNC(O)=O Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)S(=O)(=O)N(CCCC1=CC=CC=C1)C)F.C1(=CC=CC=C1)CCNC(O)=O RMVPLSSKKGJMDZ-UHFFFAOYSA-N 0.000 description 1
- 101100162703 Caenorhabditis elegans ani-1 gene Proteins 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 208000009458 Carcinoma in Situ Diseases 0.000 description 1
- 206010008263 Cervical dysplasia Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 201000005262 Chondroma Diseases 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 201000009047 Chordoma Diseases 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 description 1
- 206010048832 Colon adenoma Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- 208000007033 Dysgerminoma Diseases 0.000 description 1
- 208000000471 Dysplastic Nevus Syndrome Diseases 0.000 description 1
- 102100021757 E3 ubiquitin-protein ligase RNF135 Human genes 0.000 description 1
- 201000009051 Embryonal Carcinoma Diseases 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 208000006168 Ewing Sarcoma Diseases 0.000 description 1
- 208000007659 Fibroadenoma Diseases 0.000 description 1
- 206010053717 Fibrous histiocytoma Diseases 0.000 description 1
- 108010029961 Filgrastim Proteins 0.000 description 1
- 208000000527 Germinoma Diseases 0.000 description 1
- 208000007569 Giant Cell Tumors Diseases 0.000 description 1
- 201000005409 Gliomatosis cerebri Diseases 0.000 description 1
- 206010018404 Glucagonoma Diseases 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 208000002927 Hamartoma Diseases 0.000 description 1
- 206010019629 Hepatic adenoma Diseases 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
- 101001106984 Homo sapiens E3 ubiquitin-protein ligase RNF135 Proteins 0.000 description 1
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 1
- XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000005045 Interdigitating dendritic cell sarcoma Diseases 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102100020873 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- HQMLIDZJXVVKCW-REOHCLBHSA-N L-alaninamide Chemical compound C[C@H](N)C(N)=O HQMLIDZJXVVKCW-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FORGMRSGVSYZQR-YFKPBYRVSA-N L-leucinamide Chemical compound CC(C)C[C@H](N)C(N)=O FORGMRSGVSYZQR-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000005411 L01XE02 - Gefitinib Substances 0.000 description 1
- 239000002118 L01XE12 - Vandetanib Substances 0.000 description 1
- CZQHHVNHHHRRDU-UHFFFAOYSA-N LY294002 Chemical compound C1=CC=C2C(=O)C=C(N3CCOCC3)OC2=C1C1=CC=CC=C1 CZQHHVNHHHRRDU-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000002404 Liver Cell Adenoma Diseases 0.000 description 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
- 208000014767 Myeloproliferative disease Diseases 0.000 description 1
- AOJHSTBXOYQDKL-UHFFFAOYSA-N N'-(2,2-diphenylethyl)-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1(=CC=CC=C1)C(CN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F)C1=CC=CC=C1 AOJHSTBXOYQDKL-UHFFFAOYSA-N 0.000 description 1
- QANDDOAGOAYEMD-UHFFFAOYSA-N N'-(2,3-dihydro-1H-inden-2-yl)-N'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCN(CC1)C)N(C(C(=O)N)=O)C1CC2=CC=CC=C2C1 QANDDOAGOAYEMD-UHFFFAOYSA-N 0.000 description 1
- SHBRJGOJKCUXJD-UHFFFAOYSA-N N'-[(2,3-difluorophenyl)methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound FC1=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=CC=C1F SHBRJGOJKCUXJD-UHFFFAOYSA-N 0.000 description 1
- IDPUPNAYWVEHQL-UHFFFAOYSA-N N'-[(2,4-dichlorophenyl)methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC1=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=CC(=C1)Cl IDPUPNAYWVEHQL-UHFFFAOYSA-N 0.000 description 1
- WWIXWCNBCIYDPW-UHFFFAOYSA-N N'-[(3-chlorophenyl)methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC=1C=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=CC1 WWIXWCNBCIYDPW-UHFFFAOYSA-N 0.000 description 1
- BRVANNJFPHCTLN-UHFFFAOYSA-N N'-[2-(2,4-dimethylphenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound CC1=C(C=CC(=C1)C)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F BRVANNJFPHCTLN-UHFFFAOYSA-N 0.000 description 1
- ZJOVUVCWUCVORP-UHFFFAOYSA-N N'-[2-(2-chloro-6-fluorophenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC1=C(C(=CC=C1)F)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F ZJOVUVCWUCVORP-UHFFFAOYSA-N 0.000 description 1
- SGIRDFOIYLKJQR-UHFFFAOYSA-N N'-[2-(3-chlorophenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC=1C=C(C=CC1)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F SGIRDFOIYLKJQR-UHFFFAOYSA-N 0.000 description 1
- OWJQRCKMDNDTCX-UHFFFAOYSA-N N'-[2-(4-ethoxyphenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C(C)OC1=CC=C(C=C1)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F OWJQRCKMDNDTCX-UHFFFAOYSA-N 0.000 description 1
- CUHFKKHWKYNIBZ-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinolin-4-yl]oxyphenyl]-N'-(2-phenylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCCCC1)N(C(C(=O)N)=O)CCC1=CC=CC=C1 CUHFKKHWKYNIBZ-UHFFFAOYSA-N 0.000 description 1
- GUOMYCUWNVYIAU-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-yl]oxyphenyl]-N'-(2-phenylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=NC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC=CC=C1 GUOMYCUWNVYIAU-UHFFFAOYSA-N 0.000 description 1
- TZWUMSSNEHVFDA-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-(2-hydroxy-2-phenylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CC(C1=CC=CC=C1)O TZWUMSSNEHVFDA-UHFFFAOYSA-N 0.000 description 1
- RQWNGPCPOMYOSD-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-(2-phenoxyethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCOC1=CC=CC=C1 RQWNGPCPOMYOSD-UHFFFAOYSA-N 0.000 description 1
- PSYAQEPXKRMVFQ-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-(2-pyridin-3-ylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC=1C=NC=CC1 PSYAQEPXKRMVFQ-UHFFFAOYSA-N 0.000 description 1
- KVXNIXCBQWJMIU-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-(3-methylbutyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC(C)C KVXNIXCBQWJMIU-UHFFFAOYSA-N 0.000 description 1
- YQQDFIJZERXPLT-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-(pyridin-2-ylmethyl)oxamide Chemical compound COc1cc2c(Oc3ccc(cc3F)N(Cc3ccccn3)C(=O)C(N)=O)ccnc2cc1OCC1CCNCC1 YQQDFIJZERXPLT-UHFFFAOYSA-N 0.000 description 1
- UBOLFIMFOLUPNC-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[(2-methylphenyl)methyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CC1=C(C=CC=C1)C UBOLFIMFOLUPNC-UHFFFAOYSA-N 0.000 description 1
- AKWCWLMHWBFYKL-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(2-methylphenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=C(C=CC=C1)C AKWCWLMHWBFYKL-UHFFFAOYSA-N 0.000 description 1
- KDKVAIBOMQVGRL-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(3-hydroxy-4-methoxyphenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC(=C(C=C1)OC)O KDKVAIBOMQVGRL-UHFFFAOYSA-N 0.000 description 1
- JNBMJGDYYQVTTB-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(4-fluorophenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC=C(C=C1)F JNBMJGDYYQVTTB-UHFFFAOYSA-N 0.000 description 1
- PYCYCPBXZZINIA-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(4-hydroxy-3-methoxyphenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC(=C(C=C1)O)OC PYCYCPBXZZINIA-UHFFFAOYSA-N 0.000 description 1
- NTTNWCDUUDLYCW-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(4-methoxyphenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC=C(C=C1)OC NTTNWCDUUDLYCW-UHFFFAOYSA-N 0.000 description 1
- CLFPTPMBLVTAMA-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(4-sulfamoylphenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC=C(C=C1)S(N)(=O)=O CLFPTPMBLVTAMA-UHFFFAOYSA-N 0.000 description 1
- UQEBZRGOCBSPOH-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[[4-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CC1=CC=C(C=C1)C(F)(F)F UQEBZRGOCBSPOH-UHFFFAOYSA-N 0.000 description 1
- JGYSJPOSQLNGAC-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-[(1-methylazetidin-3-yl)methoxy]quinolin-4-yl]oxyphenyl]-N'-(2-phenylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CN(C1)C)N(C(C(=O)N)=O)CCC1=CC=CC=C1 JGYSJPOSQLNGAC-UHFFFAOYSA-N 0.000 description 1
- LGKCOPJSURTSNG-UHFFFAOYSA-N N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-N'-(1,2,3,4-tetrahydronaphthalen-2-yl)oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)C1CC2=CC=CC=C2CC1)F LGKCOPJSURTSNG-UHFFFAOYSA-N 0.000 description 1
- XOKVUNXENCKGMY-UHFFFAOYSA-N N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-N'-[(2-ethyl-3,4-dihydro-1H-isoquinolin-1-yl)methyl]oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)CC1N(CCC2=CC=CC=C12)CC)F XOKVUNXENCKGMY-UHFFFAOYSA-N 0.000 description 1
- DAGPGIWGYBJKGR-UHFFFAOYSA-N N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-N'-[(2-propan-2-yl-3,4-dihydro-1H-isoquinolin-1-yl)methyl]oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)CC1N(CCC2=CC=CC=C12)C(C)C)F DAGPGIWGYBJKGR-UHFFFAOYSA-N 0.000 description 1
- LGKCOPJSURTSNG-IBGZPJMESA-N N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-N'-[(2S)-1,2,3,4-tetrahydronaphthalen-2-yl]oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)[C@@H]1CC2=CC=CC=C2CC1)F LGKCOPJSURTSNG-IBGZPJMESA-N 0.000 description 1
- QYWQSWRKYVITFF-UHFFFAOYSA-N N'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-N'-(4-fluorophenyl)propanediamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=CC=C(C=C1)N(C(CC(=O)N)=O)C1=CC=C(C=C1)F QYWQSWRKYVITFF-UHFFFAOYSA-N 0.000 description 1
- UVCZDEPACFHYOL-UHFFFAOYSA-N N'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-N'-(3-fluorophenyl)propanediamide Chemical compound ClC=1C=C(C=NC1OC1=CC=NC2=CC(=C(C=C12)OC)OC)N(C(CC(=O)N)=O)C1=CC(=CC=C1)F UVCZDEPACFHYOL-UHFFFAOYSA-N 0.000 description 1
- NMUORFMLPBHECQ-UHFFFAOYSA-N N'-[5-chloro-6-[7-[3-(diethylamino)propoxy]-6-methoxyquinolin-4-yl]oxypyridin-3-yl]-N'-(4-fluorophenyl)propanediamide Chemical compound ClC=1C=C(C=NC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN(CC)CC)N(C(CC(=O)N)=O)C1=CC=C(C=C1)F NMUORFMLPBHECQ-UHFFFAOYSA-N 0.000 description 1
- GMYSTEHZXYWNSK-UHFFFAOYSA-N N'-[6-(6,7-dimethoxyquinolin-4-yl)oxypyridazin-3-yl]-N'-(4-fluorophenyl)propanediamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=CC=C(N=N1)N(C(CC(=O)N)=O)C1=CC=C(C=C1)F GMYSTEHZXYWNSK-UHFFFAOYSA-N 0.000 description 1
- MXKYMGXRGFJPAR-UHFFFAOYSA-N N'-[[3,5-bis(trifluoromethyl)phenyl]methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound FC(C=1C=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=C(C1)C(F)(F)F)(F)F MXKYMGXRGFJPAR-UHFFFAOYSA-N 0.000 description 1
- YMKDWDPLUGMEHP-UHFFFAOYSA-N N'-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC1=C(C=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=C1)C(F)(F)F YMKDWDPLUGMEHP-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- GCIKSSRWRFVXBI-UHFFFAOYSA-N N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide Chemical compound C1CN(C)CCN1C1=CC(NC2=NNC(C)=C2)=NC(SC=2C=CC(NC(=O)C3CC3)=CC=2)=N1 GCIKSSRWRFVXBI-UHFFFAOYSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 201000004404 Neurofibroma Diseases 0.000 description 1
- 108010016076 Octreotide Proteins 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- 206010031149 Osteitis Diseases 0.000 description 1
- 208000000035 Osteochondroma Diseases 0.000 description 1
- 102000038030 PI3Ks Human genes 0.000 description 1
- 101150073900 PTEN gene Proteins 0.000 description 1
- 208000034038 Pathologic Neovascularization Diseases 0.000 description 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
- 208000007641 Pinealoma Diseases 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 101710113459 RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 1
- 229940127361 Receptor Tyrosine Kinase Inhibitors Drugs 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 208000005678 Rhabdomyoma Diseases 0.000 description 1
- 201000010208 Seminoma Diseases 0.000 description 1
- 208000000097 Sertoli-Leydig cell tumor Diseases 0.000 description 1
- 101000655609 Streptomyces azureus Thiostrepton Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- IVTVGDXNLFLDRM-HNNXBMFYSA-N Tomudex Chemical compound C=1C=C2NC(C)=NC(=O)C2=CC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)S1 IVTVGDXNLFLDRM-HNNXBMFYSA-N 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 description 1
- 108091008605 VEGF receptors Proteins 0.000 description 1
- 208000009311 VIPoma Diseases 0.000 description 1
- 206010048214 Xanthoma Diseases 0.000 description 1
- 206010048215 Xanthomatosis Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 102100025093 Zinc fingers and homeoboxes protein 2 Human genes 0.000 description 1
- IXRXEXNQINCIRZ-UHFFFAOYSA-N [1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 IXRXEXNQINCIRZ-UHFFFAOYSA-N 0.000 description 1
- FTDNIAMWPZPKLR-UHFFFAOYSA-N [1-(3-chlorophenyl)-4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-2-yl]methanol Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1CO)CCN1C1=CC=CC(Cl)=C1 FTDNIAMWPZPKLR-UHFFFAOYSA-N 0.000 description 1
- URDNYNTUOXZTMC-UHFFFAOYSA-N [3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]-cyclopropylmethanone Chemical compound C1=C(C(=O)C2CC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 URDNYNTUOXZTMC-UHFFFAOYSA-N 0.000 description 1
- QMSVBRCEGLXJLU-UHFFFAOYSA-N [3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]-phenylmethanone Chemical compound C1=C(C(=O)C=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 QMSVBRCEGLXJLU-UHFFFAOYSA-N 0.000 description 1
- KXAKPLZFCFFJSW-UHFFFAOYSA-N [3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]methanol Chemical compound C1=C(CO)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 KXAKPLZFCFFJSW-UHFFFAOYSA-N 0.000 description 1
- CGOHQJJEFSEPIG-UHFFFAOYSA-N [4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-(1h-indol-6-yl)methanol Chemical compound C1=C2C=CNC2=CC(C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)O)=C1 CGOHQJJEFSEPIG-UHFFFAOYSA-N 0.000 description 1
- JVFJIPKDZWTIPS-UHFFFAOYSA-N [4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-(1h-indol-6-yl)methanone Chemical compound C1=C2C=CNC2=CC(C(=O)N2CCN(CC2)C=2N=CN=C3NN=C(C=23)Br)=C1 JVFJIPKDZWTIPS-UHFFFAOYSA-N 0.000 description 1
- RXZBKYRMJPSQSI-UHFFFAOYSA-N [4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-(furan-2-yl)methanone Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 RXZBKYRMJPSQSI-UHFFFAOYSA-N 0.000 description 1
- ATNQJIZWZJGBST-UHFFFAOYSA-N [4-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,3-thiazol-2-yl]methanol Chemical compound N1=CN=C2C=C(OCC=3N=C(CO)SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ATNQJIZWZJGBST-UHFFFAOYSA-N 0.000 description 1
- SROSEDFOBYVYCH-UHFFFAOYSA-N [4-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,3-thiazol-2-yl]methyl benzoate Chemical compound N1=CN=C2C=C(OCC=3N=C(COC(=O)C=4C=CC=CC=4)SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 SROSEDFOBYVYCH-UHFFFAOYSA-N 0.000 description 1
- BKYQHYYQDPBHJM-UHFFFAOYSA-N [5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methoxyphenyl]-(4-methylpiperazin-1-yl)methanone Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1OC)=CC(Cl)=CC=1C(=O)N1CCN(C)CC1 BKYQHYYQDPBHJM-UHFFFAOYSA-N 0.000 description 1
- XRLQDQSANHSNIL-UHFFFAOYSA-N [5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methoxyphenyl]methanol Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC(CO)=C1OC XRLQDQSANHSNIL-UHFFFAOYSA-N 0.000 description 1
- 229940028652 abraxane Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000002718 adenomatoid tumor Diseases 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 229940060265 aldara Drugs 0.000 description 1
- 125000006524 alkoxy alkyl amino group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229960000473 altretamine Drugs 0.000 description 1
- 229960003437 aminoglutethimide Drugs 0.000 description 1
- ROBVIMPUHSLWNV-UHFFFAOYSA-N aminoglutethimide Chemical compound C=1C=C(N)C=CC=1C1(CC)CCC(=O)NC1=O ROBVIMPUHSLWNV-UHFFFAOYSA-N 0.000 description 1
- XCPGHVQEEXUHNC-UHFFFAOYSA-N amsacrine Chemical compound COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 XCPGHVQEEXUHNC-UHFFFAOYSA-N 0.000 description 1
- 229960001220 amsacrine Drugs 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 229940046844 aromatase inhibitors Drugs 0.000 description 1
- 238000007080 aromatic substitution reaction Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000001119 benign fibrous histiocytoma Diseases 0.000 description 1
- 125000004244 benzofuran-2-yl group Chemical group [H]C1=C(*)OC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 125000004532 benzofuran-3-yl group Chemical group O1C=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000004533 benzofuran-5-yl group Chemical group O1C=CC2=C1C=CC(=C2)* 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- MFKRXVSUXUOTFP-PLQXJYEYSA-N benzyl (3ar,6as)-5-[[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]methylidene]-1,3,3a,4,6,6a-hexahydrocyclopenta[c]pyrrole-2-carboxylate Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=C4C[C@H]5CN(C[C@H]5C4)C(=O)OCC=4C=CC=CC=4)=NNC=3N=CN=2)CC1 MFKRXVSUXUOTFP-PLQXJYEYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000018339 bone inflammation disease Diseases 0.000 description 1
- 201000009480 botryoid rhabdomyosarcoma Diseases 0.000 description 1
- 238000002725 brachytherapy Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000003149 breast fibroadenoma Diseases 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 201000002143 bronchus adenoma Diseases 0.000 description 1
- 229960002092 busulfan Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- 229940088954 camptosar Drugs 0.000 description 1
- 229940127093 camptothecin Drugs 0.000 description 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004709 cell invasion Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000010109 chemoembolization Effects 0.000 description 1
- 239000012829 chemotherapy agent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 201000005217 chondroblastoma Diseases 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 229960002436 cladribine Drugs 0.000 description 1
- 208000009060 clear cell adenocarcinoma Diseases 0.000 description 1
- WDDPHFBMKLOVOX-AYQXTPAHSA-N clofarabine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F WDDPHFBMKLOVOX-AYQXTPAHSA-N 0.000 description 1
- 229960000928 clofarabine Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 201000010305 cutaneous fibrous histiocytoma Diseases 0.000 description 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- KSFMKTNHEIDMFI-UHFFFAOYSA-N cyclopentyl-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]methanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C3CCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KSFMKTNHEIDMFI-UHFFFAOYSA-N 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
- 229960001140 cyproheptadine Drugs 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000003436 cytoskeletal effect Effects 0.000 description 1
- 229940026692 decadron Drugs 0.000 description 1
- 125000005507 decahydroisoquinolyl group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 229940064790 dilantin Drugs 0.000 description 1
- 125000005805 dimethoxy phenyl group Chemical group 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 229940115080 doxil Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 201000009409 embryonal rhabdomyosarcoma Diseases 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960001904 epirubicin Drugs 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- BNUGLBWENYXRLR-UHFFFAOYSA-N ethyl 4-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-(trifluoromethyl)pyrimidine-5-carboxylate Chemical compound CCOC(=O)C1=CN=C(C(F)(F)F)N=C1N1CCN(C=2C=3C(CC)=NNC=3N=CN=2)CC1 BNUGLBWENYXRLR-UHFFFAOYSA-N 0.000 description 1
- 229940012017 ethylenediamine Drugs 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- LIQODXNTTZAGID-OCBXBXKTSA-N etoposide phosphate Chemical compound COC1=C(OP(O)(O)=O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 LIQODXNTTZAGID-OCBXBXKTSA-N 0.000 description 1
- 229960000752 etoposide phosphate Drugs 0.000 description 1
- ZVYVPGLRVWUPMP-FYSMJZIKSA-N exatecan Chemical compound C1C[C@H](N)C2=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC3=CC(F)=C(C)C1=C32 ZVYVPGLRVWUPMP-FYSMJZIKSA-N 0.000 description 1
- 229950009429 exatecan Drugs 0.000 description 1
- 238000002710 external beam radiation therapy Methods 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- YAKWPXVTIGTRJH-UHFFFAOYSA-N fotemustine Chemical compound CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)N=O YAKWPXVTIGTRJH-UHFFFAOYSA-N 0.000 description 1
- 229960004783 fotemustine Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000015419 gastrin-producing neuroendocrine tumor Diseases 0.000 description 1
- 201000000052 gastrinoma Diseases 0.000 description 1
- 229960002584 gefitinib Drugs 0.000 description 1
- 229940020967 gemzar Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 201000003115 germ cell cancer Diseases 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 230000036433 growing body Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 125000005291 haloalkenyloxy group Chemical group 0.000 description 1
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 210000002767 hepatic artery Anatomy 0.000 description 1
- 208000006359 hepatoblastoma Diseases 0.000 description 1
- 201000002735 hepatocellular adenoma Diseases 0.000 description 1
- 125000004475 heteroaralkyl group Chemical group 0.000 description 1
- UUVWYPNAQBNQJQ-UHFFFAOYSA-N hexamethylmelamine Chemical compound CN(C)C1=NC(N(C)C)=NC(N(C)C)=N1 UUVWYPNAQBNQJQ-UHFFFAOYSA-N 0.000 description 1
- AILKHAQXUAOOFU-UHFFFAOYSA-N hexanenitrile Chemical compound CCCCCC#N AILKHAQXUAOOFU-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 1
- 229940096120 hydrea Drugs 0.000 description 1
- 229960001330 hydroxycarbamide Drugs 0.000 description 1
- 238000009802 hysterectomy Methods 0.000 description 1
- 229940099279 idamycin Drugs 0.000 description 1
- 229960000908 idarubicin Drugs 0.000 description 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 229960002751 imiquimod Drugs 0.000 description 1
- 201000004933 in situ carcinoma Diseases 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 description 1
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 description 1
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 201000010985 invasive ductal carcinoma Diseases 0.000 description 1
- 239000011630 iodine Chemical group 0.000 description 1
- XMBWDFGMSWQBCA-RNFDNDRNSA-M iodine-131(1-) Chemical group [131I-] XMBWDFGMSWQBCA-RNFDNDRNSA-M 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229960005386 ipilimumab Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- SANOUVWGPVYVAV-UHFFFAOYSA-N isovaleramide Chemical compound CC(C)CC(N)=O SANOUVWGPVYVAV-UHFFFAOYSA-N 0.000 description 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000022013 kidney Wilms tumor Diseases 0.000 description 1
- 229960002437 lanreotide Drugs 0.000 description 1
- 108010021336 lanreotide Proteins 0.000 description 1
- 238000002430 laser surgery Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229940087875 leukine Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 206010024627 liposarcoma Diseases 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- NDAZATDQFDPQBD-UHFFFAOYSA-N luminespib Chemical compound CCNC(=O)C1=NOC(C=2C(=CC(O)=C(C(C)C)C=2)O)=C1C(C=C1)=CC=C1CN1CCOCC1 NDAZATDQFDPQBD-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- RVFGKBWWUQOIOU-NDEPHWFRSA-N lurtotecan Chemical compound O=C([C@]1(O)CC)OCC(C(N2CC3=4)=O)=C1C=C2C3=NC1=CC=2OCCOC=2C=C1C=4CN1CCN(C)CC1 RVFGKBWWUQOIOU-NDEPHWFRSA-N 0.000 description 1
- 229950002654 lurtotecan Drugs 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 201000004593 malignant giant cell tumor Diseases 0.000 description 1
- 201000000289 malignant teratoma Diseases 0.000 description 1
- WRIRWRKPLXCTFD-UHFFFAOYSA-N malonamide Chemical compound NC(=O)CC(N)=O WRIRWRKPLXCTFD-UHFFFAOYSA-N 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229960002985 medroxyprogesterone acetate Drugs 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 1
- 229960001428 mercaptopurine Drugs 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- MHJODCMTBYFIEJ-UHFFFAOYSA-N methyl 1-(3-chlorophenyl)-4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazine-2-carboxylate Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1C(=O)OC)CCN1C1=CC=CC(Cl)=C1 MHJODCMTBYFIEJ-UHFFFAOYSA-N 0.000 description 1
- UUZYXVMMMLOUNS-UHFFFAOYSA-N methyl 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzoate Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)OC)=CC=1NCCN1CCCC1 UUZYXVMMMLOUNS-UHFFFAOYSA-N 0.000 description 1
- PRGBKZSNTIVFOY-UHFFFAOYSA-N methyl 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 PRGBKZSNTIVFOY-UHFFFAOYSA-N 0.000 description 1
- DUAMSJLUECLRIC-UHFFFAOYSA-N methyl 3-bromo-5-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylbenzoate Chemical compound COC(=O)C1=CC(Br)=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 DUAMSJLUECLRIC-UHFFFAOYSA-N 0.000 description 1
- VPIMYSTZNLMODO-UHFFFAOYSA-N methyl 4-(3-chlorophenyl)-1-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazine-2-carboxylate Chemical compound C=12C(CC)=NNC2=NC=NC=1N(C(C1)C(=O)OC)CCN1C1=CC=CC(Cl)=C1 VPIMYSTZNLMODO-UHFFFAOYSA-N 0.000 description 1
- VGKSTMJEMVAVLY-UHFFFAOYSA-N methyl 4-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-4-oxobutanoate Chemical compound C1N(C(=O)CCC(=O)OC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC VGKSTMJEMVAVLY-UHFFFAOYSA-N 0.000 description 1
- GQBGDMIPLRKLGO-UHFFFAOYSA-N methyl 5-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]pentanoate Chemical compound C1N(CCCCC(=O)OC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC GQBGDMIPLRKLGO-UHFFFAOYSA-N 0.000 description 1
- PXZRFXUTDHJZIR-UHFFFAOYSA-N methyl 5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methoxybenzoate Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC(C(=O)OC)=C1OC PXZRFXUTDHJZIR-UHFFFAOYSA-N 0.000 description 1
- RGVJCTNUQFLEIU-UHFFFAOYSA-N methyl n-[6-(1-hydroxy-3-oxo-2-phenylisoindol-1-yl)-1h-benzimidazol-2-yl]carbamate Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(C1=CC=CC=C1C1=O)(O)N1C1=CC=CC=C1 RGVJCTNUQFLEIU-UHFFFAOYSA-N 0.000 description 1
- XIASUMPJIFQSHT-UHFFFAOYSA-N methyl n-[6-(2-benzyl-1-hydroxy-3-oxoisoindol-1-yl)-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=CC=C1 XIASUMPJIFQSHT-UHFFFAOYSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
- 229960001156 mitoxantrone Drugs 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 208000010492 mucinous cystadenocarcinoma Diseases 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- 208000009091 myxoma Diseases 0.000 description 1
- QRFBJPHWCGAUIE-UHFFFAOYSA-N n'-(1,2-diphenylethyl)-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)C(C=1C=CC=CC=1)CC1=CC=CC=C1 QRFBJPHWCGAUIE-UHFFFAOYSA-N 0.000 description 1
- MHUHNLOKYAFLLC-UHFFFAOYSA-N n'-(3,4-dimethoxyphenyl)-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=C(OC)C(OC)=CC=C1N(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 MHUHNLOKYAFLLC-UHFFFAOYSA-N 0.000 description 1
- BIHVKQQJFHZSMV-UHFFFAOYSA-N n'-[(2,6-difluorophenyl)methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=C(F)C=CC=C1F BIHVKQQJFHZSMV-UHFFFAOYSA-N 0.000 description 1
- CXTVEZVVIZOKCX-UHFFFAOYSA-N n'-[(2-chlorophenyl)methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC=C1Cl CXTVEZVVIZOKCX-UHFFFAOYSA-N 0.000 description 1
- VAZQDLJATFXDQX-UHFFFAOYSA-N n'-[(3-chloro-4-fluorophenyl)methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(F)C(Cl)=C1 VAZQDLJATFXDQX-UHFFFAOYSA-N 0.000 description 1
- SHRIWHDIQWBKEQ-UHFFFAOYSA-N n'-[(4-chlorophenyl)methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(Cl)C=C1 SHRIWHDIQWBKEQ-UHFFFAOYSA-N 0.000 description 1
- OSUZDWTYUMJTHI-UHFFFAOYSA-N n'-[1-(4-bromophenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)C(C)C1=CC=C(Br)C=C1 OSUZDWTYUMJTHI-UHFFFAOYSA-N 0.000 description 1
- ADHUJWPENAXHHO-UHFFFAOYSA-N n'-[2-(2,6-dichlorophenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=C(Cl)C=CC=C1Cl ADHUJWPENAXHHO-UHFFFAOYSA-N 0.000 description 1
- BJAQGIFSUNQBIK-UHFFFAOYSA-N n'-[2-(2-bromophenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=C1Br BJAQGIFSUNQBIK-UHFFFAOYSA-N 0.000 description 1
- UJVMZIXXQGHOAU-UHFFFAOYSA-N n'-[2-(3,4-dimethylphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=C(C)C(C)=C1 UJVMZIXXQGHOAU-UHFFFAOYSA-N 0.000 description 1
- HXDRSIHFHWJUTM-UHFFFAOYSA-N n'-[2-(3-chloro-4-propoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=C(Cl)C(OCCC)=CC=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 HXDRSIHFHWJUTM-UHFFFAOYSA-N 0.000 description 1
- MIONBUGKIMNZDK-UHFFFAOYSA-N n'-[2-(3-ethoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound CCOC1=CC=CC(CCN(C(=O)C(N)=O)C=2C=C(F)C(OC=3C4=CC(OC)=C(OCC5CCNCC5)C=C4N=CC=3)=CC=2)=C1 MIONBUGKIMNZDK-UHFFFAOYSA-N 0.000 description 1
- OARSLOGGCXJZEQ-UHFFFAOYSA-N n'-[2-(4-ethylphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CC(CC)=CC=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 OARSLOGGCXJZEQ-UHFFFAOYSA-N 0.000 description 1
- UXFDYZMSAGLGQI-UHFFFAOYSA-N n'-[2-(5-bromo-2-methoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound COC1=CC=C(Br)C=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 UXFDYZMSAGLGQI-UHFFFAOYSA-N 0.000 description 1
- WEDJHNSKRMELGF-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-(2-morpholin-4-ylethyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCN1CCOCC1 WEDJHNSKRMELGF-UHFFFAOYSA-N 0.000 description 1
- GUFMREBOILTMHX-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-(3-fluorophenyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)C1=CC=CC(F)=C1 GUFMREBOILTMHX-UHFFFAOYSA-N 0.000 description 1
- PRBUXCUVQDBAEH-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-(pyrazin-2-ylmethyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CN=CC=N1 PRBUXCUVQDBAEH-UHFFFAOYSA-N 0.000 description 1
- JBLRNTDNUUTQTR-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[(3-methoxyphenyl)methyl]oxamide Chemical compound COC1=CC=CC(CN(C(=O)C(N)=O)C=2C=C(F)C(OC=3C4=CC(OC)=C(OCC5CCNCC5)C=C4N=CC=3)=CC=2)=C1 JBLRNTDNUUTQTR-UHFFFAOYSA-N 0.000 description 1
- UYERONFVMOQSNI-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[2-(2-methoxyphenyl)ethyl]oxamide Chemical compound COC1=CC=CC=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 UYERONFVMOQSNI-UHFFFAOYSA-N 0.000 description 1
- SAQSBEAOAXKHOY-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[2-(trifluoromethoxy)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC=C1OC(F)(F)F SAQSBEAOAXKHOY-UHFFFAOYSA-N 0.000 description 1
- RFCGTWIISNFCDF-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[2-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC=C1C(F)(F)F RFCGTWIISNFCDF-UHFFFAOYSA-N 0.000 description 1
- AHGKJVQWGDQNJJ-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[2-fluoro-5-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC(C(F)(F)F)=CC=C1F AHGKJVQWGDQNJJ-UHFFFAOYSA-N 0.000 description 1
- VHVQDPDVJSMCGN-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[3-fluoro-4-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(C(F)(F)F)C(F)=C1 VHVQDPDVJSMCGN-UHFFFAOYSA-N 0.000 description 1
- AMAWTSSJAPQBAS-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[4-(trifluoromethoxy)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(OC(F)(F)F)C=C1 AMAWTSSJAPQBAS-UHFFFAOYSA-N 0.000 description 1
- GSGZYCQNRMNINF-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[4-fluoro-2-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(F)C=C1C(F)(F)F GSGZYCQNRMNINF-UHFFFAOYSA-N 0.000 description 1
- HOAPRTSJSQDTEC-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-phenacyloxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC(=O)C1=CC=CC=C1 HOAPRTSJSQDTEC-UHFFFAOYSA-N 0.000 description 1
- YEBVMRNEJPVYMT-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]-n'-(3-methylbutyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCN(C)CC3)C(OC)=CC2=C1OC1=CC=C(N(CCC(C)C)C(=O)C(N)=O)C=C1F YEBVMRNEJPVYMT-UHFFFAOYSA-N 0.000 description 1
- PTUAKBITUGWEJK-QFIPXVFZSA-N n'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]-n'-[(2r)-2-phenylpropyl]oxamide Chemical compound C1([C@@H](C)CN(C2=CC=C(C(=C2)F)OC2=C3C=C(C(=CC3=NC=C2)OCC2CCN(C)CC2)OC)C(=O)C(N)=O)=CC=CC=C1 PTUAKBITUGWEJK-QFIPXVFZSA-N 0.000 description 1
- WEWCSGQKQILLHC-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]-n'-[[4-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCN(C)CC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(C(F)(F)F)C=C1 WEWCSGQKQILLHC-UHFFFAOYSA-N 0.000 description 1
- FPLZJOOLXIRTQZ-UHFFFAOYSA-N n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-n'-[2-(1-methylpyrrolidin-2-yl)ethyl]oxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1CCCN1C FPLZJOOLXIRTQZ-UHFFFAOYSA-N 0.000 description 1
- FXVKXMPLCGOGOJ-UHFFFAOYSA-N n'-[4-[7-(azetidin-3-ylmethoxy)-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-n'-(2-phenylethyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CNC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=C1 FXVKXMPLCGOGOJ-UHFFFAOYSA-N 0.000 description 1
- WMWYFIPYHAOQOZ-UHFFFAOYSA-N n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-2,2-difluoro-n'-(4-fluorophenyl)propanediamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C(=O)C(F)(F)C(N)=O)C1=CC=C(F)C=C1 WMWYFIPYHAOQOZ-UHFFFAOYSA-N 0.000 description 1
- XHIMDSBXPZOCFR-UHFFFAOYSA-N n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-n'-(4-fluorophenyl)-2,2-dimethylpropanediamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C(=O)C(C)(C)C(N)=O)C1=CC=C(F)C=C1 XHIMDSBXPZOCFR-UHFFFAOYSA-N 0.000 description 1
- AQGFALYMBJAAHT-UHFFFAOYSA-N n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-n'-phenylpropanediamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C(=O)CC(N)=O)C1=CC=CC=C1 AQGFALYMBJAAHT-UHFFFAOYSA-N 0.000 description 1
- VCWSBVNJSGVPRT-UHFFFAOYSA-N n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-n-(3-chlorophenyl)propanediamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1NC(=O)CC(=O)NC1=CC=CC(Cl)=C1 VCWSBVNJSGVPRT-UHFFFAOYSA-N 0.000 description 1
- RBHLXTJIJYFKPJ-UHFFFAOYSA-N n'-[5-chloro-6-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxypyridin-3-yl]-n'-(4-fluorophenyl)propanediamide Chemical compound C1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1OC(C(=C1)Cl)=NC=C1N(C(=O)CC(N)=O)C1=CC=C(F)C=C1 RBHLXTJIJYFKPJ-UHFFFAOYSA-N 0.000 description 1
- IQZXEWHZDPQPOU-UHFFFAOYSA-N n'-[[2-chloro-5-(trifluoromethyl)phenyl]methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC(C(F)(F)F)=CC=C1Cl IQZXEWHZDPQPOU-UHFFFAOYSA-N 0.000 description 1
- UYQHCSWNVKEYCB-UHFFFAOYSA-N n'-benzyl-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC=C1 UYQHCSWNVKEYCB-UHFFFAOYSA-N 0.000 description 1
- QUHXFAXDRHMTPJ-UHFFFAOYSA-N n'-cyclopentyl-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)C1CCCC1 QUHXFAXDRHMTPJ-UHFFFAOYSA-N 0.000 description 1
- UKRKRPLHUUSIOI-UHFFFAOYSA-N n,n-diethyl-2-[3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylphenoxy]ethanamine Chemical compound CCN(CC)CCOC1=CC=CC(N2CCN(CC2)C=2C=3C(CC)=NNC=3N=CN=2)=C1C UKRKRPLHUUSIOI-UHFFFAOYSA-N 0.000 description 1
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 description 1
- WBWOWVVMHMPZCL-UHFFFAOYSA-N n-[2-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoroanilino]-2-oxoethyl]benzamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)CNC(=O)C1=CC=CC=C1 WBWOWVVMHMPZCL-UHFFFAOYSA-N 0.000 description 1
- QPJAQDDXUMCFFT-UHFFFAOYSA-N n-[3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-ynyl]acetamide Chemical compound C=12C(C#CCNC(=O)C)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C QPJAQDDXUMCFFT-UHFFFAOYSA-N 0.000 description 1
- LQPDMTMOALUWFE-UHFFFAOYSA-N n-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-2-oxo-2-(2-phenylmorpholin-4-yl)acetamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1NC(=O)C(=O)N(C1)CCOC1C1=CC=CC=C1 LQPDMTMOALUWFE-UHFFFAOYSA-N 0.000 description 1
- TXLQIUCCMVAHPH-UHFFFAOYSA-N n-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-2-oxo-2-pyrrolidin-1-ylacetamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1NC(=O)C(=O)N1CCCC1 TXLQIUCCMVAHPH-UHFFFAOYSA-N 0.000 description 1
- BPBNPYIAQQQYEC-UHFFFAOYSA-N n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-2-phenylethanesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NS(=O)(=O)CCC1=CC=CC=C1 BPBNPYIAQQQYEC-UHFFFAOYSA-N 0.000 description 1
- FYPKKMXVPZRAMM-UHFFFAOYSA-N n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-3-phenylpropane-1-sulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NS(=O)(=O)CCCC1=CC=CC=C1 FYPKKMXVPZRAMM-UHFFFAOYSA-N 0.000 description 1
- ZIOKLLOGXHVZMP-UHFFFAOYSA-N n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-4-phenyl-1,3-thiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(SC=1)=NC=1C1=CC=CC=C1 ZIOKLLOGXHVZMP-UHFFFAOYSA-N 0.000 description 1
- ABKNTMIBDIAIAN-UHFFFAOYSA-N n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-2-phenoxyiminopropanamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)C(C)=NOC1=CC=CC=C1 ABKNTMIBDIAIAN-UHFFFAOYSA-N 0.000 description 1
- CXRSSJQLJNMMKA-UHFFFAOYSA-N n-[4-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1C1=NNC2=NC=NC(N3CCN(CC3)C=3C(=CC=C(Cl)C=3)C)=C12 CXRSSJQLJNMMKA-UHFFFAOYSA-N 0.000 description 1
- QJPVWHLCDSPLDP-UHFFFAOYSA-N n-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-3-oxo-4-phenylbutanamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1NC(=O)CC(=O)CC1=CC=CC=C1 QJPVWHLCDSPLDP-UHFFFAOYSA-N 0.000 description 1
- YZENPKZLUFXKQO-UHFFFAOYSA-N n-[6-(6,7-dimethoxyquinolin-4-yl)oxy-1,3-benzothiazol-2-yl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1S2)=CC=C1N=C2NC(=O)CC1=CC=CC=C1 YZENPKZLUFXKQO-UHFFFAOYSA-N 0.000 description 1
- QZPBUTQWTXIZBI-UHFFFAOYSA-N n-[6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-1,3-benzothiazol-2-yl]-2-[3-(trifluoromethyl)phenyl]acetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2NC(=O)CC1=CC=CC(C(F)(F)F)=C1 QZPBUTQWTXIZBI-UHFFFAOYSA-N 0.000 description 1
- GMUOUSWMBPIKKN-UHFFFAOYSA-N n-[6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-1,3-benzothiazol-2-yl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2NC(=O)CC1=CC=CC=C1 GMUOUSWMBPIKKN-UHFFFAOYSA-N 0.000 description 1
- YUHXUQHYLRJVGH-UHFFFAOYSA-N n-[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1)=CC=C1NC(=O)CC1=CC=CC=C1 YUHXUQHYLRJVGH-UHFFFAOYSA-N 0.000 description 1
- ZTBPIFOODBSHSC-UHFFFAOYSA-N n-[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-4-phenylbutanamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1)=CC=C1NC(=O)CCCC1=CC=CC=C1 ZTBPIFOODBSHSC-UHFFFAOYSA-N 0.000 description 1
- IMKFRXAZXQVUGC-UHFFFAOYSA-N n-[[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-methylcarbamothioyl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C)C(=S)NC(=O)CC1=CC=CC=C1 IMKFRXAZXQVUGC-UHFFFAOYSA-N 0.000 description 1
- IENFVEIDSNCJNT-UHFFFAOYSA-N n-[[4-[(6,7-dimethoxyquinolin-4-yl)amino]phenyl]carbamothioyl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1NC(C=C1)=CC=C1NC(=S)NC(=O)CC1=CC=CC=C1 IENFVEIDSNCJNT-UHFFFAOYSA-N 0.000 description 1
- DISNXOWVAZSHEX-KRWDZBQOSA-N n-benzyl-3-[(2s)-4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-2-methylpiperazin-1-yl]-4-methylbenzamide Chemical compound C([C@@H]1C)N(C=2C=3C(Br)=NNC=3N=CN=2)CCN1C(C(=CC=1)C)=CC=1C(=O)NCC1=CC=CC=C1 DISNXOWVAZSHEX-KRWDZBQOSA-N 0.000 description 1
- VDYBDRMRZBRUNP-UHFFFAOYSA-N n-benzyl-4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoro-n-methylbenzenesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1S(=O)(=O)N(C)CC1=CC=CC=C1 VDYBDRMRZBRUNP-UHFFFAOYSA-N 0.000 description 1
- RLISRDRNWILGLD-UHFFFAOYSA-N n-benzyl-4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorobenzenesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1S(=O)(=O)NCC1=CC=CC=C1 RLISRDRNWILGLD-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 201000008026 nephroblastoma Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229940029345 neupogen Drugs 0.000 description 1
- 208000007538 neurilemmoma Diseases 0.000 description 1
- 201000004662 neurofibroma of spinal cord Diseases 0.000 description 1
- 208000004649 neutrophil actin dysfunction Diseases 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- 125000005060 octahydroindolyl group Chemical group N1(CCC2CCCCC12)* 0.000 description 1
- 125000005061 octahydroisoindolyl group Chemical group C1(NCC2CCCCC12)* 0.000 description 1
- 229960002700 octreotide Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 208000003388 osteoid osteoma Diseases 0.000 description 1
- 208000008798 osteoma Diseases 0.000 description 1
- 229940127084 other anti-cancer agent Drugs 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000005968 oxazolinyl group Chemical group 0.000 description 1
- 125000005476 oxopyrrolidinyl group Chemical group 0.000 description 1
- 239000001301 oxygen Chemical group 0.000 description 1
- WRUUGTRCQOWXEG-UHFFFAOYSA-N pamidronate Chemical compound NCCC(O)(P(O)(O)=O)P(O)(O)=O WRUUGTRCQOWXEG-UHFFFAOYSA-N 0.000 description 1
- 229940046231 pamidronate Drugs 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229960005415 pasireotide Drugs 0.000 description 1
- 108700017947 pasireotide Proteins 0.000 description 1
- NEEFMPSSNFRRNC-HQUONIRXSA-N pasireotide aspartate Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CC(O)=O.C([C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@H](C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@H](C(N[C@@H](CC=2C=CC(OCC=3C=CC=CC=3)=CC=2)C(=O)N1)=O)CCCCN)C=1C=CC=CC=1)OC(=O)NCCN)C1=CC=CC=C1 NEEFMPSSNFRRNC-HQUONIRXSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940046159 pegylated liposomal doxorubicin Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 150000003911 phosphatidylinositol 4-phosphates Chemical class 0.000 description 1
- 125000005545 phthalimidyl group Chemical group 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 208000024724 pineal body neoplasm Diseases 0.000 description 1
- 201000004123 pineal gland cancer Diseases 0.000 description 1
- JSSXHAMIXJGYCS-UHFFFAOYSA-N piperazin-4-ium-2-carboxylate Chemical compound OC(=O)C1CNCCN1 JSSXHAMIXJGYCS-UHFFFAOYSA-N 0.000 description 1
- RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 description 1
- BRYCUMKDWMEGMK-UHFFFAOYSA-N piperazine-2-carboxamide Chemical compound NC(=O)C1CNCCN1 BRYCUMKDWMEGMK-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229940063179 platinol Drugs 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 150000003140 primary amides Chemical class 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 229940063222 provera Drugs 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004353 pyrazol-1-yl group Chemical group [H]C1=NN(*)C([H])=C1[H] 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical compound NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 description 1
- 125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
- 238000009803 radical hysterectomy Methods 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 229960004432 raltitrexed Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 208000029922 reticulum cell sarcoma Diseases 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 108010038379 sargramostim Proteins 0.000 description 1
- 206010039667 schwannoma Diseases 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000004548 serous cystadenocarcinoma Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000002719 stereotactic radiosurgery Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940061353 temodar Drugs 0.000 description 1
- NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 description 1
- 229960001278 teniposide Drugs 0.000 description 1
- 208000001608 teratocarcinoma Diseases 0.000 description 1
- QFEUXSBOVSOXOY-UHFFFAOYSA-N tert-butyl 2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholine-4-carboxylate Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)OC(C)(C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QFEUXSBOVSOXOY-UHFFFAOYSA-N 0.000 description 1
- SLLUOPOEOBQREW-UHFFFAOYSA-N tert-butyl n-benzyl-n-[2-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoroanilino]-2-oxoethyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)CN(C(=O)OC(C)(C)C)CC1=CC=CC=C1 SLLUOPOEOBQREW-UHFFFAOYSA-N 0.000 description 1
- PWGVSIWIAVUFHH-UHFFFAOYSA-N tert-butyl n-benzyl-n-[2-[[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]amino]-2-oxoethyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1NC(=O)CN(C(=O)OC(C)(C)C)CC1=CC=CC=C1 PWGVSIWIAVUFHH-UHFFFAOYSA-N 0.000 description 1
- GQYUKDJBUGAKLD-UHFFFAOYSA-N tert-butyl n-benzyl-n-[2-[[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]amino]-2-oxoethyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1)=CC=C1NC(=O)CN(C(=O)OC(C)(C)C)CC1=CC=CC=C1 GQYUKDJBUGAKLD-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- LAWUZBKFMNSOGG-UHFFFAOYSA-N thiophene-2-carbonitrile Chemical compound N#CC1=CC=[C]S1 LAWUZBKFMNSOGG-UHFFFAOYSA-N 0.000 description 1
- 229960001196 thiotepa Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 206010044412 transitional cell carcinoma Diseases 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 229940086542 triethylamine Drugs 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 208000022271 tubular adenoma Diseases 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229960001055 uracil mustard Drugs 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000028973 vesicle-mediated transport Effects 0.000 description 1
- 208000009540 villous adenoma Diseases 0.000 description 1
- UGGWPQSBPIFKDZ-KOTLKJBCSA-N vindesine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 UGGWPQSBPIFKDZ-KOTLKJBCSA-N 0.000 description 1
- 229960004355 vindesine Drugs 0.000 description 1
- NMDYYWFGPIMTKO-HBVLKOHWSA-N vinflunine Chemical compound C([C@@](C1=C(C2=CC=CC=C2N1)C1)(C2=C(OC)C=C3N(C)[C@@H]4[C@@]5(C3=C2)CCN2CC=C[C@]([C@@H]52)([C@H]([C@]4(O)C(=O)OC)OC(C)=O)CC)C(=O)OC)[C@H]2C[C@@H](C(C)(F)F)CN1C2 NMDYYWFGPIMTKO-HBVLKOHWSA-N 0.000 description 1
- 229960000922 vinflunine Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 description 1
- 229960004276 zoledronic acid Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92289907P | 2007-04-10 | 2007-04-10 | |
| US60/922,899 | 2007-04-10 | ||
| PCT/US2008/004573 WO2008124161A1 (fr) | 2007-04-10 | 2008-04-09 | Méthodes de traitement du cancer à l'aide d'inhibiteurs de pi3k alpha à base de pyridopyrimidinone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2683641A1 true CA2683641A1 (fr) | 2008-10-16 |
| CA2683641C CA2683641C (fr) | 2016-08-16 |
Family
ID=39627802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2683641A Expired - Fee Related CA2683641C (fr) | 2007-04-10 | 2008-04-09 | Methodes de traitement du cancer a l'aide d'inhibiteurs de pi3k alpha a base de pyridopyrimidinone |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US8513266B2 (fr) |
| EP (1) | EP2139484B9 (fr) |
| JP (3) | JP2010523670A (fr) |
| KR (1) | KR101626435B1 (fr) |
| CN (2) | CN102727498B (fr) |
| AU (1) | AU2008236562B2 (fr) |
| BR (1) | BRPI0810206A2 (fr) |
| CA (1) | CA2683641C (fr) |
| CO (1) | CO6251254A2 (fr) |
| CR (1) | CR11100A (fr) |
| DK (1) | DK2139484T3 (fr) |
| DO (1) | DOP2009000243A (fr) |
| EA (1) | EA020022B1 (fr) |
| EC (1) | ECSP099724A (fr) |
| ES (1) | ES2430614T3 (fr) |
| HK (1) | HK1139863A1 (fr) |
| HN (1) | HN2009003002A (fr) |
| HR (1) | HRP20130688T1 (fr) |
| IL (1) | IL201284A (fr) |
| MA (1) | MA31358B1 (fr) |
| ME (1) | ME00936B (fr) |
| MX (1) | MX2009010930A (fr) |
| MY (1) | MY150697A (fr) |
| NZ (1) | NZ580110A (fr) |
| PL (1) | PL2139484T3 (fr) |
| PT (1) | PT2139484E (fr) |
| RS (1) | RS52939B (fr) |
| SI (1) | SI2139484T1 (fr) |
| TN (1) | TN2009000400A1 (fr) |
| UA (1) | UA100979C2 (fr) |
| WO (1) | WO2008124161A1 (fr) |
| ZA (1) | ZA200906764B (fr) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200726767A (en) * | 2005-07-04 | 2007-07-16 | Astrazeneca Ab | Chemical compounds 2 |
| KR101538412B1 (ko) * | 2005-10-07 | 2015-07-22 | 엑셀리시스, 인코포레이티드 | ＰＩ３Ｋα의 피리도피리미디논 억제제 |
| KR101396783B1 (ko) * | 2005-10-07 | 2014-05-21 | 엑셀리시스, 인코포레이티드 | 포스파티딜이노시톨 3-키나아제 억제제 및 이의 사용 방법 |
| JP2010500994A (ja) | 2006-08-16 | 2010-01-14 | エグゼリクシス， インコーポレイテッド | Ｐｉ３ｋおよびｍｅｋモジュレーターを使用する方法 |
| US8188113B2 (en) * | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| SA08280783B1 (ar) * | 2007-01-11 | 2011-04-24 | استرازينيكا ايه بي | مشتقات بيريدوبيريميدين كمثبطات pde4 |
| JP2010523670A (ja) | 2007-04-10 | 2010-07-15 | エクセリクシス， インク． | Ｐｉ３ｋアルファのピリドピリミジノン阻害剤を使用した治療方法 |
| MY150797A (en) * | 2007-04-11 | 2014-02-28 | Exelixis Inc | Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer |
| AU2009282567B2 (en) | 2008-08-20 | 2014-10-02 | Merck Sharp & Dohme Corp. | Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| TW201019939A (en) | 2008-08-20 | 2010-06-01 | Schering Corp | Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| AU2009282574B2 (en) * | 2008-08-20 | 2014-08-21 | Merck Sharp & Dohme Corp. | Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| AU2009282571B2 (en) | 2008-08-20 | 2014-12-11 | Merck Sharp & Dohme Corp. | Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| TW201139436A (en) | 2010-02-09 | 2011-11-16 | Exelixis Inc | Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K and mTOR in combination with autophagy inhibitors |
| US20130156768A1 (en) * | 2010-08-26 | 2013-06-20 | Bristol-Myers Squibb Company | Combination of anti-ctla4 antibody with braf inhibitors for the synergistic treatment of proliferative diseases |
| US9670212B2 (en) | 2010-09-14 | 2017-06-06 | Exelixis, Inc. | Inhibitors of PI3K-delta and methods of their use and manufacture |
| WO2012065019A2 (fr) | 2010-11-12 | 2012-05-18 | Exelixis, Inc. | Inhibiteurs pyridopyrimidinone de p13k alpha |
| WO2012158960A2 (fr) * | 2011-05-17 | 2012-11-22 | H. Lee Moffitt Cancer Center & Research Institute, Inc. | Ligands du récepteur à la mélanocortine de type 1 et leurs procédés d'utilisation |
| TW201306842A (zh) * | 2011-06-15 | 2013-02-16 | Exelixis Inc | 使用ｐｉ３ｋ／ｍｔｏｒ吡啶並嘧啶酮抑制劑及苯達莫司汀及／或利妥昔單抗治療惡性血液疾病之組合療法 |
| RU2014107713A (ru) * | 2011-07-28 | 2015-09-10 | Дженентек, Инк | Модель рака молочной железы у животных, кроме человека, с активируемым pik3ca h1047r |
| WO2013056067A1 (fr) * | 2011-10-13 | 2013-04-18 | Exelixis, Inc. | Composés pour une utilisation dans le traitement de carcinome des cellules basales |
| SG11201401961UA (en) | 2011-11-01 | 2014-05-29 | Exelixis Inc | N- (3- { [ (3- { [2-chloro-5- (methoxy) phenyl] amino} quinoxalin- 2 -yl) amino] sulfonyl} phe nyl) - 2 -methylalaninamide as phosphatidylinositol 3 - kinase inhibitor for the treatment of lymphoproliferative malignancies |
| US9682141B2 (en) | 2011-11-11 | 2017-06-20 | Intellikine Llc | Combination of kinase inhibitors and uses thereof |
| WO2013101964A1 (fr) * | 2011-12-27 | 2013-07-04 | Kadmon Corporation, Llc | Procédés de traitement d'un cancer du sein ne répondant pas au trastuzumab |
| US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| SG10201805807PA (en) | 2012-06-26 | 2018-08-30 | Del Mar Pharmaceuticals | Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof |
| US8980259B2 (en) * | 2012-07-20 | 2015-03-17 | Novartis Ag | Combination therapy |
| LT2882440T (lt) | 2012-08-07 | 2019-04-25 | Novartis Ag | Farmaciniai deriniai, apimantys b-raf slopiklį, egfr slopiklį ir nebūtinai pi3k-alfa slopiklį |
| KR20160061911A (ko) | 2013-04-08 | 2016-06-01 | 데니스 엠. 브라운 | 최적하 투여된 화학 화합물의 치료 효과 |
| US9950194B2 (en) | 2014-09-09 | 2018-04-24 | Mevion Medical Systems, Inc. | Patient positioning system |
| TWI782906B (zh) | 2016-03-04 | 2022-11-11 | 日商大鵬藥品工業股份有限公司 | 惡性腫瘤治療用製劑及組合物 |
| US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
| MD3497103T2 (ro) * | 2016-08-15 | 2021-08-31 | Pfizer | Inhibitori de piridopirimidinonă CDK2/4/6 |
| JP7027699B2 (ja) * | 2017-05-09 | 2022-03-02 | 住友ゴム工業株式会社 | タイヤトレッドおよびタイヤ |
| CA3089566A1 (fr) | 2018-01-31 | 2019-08-08 | Deciphera Pharmaceuticals, Llc | Polytherapie pour le traitement de tumeurs stromales gastro-intestinales |
| WO2019181876A1 (fr) | 2018-03-19 | 2019-09-26 | 大鵬薬品工業株式会社 | Composition pharmaceutique comprenant du sulfate d'alkyle de sodium |
| CN114615982A (zh) | 2019-08-12 | 2022-06-10 | 德西费拉制药有限责任公司 | 用于治疗胃肠道间质瘤的瑞普替尼 |
| WO2021030405A1 (fr) | 2019-08-12 | 2021-02-18 | Deciphera Pharmaceuticals, Llc | Ripretinib pour le traitement de tumeurs stromales gastro-intestinales |
| WO2021119242A1 (fr) * | 2019-12-10 | 2021-06-17 | The Trustees Of Indiana University | Inhibiteurs de l'interaction protéine a de réplication (rpa)-adn |
| LT4084778T (lt) | 2019-12-30 | 2024-01-25 | Deciphera Pharmaceuticals, Llc | Amorfinės kinazės inhibitoriaus vaistinės formos ir jų panaudojimo būdai |
| CN115243681A (zh) | 2019-12-30 | 2022-10-25 | 德西费拉制药有限责任公司 | 1-(4-溴-5-(1-乙基-7-(甲氨基)-2-侧氧基-1,2-二氢-1,6-萘啶-3-基)-2-氟苯基)-3-苯基脲的组合物 |
| KR102195221B1 (ko) | 2019-12-31 | 2020-12-24 | 서울대학교산학협력단 | 포스파티딜이노시톨 3-키나아제 억제제 및 프로그램화 세포 사멸 단백질 1 억제제를 포함하는, 삼중음성 유방암의 방사선 병용 치료용 약학적 조성물 |
| CN111358952B (zh) * | 2020-04-15 | 2022-03-15 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种抗肿瘤药物组合物及其制剂和应用 |
| WO2023092104A1 (fr) * | 2021-11-18 | 2023-05-25 | Onconova Therapeutics, Inc. | Méthodes et compositions pour traitement du cancer |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7019002B2 (en) * | 2001-12-11 | 2006-03-28 | Pharmacia & Upjohn, S.P.A. | Pyridopyrimidinones derivatives as telomerase inhibitors |
| CA2491191C (fr) * | 2002-07-15 | 2014-02-04 | Exelixis, Inc. | Modulateurs de kinase de type recepteur et procedes d'utilisation |
| CA2555724A1 (fr) * | 2004-02-18 | 2005-09-09 | Warner-Lambert Company Llc | 2-(pyridin-3-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| JP2007536370A (ja) * | 2004-05-04 | 2007-12-13 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 療法薬としてのピロリル置換ピリド［２，３−ｄ］ピリミジン−７−オンおよびその誘導体 |
| WO2007004698A1 (fr) * | 2005-07-06 | 2007-01-11 | Sbc Corporation | Dispositif et procédé de détection de courant de fuite |
| KR101396783B1 (ko) * | 2005-10-07 | 2014-05-21 | 엑셀리시스, 인코포레이티드 | 포스파티딜이노시톨 3-키나아제 억제제 및 이의 사용 방법 |
| CN102746298A (zh) | 2005-10-07 | 2012-10-24 | 埃克塞里艾克西斯公司 | PI3Kα的吡啶并嘧啶酮抑制剂 |
| KR101538412B1 (ko) * | 2005-10-07 | 2015-07-22 | 엑셀리시스, 인코포레이티드 | ＰＩ３Ｋα의 피리도피리미디논 억제제 |
| JP2010500994A (ja) | 2006-08-16 | 2010-01-14 | エグゼリクシス， インコーポレイテッド | Ｐｉ３ｋおよびｍｅｋモジュレーターを使用する方法 |
| WO2008032162A1 (fr) * | 2006-09-15 | 2008-03-20 | Pfizer Products Inc. | Composés de pyrido (2, 3-d) pyrimidin0ne et leur utilisation en tant qu'inhibiteurs de pi3 |
| JP2010523670A (ja) | 2007-04-10 | 2010-07-15 | エクセリクシス， インク． | Ｐｉ３ｋアルファのピリドピリミジノン阻害剤を使用した治療方法 |
| EA018964B1 (ru) | 2007-04-11 | 2013-12-30 | Экселиксис, Инк. | СОЕДИНЕНИЯ ПИРИДО[2,3-d]ПИРИМИДИН-7-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3K-АЛЬФА ДЛЯ ЛЕЧЕНИЯ РАКА |
| MY150797A (en) * | 2007-04-11 | 2014-02-28 | Exelixis Inc | Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer |
| EP2142543B8 (fr) | 2007-04-11 | 2013-07-03 | Exelixis, Inc. | Composés pyrido [2, 3-d]pyrimidin-7-one utilisés en tant qu'inhibiteurs de pi3k-alpha pour le traitement du cancer |
| AR073524A1 (es) * | 2008-09-30 | 2010-11-10 | Exelixis Inc | Piridopirimidinonas inhibidores de pi3k a y m tor |
-
2008
- 2008-04-09 JP JP2010503045A patent/JP2010523670A/ja active Pending
- 2008-04-09 MY MYPI20094214 patent/MY150697A/en unknown
- 2008-04-09 DK DK08742677.1T patent/DK2139484T3/da active
- 2008-04-09 WO PCT/US2008/004573 patent/WO2008124161A1/fr active Application Filing
- 2008-04-09 EP EP08742677.1A patent/EP2139484B9/fr active Active
- 2008-04-09 RS RS20130384A patent/RS52939B/en unknown
- 2008-04-09 BR BRPI0810206-6A2A patent/BRPI0810206A2/pt not_active IP Right Cessation
- 2008-04-09 ME MEP-2009-303A patent/ME00936B/fr unknown
- 2008-04-09 KR KR1020097023351A patent/KR101626435B1/ko active IP Right Grant
- 2008-04-09 PL PL08742677T patent/PL2139484T3/pl unknown
- 2008-04-09 CN CN201210032620.4A patent/CN102727498B/zh not_active Expired - Fee Related
- 2008-04-09 UA UAA200911419A patent/UA100979C2/ru unknown
- 2008-04-09 AU AU2008236562A patent/AU2008236562B2/en not_active Ceased
- 2008-04-09 CA CA2683641A patent/CA2683641C/fr not_active Expired - Fee Related
- 2008-04-09 MX MX2009010930A patent/MX2009010930A/es active IP Right Grant
- 2008-04-09 SI SI200831004T patent/SI2139484T1/sl unknown
- 2008-04-09 NZ NZ580110A patent/NZ580110A/en not_active IP Right Cessation
- 2008-04-09 CN CN200880018725A patent/CN101715345A/zh active Pending
- 2008-04-09 PT PT87426771T patent/PT2139484E/pt unknown
- 2008-04-09 EA EA200970932A patent/EA020022B1/ru not_active IP Right Cessation
- 2008-04-09 US US12/595,219 patent/US8513266B2/en active Active
- 2008-04-09 ES ES08742677T patent/ES2430614T3/es active Active
-
2009
- 2009-09-29 ZA ZA200906764A patent/ZA200906764B/xx unknown
- 2009-09-30 TN TNP2009000400A patent/TN2009000400A1/fr unknown
- 2009-10-01 IL IL201284A patent/IL201284A/en active IP Right Grant
- 2009-10-09 HN HN2009003002A patent/HN2009003002A/es unknown
- 2009-10-09 DO DO2009000243A patent/DOP2009000243A/es unknown
- 2009-11-02 MA MA32318A patent/MA31358B1/fr unknown
- 2009-11-09 EC EC2009009724A patent/ECSP099724A/es unknown
- 2009-11-09 CR CR11100A patent/CR11100A/es unknown
- 2009-11-09 CO CO09126924A patent/CO6251254A2/es not_active Application Discontinuation
-
2010
- 2010-07-05 HK HK10106503.5A patent/HK1139863A1/xx not_active IP Right Cessation
-
2013
- 2013-07-22 HR HRP20130688AT patent/HRP20130688T1/hr unknown
- 2013-09-19 JP JP2013194611A patent/JP2014034576A/ja active Pending
-
2014
- 2014-03-24 JP JP2014059561A patent/JP2014139217A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008236562B2 (en) | Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha | |
| AU2008239668B2 (en) | Combination therapies comprising quinoxaline inhibitors of PI3K-alpha for use in the treatment of cancer | |
| CA2671982C (fr) | Procedes d'utilisation d'inhibiteurs de mek | |
| AU2008239596B2 (en) | Pyrido [2,3-D] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer | |
| EP2142543B1 (fr) | Composés pyrido [2, 3-d]pyrimidin-7-one utilisés en tant qu'inhibiteurs de pi3k-alpha pour le traitement du cancer | |
| TW201529071A (zh) | 癌症治療組合療法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20130318 |
|
| MKLA | Lapsed |
Effective date: 20210409 |